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Abstract 
Rift Valley fever phlebovirus (RVFV) is an arbovirus of medical and veterinary importance 
causing severe disease and mortality in humans and ruminants in endemic regions in Africa and 
the Arabian Peninsula. Understanding the capability, and limiting factors, of temperate British 
mosquitoes to support replication and transmission of RVFV is critical in order to understand the 
potential for RVFV establishment were it introduced to the UK. 
 Using in vitro cell culture the effect of temperature on viral replication kinetics 
independently of the mosquito was investigated; demonstrating temperatures below 20˚C 
negatively affect RVFV replication. The full replication cycle was supported at 20˚C in vitro, and 
this was confirmed within in vivo mosquito experiments with wild-caught Aedes detritus 
demonstrating a transmission potential for RVFV at 20˚C and 25˚C. Experiments with two 
colonised lines of Cx. pipiens further demonstrated the transmission potential for RVFV by 
mosquitoes present in the UK. A novel RNA in situ hybridisation technique substantiated this 
result showing widespread dissemination of virus from the primary site of infection and 
evidence of secondary sites of replication within a single mosquito. 
Characterisation of the consensus sequence of RVFV propagated within these British 
mosquitoes in comparison to an in vivo mouse model showed potential for virus adaptation 
when switching between disparate hosts. Reproducible changes at the consensus level within 
each host had not previously been shown in early passages of RVFV in studies utilising in vitro 
models of replication. This suggests that RVFV replication generates genomic variation that may 
lead to adaptations that could promote potential survival in temperate regions. 
Taken together these findings indicate that transmission of RVFV within the UK by 
indigenous mosquitoes is possible. However, factors affecting mosquito survival including 
temperatures greater than 20˚C and ingestion of the higher virus dose (107 PFU/mL) will limit 
the likelihood of such events occurring. 
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1 Introduction 
1.1 Rift Valley fever virus 
1.1.1 Pathogenicity and control 
Rift Valley fever phlebovirus (RVFV: Bunyavirales; Phenuiviridae; Phlebovirus) is the 
causative agent of Rift Valley fever (RVF) a disease of veterinary and human health importance, 
transmitted primarily by mosquitoes (Daubney et al., 1931; Hoogstraal et al., 1979). Severity and 
mortality rates in vertebrates are influenced by age and species. A distinctive feature is the 
widespread simultaneous abortions in ruminants described as ‘abortion storms’ (Daubney et al., 
1931). Common signs are fever, weakness, lethargy and anorexia (Bird et al., 2009). Hepatic 
lesions of necrotic foci in fatal cases are similarly reported in all susceptible species (Coetzer, 
1982; Daubney et al., 1931). Sheep are most susceptible with rapidly amplifying virus causing 
fatality in ≤95% of lambs within 24 hours of onset, 5-30% in adults and near 100% abortion rates 
(Daubney et al., 1931). Cattle, goats, camels and buffalo are susceptible but the disease is 
typically less severe, with lower mortality rates (EFSA, 2005). 
In addition to transmission by mosquito bite, humans are infected by aerosol or 
percutaneous routes causing occupational hazards for veterinarians, abattoir workers and 
farmers working closely with infected animals and handling aborted foetuses (van Velden et al., 
1977). The shift in concern for RVFV as a human health threat was triggered by the first reports 
of human fatalities attributed to RVF in 1975 (van Velden et al., 1977). This was substantiated by 
an outbreak of unprecedented size and severity in Egypt in 1977, with an estimated 200,000 
human cases and 594 recorded fatalities (Meegan, 1979). Five distinct manifestations in man 
were observed including asymptomatic infections, febrile illness, ocular, or neurological 
complications to haemorrhagic fever (Laughlin et al., 1979). After a two to six day incubation 
period symptoms include; headache, malaise, myalgia, arthralgia, diarrhoea and vomiting, 
typically resolving within two weeks with no lasting sequalae. Ocular complications are 
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estimated to occur in 1% of cases, these symptoms range from blurred vision to ocular lesions 
developing after 1-4 weeks, and result in permanent vision loss in half those affected. 
Encephalitis occurs in less than 1% of cases, although rarely fatal, the symptoms can be long 
lasting. Haemorrhagic fever develops in less than 1%, the sudden onset of symptoms include 
jaundice indicative of hepatic involvement and haemorrhage, and is fatal in 50% of cases. 
Increased rates of abortion has been linked with pregnant women infected with RVFV although 
data are limited due to few studies investigating human populations (Baudin et al., 2016). 
Despite severity there is no licensed vaccine to protect humans but there are three for 
animal use in endemic regions each with limitations (Reviewed by Mansfield et al., 2015). Two 
are attenuated live vaccines (Smithburn strain and Clone 13) and are limited by their potential 
for reversion or reassortment events, with reported abortions in cattle post-vaccination (Botros 
et al., 2006). The alternative formalin inactivated vaccine removes these risks but is limited by 
the logistically challenging and resource prohibitive requirement for booster vaccination. 
Surveillance coupled with preventative measures such as eliminating mosquito breeding sites or 
restricting animal movements are therefore essential for disease control. 
Outbreaks are usually identified after the occurrence of human cases of disease (OIE, 
2017). Characteristic abortion storms also indicate the presence of RVFV although the higher 
proportion of asymptomatic cases in adult ruminants impedes identification outside of the 
lambing season. Laboratory confirmation is required for a differential diagnosis of nonspecific 
disease manifestations. In humans these include: dengue fever; malaria; Lassa fever; and 
brucellosis. In animals these include: bluetongue and Nairobi sheep disease. The detection of 
IgM and IgG antibodies in paired sera samples by ELISA is the most widely used technique 
(Madani et al., 2003; OIE, 2017; “Rift Valley Fever (RVF) Outbreak, South Sudan,” 2018). Virus 
can be detected during early stages of disease but should be performed in appropriate 
biosecurity facilities. These include isolation in suckling mice or in vitro cell culture but most 
Introduction 
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commonly virus is inactivated followed by extraction and molecular detection of viral nucleic 
acids (Jupp et al., 2000; Njenga et al., 2009; Sall et al., 2002). 
 
1.1.2 Genome structure 
RVFV has a single-stranded RNA genome arranged in a tri-segmented assembly shown in 
Figure 1.1A (Knipe and Howley, 2013). The terminal eight nucleotides of each segment are 
highly conserved amongst phleboviruses and are complementary, resulting in the formation of a 
pan-handle loop visible as circularised structures by electron microscopy (EM) (Figure 1.1A) 
(Ikegami et al., 2007; Pettersson and von Bonsdorff, 1975). 
The small (S) segment is ambisense encoding the nucleoprotein (N) in the negative sense 
and the non-structural protein (NSs) in the positive sense. Segments are individually 
encapsidated within the virion by N, forming a ribonucleocapsid (RNP) complex that protects 
the RNA from degradation by RNases (Raymond et al., 2010). Like all negative sense genomes, 
non-encapsidated RNA cannot be transcribed so the RNP, in association with the viral 
polymerase, is essential for replication and transcription. The NSs is a major virulence factor 
involved in evasion of the host immune system by antagonising antiviral pathways (Brennan et 
al., 2014). Whilst non-essential for replication in cell culture, its absence in vivo results in 
attenuation, for example the naturally attenuated vaccine strain Clone 13 has a 600bp knock-
out within the NSs coding region (Muller et al., 1995). 
The negative sense medium (M) segment encodes two non-structural proteins, NSm1 
(78kDa) and NSm2 (14kDa), and two structural envelope glycoproteins, Gn and Gc (Collett et al., 
1985; Gerrard and Nichol, 2007). The proteins synthesised are determined by which of the five 
in-frame start codons are utilised for translation initiation (Figure 1.1.C). NSm1 is a large NSm-
Gn fusion protein translated together with Gc from the first start codon. A full length protein 
containing NSm2, Gn and Gc is translated from the second start codon, and Gc and Gn are 
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translated from the fourth and fifth start codon (Gerrard and Nichol, 2007; Kreher et al., 2014). 
Although conserved the role of the third start codon is not known. These polyprotein precursors 
(GPc) are then co-translationally cleaved to produce the individual proteins. 
 
 
Figure 1.1 Schematic of the virion and coding strategy of Rift Valley fever phlebovirus. A. 
Phlebovirus virion (Obtained from ViralZone, 2017). B. The coding strategy of the RVFV small (S), 
medium (M) and large (L) segments. Coloured boxes represent the seven proteins with the 
molecular weight in kilodaltons (kDa). The intergenic region of the S segment is depicted in red. 
Arrows indicate the direction of transcription, with the flanking lines representing the untranslated 
terminal sequences. C. Boxes represent the polyprotein precursors expressed from each start codon 
(methionine); different colours represent the proteins that are post-translationally cleaved. 
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Though poorly characterised, the lack of an NSm homologue in tick-borne phleboviruses, such 
as Uukeniemi virus (UUKV) is suggestive of a mosquito specific function. Furthermore whilst the 
non-structural proteins are dispensable for in vitro replication demonstrated by mutants lacking 
both NSm proteins remaining stable and infectious in mammalian cells (Gerrard et al., 2007), 
these mutants were attenuated in mosquitoes (Crabtree et al., 2012). Similarly mutants lacking 
NSm1 produce reduced titres and dissemination in mosquitoes but have no reduced virulence in 
mice (Kreher et al., 2014). Taken together these observations suggest an essential role for NSm 
in the mosquito host, further supported by the observation of the full length NSm1 (78kDa) 
protein incorporated into the membranes of virions propagated in mosquito but not in 
mammalian cell lines (Weingartl et al., 2014c). 
The negative sense large (L) segment encodes the RNA-dependent RNA polymerase 
(RdRp) (L protein) responsible for both replication and transcription in association with the RNP 
(Lopez et al., 1995). The structure and the sequence of the 3’ and 5’ termini, within the 
untranslated regions (UTRs), of each segment act as promotors initiating and regulating 
transcription and replication occurring within the cytoplasm. 
 
1.1.3 Replication cycle 
Replication begins with attachment and entry of the virion, mediated by the glycoproteins 
and host cell receptors. Once endocytosed, viral uncoating is prompted by low pH, followed by 
primary transcription and translation within the cytoplasm. Replication and transcription occur 
in the cytoplasm (Brennan et al., 2011a) with assembly within the membranes of the Golgi 
complex culminating in viral budding into the Golgi cisternae. The glycoproteins are 
incorporated into the host cell derived lipid bilayer envelope, projecting as spikes. These spiked, 
spherical progeny virions, 80-120nm in diameter, are released into the extracellular space when 
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the Golgi derived vesicles fuse with the plasma membrane (Elliott and Schmaljohn, 2013) (Figure 
1.2). 
 
 
Figure 1.2 Bunyavirus replication cycle. (Obtained from Knipe and Howley, 2013). 
 
1.1.4 RVFV transmission cycle  
1.1.4.1 Epidemic/epizootic cycle 
RVFV is maintained in a transmission cycle between its arthropod vector and mammalian 
hosts shown in Figure 1.3. Humans are generally considered a dead-end host with minimal 
involvement in viral amplification (Chevalier et al., 2010). The role of humans in the epidemic 
life cycle has not been comprehensively resolved (Bird et al., 2009) but with natural viraemia in 
humans (typically reported on day 3 post onset of symptoms) ranging between 101-108 PFU/mL 
it could be postulated that onward transmission to mosquitoes may be supported (Meegan, 
1979; Njenga et al., 2009). With high viral loads correlating significantly with high morbidity and  
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Figure 1.3 Transmission cycle of Rift Valley fever phlebovirus. Arrows represent transmission 
direction. Solid lines represent established routes supported by experimental data and dotted lines 
suspected routes but current data is insufficient to verify (Modified from: Chevalier et al., 2010). 
 
fatal outcomes (Njenga et al., 2009) it is feasible that hospitalisation of such cases removes 
them from the transmission cycle contributing to lack of reports of humans as amplifying hosts 
of RVFV. Peak RVFV viraemia in livestock are reported on day 3 post infection at 106-108 PFU/mL 
and a summary of viraemia reported in experimental infections of ruminants shown in Figure 
1.4. 
RVFV transmission is halted during periods of adverse conditions for the vector, such as 
drought or temperate seasons, resulting in insufficient vector activity to support horizontal 
transmission. 
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Figure 1.4 Mean viraemia profile of ruminants experimentally challenged with Rift Valley fever 
phlebovirus. Data were collated from 17 published articles; values represent the mean viraemia per 
study group. Data were pooled if experiments were performed on the same host, challenged by the 
same route of inoculation and with the same titre and strain of virus. TCID50 results have been 
standardised to plaque forming units by multiplying by 0.69. (Antonis et al., 2013; Bird et al., 2011; 
Busquets et al., 2014, 2010; Davies and Karstad, 1981; Faburay et al., 2016; Kortekaas et al., 2014, 
2012; Morrill et al., 1991; Nfon et al., 2012; Olaleye et al., 1996; Rippy et al., 1992; Schreur et al., 
2016; Weingartl et al., 2014a, 2014b; Wichgers Schreur et al., 2015; Wilson et al., 2016). 
 
1.1.4.2 Endemic/enzootic cycle 
The mechanism of RVFV maintenance during these long inter-epizootic periods, which can 
last for five to fifteen years (Davies et al., 1985), is not fully resolved and there are two main 
hypotheses postulated: 
The principal hypothesis for survival during inter-epizootics is by the passage of virus from 
infected female mosquitoes to their offspring via the egg, known as transovarial transmission 
(TOT) (Linthicum et al., 1985). Floodwater Aedes that become infected after feeding upon a 
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viraemic ruminant host are postulated to oviposit infected eggs in low lying grasslands 
predisposed to seasonal flooding, referred to locally as dambos in eastern and central Africa and 
pans or vleis in South Africa (Mäckel, 1973). The eggs, require desiccation as part of the Aedine 
mosquito lifecycle but remain viable for several years facilitating maintenance of the virus, and 
was demonstrated for 19 months with Californian encephalitis virus (CEV; Orthobunyavirus) 
(Turell et al., 1982). Furthermore, RVFV outbreaks are often associated with intense flooding 
(Anyamba et al., 2010; Davies et al., 1985) resulting in the emergence of huge numbers of 
mosquitoes of which a small percentage are thought to be infected. This hypothesis was 
supported by the isolation of RVFV in field-caught mosquitoes in Kenya occurring exclusively 
during periods of natural or artificial flooding (Linthicum et al., 1985). These mosquitoes then 
feed upon livestock in the local area passing the virus horizontally. Secondary amplifying vectors 
such as Culex spp. lay their eggs in rafts on the surface of the semi-permanent water reservoir 
created by the floods (Linthicum et al., 1984), superseding the Aedes spp., and intensifying 
transmission. The isolation of RVFV in adult male and female Ae. mcintoshi (originally reported 
as Ae. lineatopennis Huang, 1985) reared from field collected eggs (Linthicum et al., 1985) 
supports the TOT hypothesis for maintenance of RVFV but further support is limited to a single 
study observing RVFV antigen in the tissues and eggs of four infected Ae. mcintoshi by 
immunohistochemistry (IHC) (Romoser, 2011). Factors contributing to the limited experimental 
support of TOT has been reviewed comparing findings for RVFV with other mosquito-borne 
arboviruses by Lumley et al. (2017), including: the role of environmental conditions; inhibitory 
effects of testing pooled larvae; and temporal differences in both the development stage and 
ovarian cycle tested (Beaty and Thompson, 1976; Hardy et al., 1980; Ksiazek et al., 1985; Miller 
et al., 1979; Turell et al., 1986; Watts et al., 1973). 
The second hypothesis is that livestock can contribute to virus maintenance, causing 
localised outbreaks with a low incidence of infection to occur when conditions are favourable 
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and susceptible hosts available as demonstrated in Zimbabwe (Swanepoel, 1981) and Kenya 
(Lichoti et al., 2014). However, in the absence of longitudinal surveillance studies, low or sub-
clinical infection in humans and animals are likely missed. Further support for this hypothesis is 
offered by retrospective sequence analysis demonstrating multiple circulating lineages and 
genome evolution; each suggestive of a continued maintenance of virus within the region (Bird 
et al., 2008; Ikegami, 2012). A role for wildlife species as hosts has not been established, 
although mortality has been occasionally reported in buffalo, giraffe, waterbuck and springbok 
(Olive et al., 2012; Swanepoel et al., 2004). Whether a low level of continued virus circulation in 
Buffalo as demonstrated in areas of Kenya, Botswana and South Africa, is sufficient to maintain 
RVFV during inter-epizootic periods is yet to be determined (Beechler et al., 2015; Jori et al., 
2015; Lwande et al., 2015). The immune status of the population is thought to be key to driving 
new outbreaks; with inter-epizootics allowing the replenishment of susceptible immune naive 
hosts (Swanepoel, 1981). The scale of the epidemic in Egypt in 1977 was attributed to the lack of 
background immunity in the livestock population (Hoogstraal et al., 1979). 
The benefits of a mixed transmission mode supporting survival under a range of ecological 
conditions and pressures, makes it logical to postulate that arboviruses persist by both vertical 
and horizontal transmission strategies (Ebert, 2013). Manore and Beechler (2015) concluded 
RVFV maintenance exclusively by vertical transmission is ecologically improbable based on the 
mathematically predicted rates of occurrence. The likely involvement of a mammalian reservoir 
is further supported by the predicted low rates of occurrence (typically <0.1%) of vertical 
transmission reviewed for flaviviruses, alphaviruses, orthobunyaviruses and phleboviruses 
(Adams and Boots, 2010; Lequime and Lambrechts, 2014; Rosen, 1987). Whilst the theoretical 
ability for virus to overwinter within eggs in temperate regions until summer temperatures may 
support transmission offers a potential mechanism for survival in temperate environments, its 
evaluation falls outside of the remit of this thesis. Although there is considerable crossover in 
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the factors affecting horizontal and vertical transmission factors, subsequent review of the 
literature and knowledge are primarily focussed on horizontal transmission. 
 
1.1.5 Geographic distribution 
RVFV was first isolated in 1930 following the death of around 4,700 sheep on a farm in 
Kenya, with retrospective analysis of case reports suggesting its presence since the early 1900s 
(Daubney et al., 1931). This is supported by sequence analysis dating the most recent common 
ancestor (MRCA) to the 1880s (Bird et al., 2007; Grobbelaar et al., 2011). In the nine decades 
since its discovery RVFV has been detected across the African continent and spread into the 
Arabian Peninsula, highlighted in Figure 1.5, and major events in its subsequent spread and 
establishment in new regions are discussed. The next large outbreak followed in 1951 in South 
Africa causing an estimated 100,000 deaths and 500,000 abortions in sheep (reviewed by 
Pienaar and Thompson, 2013). The aforementioned RVF outbreak in Egypt 1977 presented a 
major milestone in the geographic expansion of a virus that had been previously confined to 
sub-Saharan Africa (Meegan, 1979). Virus was postulated to have been introduced by the 
importation of infected camels from the South, with the abundance of mosquito hosts, due to 
breeding grounds along the Nile delta, and susceptible immune naïve vertebrate hosts resulting 
in a large number of infections (Hoogstraal et al., 1979). The first isolation outside of continental 
Africa was from mosquitoes collected in Madagascar in 1979 (Fontenille, 1989), with the first 
epidemic in this area reported 11 years later linked to an unconnected importation event from 
the East African mainland (Carroll et al., 2011; Morvan et al., 1991). RVFV was introduced to 
West Africa in 1987 in Mauritania and Senegal causing an estimated 224 human fatalities (Jouan 
et al., 1988). It was detected outside of Africa for the first time in the Arabian Peninsula in 2000 
causing 683 confirmed human cases and 95 fatalities in Saudi Arabia (Madani et al., 2003), with 
sequence data suggesting East Africa as the origin of the virus (Shoemaker et al., 2002). This  
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Figure 1.5 Geographic distribution of Rift Valley fever phlebovirus. Major outbreaks are highlighted 
in red text (Adapted and updated from “RVF Distribution Map | Rift Valley Fever | CDC,” 2016). 
 
demonstrated the ability of this virus to cross geographic barriers and establish in previously 
non-endemic regions raising concerns for its introduction into Europe and the USA. Widespread 
geographic dispersal of the virus is supported by phylogenetic analysis with isolates from 
distinct geographic areas present in each of the identified lineages (Bird et al., 2007). The 
potential for RVFV to continue to spread into non-endemic regions is substantiated by recent 
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reports of detection of antibodies to RVFV in ruminants in Turkey and Iran (Fakour et al., 2017; 
Gür et al., 2017). 
Introduction of RVFV into Europe would have a severe impact on livestock and human 
health with devastating effects on the economy. The huge economic burden to the livestock 
industry as a direct result of animal losses and indirect loss due to imposed trade restrictions 
were estimated to cost US$115 million and US$90 million (at the time) in the Egyptian outbreak 
in 1977 and the Saudi Arabian outbreak in 2000 respectively (Al-Afaleq and Hussein, 2011; 
Shimshony, 1999). 
 
1.1.6 Arbovirus emergence 
The detection of West Nile virus (WNV; Flavivirus) in New York in 1999 leading to its 
subsequent spread across the USA (CDC, 1999; Petersen and Hayes, 2004); autochthonous cases 
of chikungunya virus (CHIKV; Alphavirus) (Calba et al., 2017; Grandadam et al., 2011) and 
dengue virus (DENV; Flavivirus) in France (La Ruche et al., 2010; Succo et al., 2016); and the 
recent spread of Zika virus (ZIKV; Flavivirus) to the Americas (Gatherer and Kohl, 2016) serve as 
a reminder of the ability of arboviruses to emerge in new geographic locations. The critical 
stages for pathogen emergence are; introduction, establishment and spread (Randolph and 
Rogers, 2010). 
There are a several potential routes for entry of RVFV into the UK including accidental 
(Gale et al., 2015) and intentional release (Rolin et al., 2013). These include the importation of: 
infected mosquitoes (assuming the ability to transmit vertically this can be importation of both 
juvenile and adult life stage); the legal or illegal importation of meat and meat products; or 
infected livestock and exotic animals. The latter are restricted by importation bans and strict 
trade routes, however, the associated risks of illegal trade cannot be determined. International 
travel poses a risk of importation in infected humans; with six confirmed imported cases in the 
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UK from endemic countries since 1979 (Beeching et al., 2010; European Centre for Disease and 
Control, 2014). The risk of RVFV importation into the UK is generally considered low, however, 
the data available are insufficient to identify the true risk (Gale et al., 2015; Rolin et al., 2013) 
and risk assessment of factors in the US suggest human travel poses the greatest threat for 
introduction (Golnar et al., 2017; Kasari et al., 2008). 
Once introduced, genetic mutation presents one mechanism that can facilitate viral 
establishment and spread and there are numerous examples of this for arboviruses in published 
literature. For example, the expansion of CHIKV was attributed to a single point mutation in the 
E1 envelope glycoprotein leading to increased transmission fitness by the more widely 
distributed Ae. albopictus vector; contributing in outbreaks within Asia, the Americas and 
Europe (Rezza et al., 2007; Tsetsarkin et al., 2007). Similarly Venezuelan equine encephalitis 
virus (VEEV; Alphavirus) emergence is supported by an amino acid substitution, also in the 
envelope glycoprotein, increasing Aedes spp. infection and transmission rates (Brault et al., 
2004). These mutations can become dominant within the population such as genotypic changes 
in WNV (characterised by three nucleotide substitutions) producing a competitive advantage 
within the mosquito host by reducing the time for virus to develop within the vector, 
contributing to the displacement of the circulating strain in New York (Davis et al., 2003; Ebel et 
al., 2004; Moudy et al., 2007). 
The presence of competent vectors and susceptible hosts are essential for onward 
transmission but must coincide with multiple favourable factors (Breiman et al., 2008), such as 
the proximity and abundance of both hosts, and temperatures that support viral replication and 
vector development. Understanding and assessing the risks of establishment are key for guiding 
control and surveillance activities in endemic and non-endemic countries (Chevalier et al., 2010; 
Rolin et al., 2013). The management of WNV in the US is now based around targeting Culex 
mosquitoes but it remains unknown as to whether earlier identification of this genus as the key 
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vector could have slowed the spread by implementing earlier targeted control programmes 
(Golnar et al., 2014). The risks of establishment of RVFV into North Africa (Arsevska et al., 2016), 
the Netherlands (E. A. Fischer et al., 2013) and Spain (Sánchez-Vizcaíno et al., 2013) have been 
reviewed and spatial-temporal hotspots for transmission identified. The conclusions of these 
studies collectively identify the need to determine competence in local vector species in order 
to accurately evaluate the risks. Any break in the transmission cycle could lead to potential 
localised cases of disease but would not support long-term maintenance. Therefore, in order to 
understand factors affecting survival of RVFV, should it be introduced to the UK, subsequent 
sections within this chapter focus upon the current knowledge of the transmission cycle and 
vector competence. 
 
1.2 Vector competence 
Vector competence is the ability of a vector to transmit an organism from one host to 
another. The sequential events shown in Figure 1.6. are: infection of the midgut, replication, 
dissemination to secondary tissues with further viral replication and transmission to a 
susceptible host (Franz et al., 2015; Hardy et al., 1983). In nature, vector competence is a single 
component of a complex relationship between a disease vector and its host, known as vectorial 
capacity. It accounts for interplay with temporal, environmental and behavioural traits such as 
vector density, lifespan, biting rate, flight distance and host feeding preferences (Eldridge and 
Edman, 2012). Consequently, studying competence is complex and reliant upon experimental 
design to control the magnitude of confounding factors. Knowledge of vector competence is 
based on data collected both in the laboratory and in nature. In non-endemic regions this relies 
solely on in vivo investigation of mosquitoes in the laboratory, the inherent advantages and 
limitations to the methods used are discussed in this section with examples of both RVFV and 
other arboviruses. 
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Figure 1.6 Schematic of the arbovirus migratory route through its mosquito vector. Blue circles 
represent virus; anatomical barriers that virus must transition are numbered; 1. Midgut infection 
barrier (MIB); 2. Midgut escape barrier (MEB); 3. Salivary gland infection barrier (SGIB); 4. Salivary 
gland escape barrier (SGEB) (Franz et al., 2015; Hardy et al., 1983). (Image obtained from Lumley et 
al., 2017). 
 
The principal benefit of laboratory studies of vector competence is the ability to 
manipulate individual variables whilst controlling others, allowing conclusions on cause and 
effect. There are, however, no standardised methods to determine vector competency and 
experimental variables include: inoculation routes and dose; preparation of virus stocks used to 
infect mosquitoes; engorgement status; sample size; and the use of populations of colonised or 
field-caught mosquitoes. This makes it challenging to decipher true variation in vector 
competency arising as a result of the specific interaction between the vector host and arbovirus 
which is often termed genotype x genotype (GxG) interactions (Hudson et al., 2016), compared 
to confounding variables due to the vast array of different experimental designs. Vogels et al. 
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(2017) proposed a number of recommendations in order to standardise both the experimental 
design and subsequent reporting of the competency data generated. In order to permit 
retrospective comparison of RVFV competency studies, Golnar et al. (2014) counteracted the 
dose variable by applying a corrective algorithm, predicting the ranking of American mosquitoes 
to disseminate and transmit RVFV starting from a theoretical uniformity. Despite the challenges 
and complexities of evaluating vector competence, the generation of such data are critical to 
guide risk and surveillance activities. The methods utilised and current knowledge are discussed 
herein. 
 
1.2.1 Midgut infection 
Not all mosquitoes that ingest a viraemic blood meal will become infected, therefore 
infection rates measure the first prerequisite step for competence. Infection status is 
determined by testing dissected mosquito midguts, or more commonly whole bodies, for virus 
following the ingestion of a viraemic meal (Turell et al., 1984). In order to avoid contamination 
with input virus in the blood, which can infer mechanical but not necessarily biological 
transmission, the collection of engorged mosquitoes is avoided (Meegan et al., 1980). The 
ingested arbovirus immediately enters the hostile midgut environment exposed to digestive 
enzymes, a change in host temperature and the blood meal is rapidly encased by the peritrophic 
membrane within the midgut lumen (Brackney et al., 2008; Whiten et al., 2018). 
In a competent mosquito, virus escapes the midgut lumen by entering the single layer of 
midgut epithelial cells theorised to occur by host-cell mediated endocytosis and demonstrated 
for flaviviruses and alphaviruses (Reviewed by Franz et al., 2015). Inability to enter or replicate 
in these cells is attributed to the midgut infection barrier (MIB). Viral incompatibility with host 
cell receptors is postulated as one mechanism attributed to this barrier, discussed in more detail 
later. Arboviruses are further restricted by the dose dependency or ‘infection threshold’ of this 
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barrier (Chamberlain and Sudia, 1961), with exposure to higher viral concentrations resulting in 
earlier and increased dissemination (Turell et al., 1988b). Peak host viraemia for RVFV is 
transitory (Figure 1.4) so ingestion of virus at a titre that supports onward transmission depends 
on temporal aspects of the host’s viraemia. Mosquitoes are typically reported to ingest between 
1-10µL of blood (Clements, 1992). These volumes are consistent with the 100-fold reduction in 
mean viral titres reported in vector competency experiments that compare viral titres detected 
within the engorged mosquitoes  to titres within the blood meal (reviewed by Lumley et al., 
2017). The lower the dose threshold is for a vector virus pair, the higher the vectorial capacity 
will be; resulting in an increase in the duration with which viral titres within the vertebrate host 
will support onward infection of the vector. 
 
1.2.2 Midgut escape 
Once virus has entered the midgut it must replicate in order to exit into the haemocoel. 
Once in the haemocoel, virus is transported in the haemolymph which is actively circulated by 
the dorsal vessel and body movement to all tissues including the salivary glands and ovaries 
(Romoser and Stoffolano, 1998). These processes are commonly simplified into a single measure 
of dissemination, with Turell et al. (1984) demonstrating detection of RVFV in mosquito legs as 
an effective measure of dissemination. Delay or prevention of dissemination from the midgut is 
attributed to the midgut escape barrier (MEB) (Sudia, 1959), which can also be (in some but not 
all cases) dose-dependent as demonstrated for RVFV (Turell et al., 2008, 1988b). The MEB was 
first visualised by IHC revealing the localisation of western equine encephalitis virus (WEEV; 
Alphavirus) in dissected mosquito tissues (Kramer et al., 1981). 
Investigating these barriers occurring early in mosquito infection has been performed by 
exploiting the differences in methods of infecting mosquitoes. Infection is typically performed 
orally via feeding on a viraemic animal or artificial blood meal containing virus to mimic the 
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natural transmission mechanism. However, injecting virus through a soft area of cuticle in the 
thorax directly into the haemocoel can be performed to bypass the midgut, termed 
intrathoracic (IT) inoculation. The principal benefit is the resulting near 100% infection rates but 
it does not represent the natural route and hosts typically thought to be refractory to infection 
can demonstrate a transmission potential; as demonstrated for Schmallenberg virus (SBV; 
Orthobunyavirus) transmission by Cx. pipiens (Manley et al., 2015). A strong MIB or MEB was 
observed in Cx. pipiens orally infected with RVFV using these two methods in combination. Oral 
infection resulted in 25% viral dissemination with all 25% capable of transmission, whereas 
circumventing the midgut by IT infection resulted in 100% transmission (Turell et al., 1984). 
Conversely barriers downstream of the midgut, which were not apparent in the Cx. pipiens, 
were postulated for Ae. fowleri infected with RVFV because the transmission rates did not differ 
significantly between orally or IT infected mosquitoes (Turell et al., 1988b) (see Salivary gland 
infection and escape below). 
 
1.2.3 Salivary gland infection and escape 
In a competent host, once virus passes to the haemocoel it is transported to the salivary 
glands where it replicates and is subsequently transmitted in the expectorated saliva as the 
mosquito blood feeds on a vertebrate host. Transmission can be studied directly allowing 
infected mosquitoes to feed on a susceptible host or artificially collecting and testing saliva 
secretions to infer a transmission potential (Aitken, 1977). The presence of the salivary gland 
infection barrier (SGIB) has been observed (Gargan et al., 1983; Kramer et al., 1981); linking 
transmission to the viral dose. This was observed using IHC to reveal the cell-to-cell spread of 
WNV in the midgut muscle tissues of orally infected Culex spp. while entry into the salivary 
glands required amplification to a threshold level (Girard et al., 2004). Ultrastructural studies of 
a refractory Anopheles spp. and a competent Culex spp. to RVFV infection, implicated the basal 
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lamina as an alternative extracellular barrier to host cell surface receptors in the salivary glands 
(Romoser et al., 2005). In the absence of microscopy to visualise virus localisation, or testing for 
the presence of virus in both the saliva and dissected salivary glands, the difference between 
salivary gland infection and escape cannot be distinguished. 
 
1.2.4 Specificity of vector-virus interactions 
The specificity of these vector virus (GxG) interactions allowing viruses to traverse these 
barriers is highlighted by the differences in rates of infection, dissemination and transmission. 
This is demonstrated in the aforementioned midgut barriers for RVFV associated with Cx. pipiens 
versus salivary gland barriers of Ae. fowleri (Turell et al., 1988b). In the broadest sense these 
GxG interactions are considered at this level of mosquito species and virus strain but 
intraspecies differences in mosquitoes should be considered, accounting for localised 
adaptation affecting phenotypic traits including susceptibility and mortality (Fansiri et al., 2013; 
Lambrechts et al., 2009; Tun-Lin et al., 2000). 
The further intricacies of these interactions is highlighted by changes occurring to a few 
nucleotide positions in the viral genome resulting in different infection and dissemination 
phenotypes described previously for VEEV, WNV and CHIKV (Brault et al., 2004; Ebel et al., 2004; 
Tsetsarkin et al., 2007). A single amino acid change in the La Crosse virus (LACV; 
Orthobunyavirus) Gn glycoprotein resulted in reduced infection of the midgut but remained 
capable of replication following IT inoculation. It was postulated that the amino acid change 
affected host cell receptor specificity or a fusion function (Sundin et al., 1987). 
These examples highlight the importance of testing multiple viral strains and mosquito 
species for vector competency and that care must be taken when extrapolating findings to 
conclude on competence in different species or geographic areas. 
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1.2.5 Impact of temperature on vector competence 
Studying competence exclusively under constant conditions is misleading if the natural 
environment limits the true transmission potential. Temperature is one of the best studied 
factors affecting vector competency and is fundamental when considering the ability of 
mosquitoes in temperate regions of Europe to transmit virus. Using relevant environmental 
temperatures is important not just across a range but at the upper and lower extremes. The 
GxG principle was extended by Thomas and Blanford (2003) to integrate the interplay of 
environmental temperatures (GxGxE) and was demonstrated with six populations of Ae. 
albopictus infected with CHIKV across two environmental temperatures (Zouache et al., 2014). 
The time taken by an organism to complete its development within the vector, 
encompassing the time from ingestion, pathogen replication and progression through the vector 
culminating in the ability to be transmitted within the saliva, is termed the extrinsic incubation 
period (EIP). As temperature increases EIP typically decreases, with low temperatures limiting 
transmission. However, there is not always a predictable inverse-linear relationship with 
temperature and transmission and results can vary between mosquito species (Turell et al., 
1985). For WEEV, reduced survival and enhanced MEB and SGIB at higher temperatures were 
observed, contributing to a reduction in transmission rates recorded at higher temperatures 
(Kramer et al., 1983). Temperature fluctuations also impact survival and infection rates 
(Lambrechts et al., 2011) and rearing temperature can impact susceptibility and phenotypic life 
traits (Turell, 1993; Westbrook et al., 2010). However, whether thermal-dependent traits in the 
vector or the virus are responsible for altering the transmission and survival phenotypes still 
needs to be determined. An hypothesis for increased susceptibility at lower rearing 
temperatures is the impairment of mosquito RNAi antiviral pathways (Adelman et al., 2013) and 
altered expression of host proteins in response to stress (Muturi et al., 2012, 2011). Producing 
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temperature dependant performance curves, whilst independently monitoring phenotypic traits 
for each genotype of virus and mosquito, could improve understanding of the relative influence 
of temperature on both vector and virus. 
Establishing these temperature thresholds to support replication and transmission is 
considered key to guide predictive models for arbovirus emergence and persistence (Johnson et 
al., 2015; Thomas and Blanford, 2003). Temperature has been predicted to limit the geographic 
distribution of arboviruses and such predictions suggest that CHIKV requires a temperature of 
20˚C for transmission to occur (Tilston et al., 2009) with only the mean temperatures in 
southern regions of Europe (compared to the rests of the continent) consistently above this 
temperature during the summer months (D. Fischer et al., 2013). However, CHIKV has a limited 
range of mosquito vectors compared to RVFV (EFSA, 2005), complicating risk models of RVFV. 
Understanding temperature thresholds for RVFV transmission could improve the accuracy of 
existing  and future risk models of RVFV in Europe (E. A. Fischer et al., 2013). 
 
1.2.6 Vectors of RVFV 
Since the identification of RVFV, mosquitoes have been implicated as the transmission 
vector (Daubney et al., 1931). The first isolation from a naturally infected mosquito however, 
was not until 1944 in the Semliki Forest, Uganda (Smithburn et al., 1948) with the first 
experimental transmission in 1949 (Smithburn et al., 1949). RVFV has subsequently been 
detected in over 50 naturally infected mosquito species in endemic regions and 47 species in 
laboratory studies in both endemic and non-endemic regions (EFSA, 2005; Reviewed by Lumley 
et al., 2017). Despite isolations from Anopheles and Mansonia signifying susceptibility, studies in 
the laboratory generally conclude their minimal involvement in RVFV transmission, with 
transmission predominantly shown to be by mosquitoes within the genera Aedes and Culex 
(EFSA, 2005). 
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1.2.7 Candidate vectors of RVFV in the UK 
There have been 36 mosquito species recorded in the UK (Harbach et al., 2017; Medlock 
et al., 2017, 2005; Medlock and Vaux, 2009; Snow et al., 1998). Mosquitoes within the genera 
Anopheles (6) and Coquillettidia (1) are excluded from consideration as candidate UK vectors of 
RVFV due to limited supportive evidence of their involvement in the transmission cycle in 
endemic regions (EFSA, 2005). Of those remaining species, based on their abundance and host 
feeding preferences (Medlock et al., 2007, 2005; Snow et al., 1998) 13 mosquito species could 
be considered potential vectors of RVFV: 
Ae. annulipes, Ae. cantans, Ae. caspius, Ae. cinereus, Ae detritus, Ae. dorsalis, Ae. 
flavescens, Ae. geniculatus, Ae. punctor, Ae. rusticus, Cs. annulata, Cx. modestus, and Cx. 
pipiens. 
This list is further reduced due to the logistical requirement to have a source of 
mosquitoes in order to assess their potential competence. Using a number of UK surveillance 
studies (Brugman, 2016; Golding et al., 2012; Mackenzie-Impoinvil et al., 2015; “Mosquitoes,” 
2013; Vaux et al., 2015), potential candidate mosquito species with known populations (and 
collection sites) are discussed in the context of RVFV transmission. 
 
1.2.7.1 Aedes detritus and Aedes caspius 
Morphologically and behaviourally Ae. detritus and Ae. caspius are similar, breeding in low 
lying grounds prone to flooding with salt water and overwintering in the egg stage (Medlock et 
al., 2005). Recently identified populations of these species in salt marshes (Chapman et al., 
2017; Clarkson and Setzkorn, 2011; Vaux et al., 2015) places them in proximity to several ports 
identified as potential entry sites for arboviruses (Gale et al., 2015). They are reported to 
aggressively bite humans, sheep and cattle (Clarkson and Setzkorn, 2011) suggesting a potential 
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to support transmission. Eggs are reported to hatch after 2-5 immersions which can be induced 
by springtides in coastal locations, with pupation occurring from March and human biting 
activity reported from March to November (Service, 1968), although more recent reports 
suggest adults may be present throughout the year (Clarkson and Setzkorn, 2011). Additionally, 
Ae. caspius from Egypt has demonstrated competency for RVFV in the laboratory (Turell et al., 
1996) and both species have been the subject of review as potential vectors of RVFV in Europe 
(Versteirt et al., 2013). Taken together: the feeding preference; abundance; proximity to hosts 
and ports; and their long active season, these species should be considered candidate bridge 
vectors of RVFV in the UK. 
 
1.2.7.2 Aedes cantans/annulipes and Aedes rusticus 
Ae. cantans/annulipes and Ae. rusticus have a widespread abundance across the UK 
preferring a woodland habitat, ovipositing in leaf litter that becomes flooded in winter and 
spring (Medlock and Vaux, 2015a; Snow et al., 1998). Although their season is not as long as that 
reported for Ae. detritus and Ae. caspius, adults are active between April to September. With an 
aggressive feeding behaviour on cattle, humans and woodland mammals, they could potentially 
support RVFV transmission (Brugman et al., 2017; Clements, 2013; Snow and Terzi, 1990). In 
particular, of these species, Ae. cantans is well characterised including temperature dependent 
traits demonstrating low biting rates at temperatures below 13˚C and larvae maturation within 
eggs ranging from 42 days at 4˚C to 4 days at 35˚C (Birley and Charlwood, 1989; Service, 1977). 
However, a complexity with these species is that Ae. cantans and Ae. annulipes are highly similar 
morphologically and distinguishing the two is by subjective analysis of a band that results in 
frequent misidentification or co-reporting (Snow et al., 1998; Snow and Terzi, 1990). The ability 
of these European species to transmit RVFV has not been evaluated previously. 
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1.2.7.3 Culex pipiens 
The Culex pipiens complex has received a lot of attention in published literature in relation 
to RVFV, attributed to its role as a major vector in endemic regions and the principal vector in 
the Egypt 1977 outbreak (Hoogstraal et al., 1979; Meegan et al., 1980; Versteirt et al., 2013). In 
the UK, Cx. pipiens (colloquially known as the northern house mosquito) is the most abundant 
mosquito (Snow et al., 1998). It is present in two morphologically identical forms: biotype 
pipiens and molestus distinguished by their defined habitat preferences, and a hybrid of the two 
(Brugman et al., 2018; Fonseca et al., 2004; Manley et al., 2015). The former is anautogenous 
(requiring blood to lay eggs), eurygamous (mates in swarms), inhabits and overwinters above 
ground, and preferentially feeds on birds and infrequently, humans. The molestus biotype is 
active throughout the year, stenogamous (mates in confined spaces), autogenous (lays its first 
eggs without blood) and shows preference for underground habitats and humans hosts (Snow 
et al., 1998). The hybrid is considered to exhibit intermediary behaviours (Fonseca et al., 2004). 
However, uncertainties surround members of the Cx. pipiens complex as historically biotypes 
were not distinguished. In the UK species were assumed to be the nominate biotype pipiens in 
the absence of evidence signifying the biotype molestus (Snow et al., 1998). 
The Egyptian outbreak likely involved the molestus form (Fonseca et al., 2004) but was not 
distinguished from another member of the complex, Cx. quinquefasciatus, known as the 
southern house mosquito. Cx. quinquefasciatus occupies tropical regions overlapping with Cx. 
pipiens in central/northern Africa and South Africa (Farajollahi et al., 2011). A range of molecular 
techniques are now available to differentiate forms (Fonseca et al., 2004; Manley et al., 2015), 
and the complex relationship between members of Cx. pipiens complex are reviewed by 
Brugman et al. (2018). Furthermore, differences in the vector competence phenotypes have 
been observed between both biotypes and hybrids in the Netherlands, USA and Spain (Brustolin 
Introduction 
39 
 
et al., 2017; Turell et al., 2014; Vogels et al., 2016). Despite rare reports of Cx. pipiens f. pipiens 
opportunistically biting humans (Brugman et al., 2017) and livestock; understanding the ability 
of Cx. pipiens biotypes within the UK to vector RVFV is of relevance due to its: abundance and 
proximity to humans and livestock; homology to known vectors in endemic regions; and the co-
occurrence of biotypes and hybrids. 
 
1.2.7.4 Culex modestus 
Until recently there were few historical reports of Cx. modestus in the UK (Medlock et al., 
2005; Snow et al., 1998) but it was detected in 2010 in the North Kent marshes (Golding et al., 
2012; Medlock and Vaux, 2012), with its subsequent expansion, in terms of both numbers and 
distribution, along the East coast of England (Vaux et al., 2015). Again these locations place it in 
close proximity to ports as potential entry routes for virus. Its presence in ditch habitat at sites 
on farmlands provides potential susceptible hosts for RVFV and its reported anthropophagic 
(human-biting) behaviour has been confirmed in the UK (Brugman et al., 2017). 
 
1.2.8 Vector competence in the UK 
The first reported study of arbovirus vector competence using native UK mosquitoes was 
performed with wild-caught Ae. detritus, confirming competence for Japanese encephalitis virus 
(JEV; Flavivirus) at 23˚C and 28˚C (Mackenzie-Impoinvil et al., 2015). Whilst adding important 
knowledge to the understanding of potential arbovirus maintenance in the UK the study 
temperatures were not representative for the UK climate. The temperatures in two established 
mosquito survey sites in England are presented in Figure 1.7, including the site used by 
Mackenzie et al. (2015), demonstrating peak averages between 12-22˚C from April through to 
October (Met Office, 2012). Further studies have been performed with this population of Ae. 
detritus at the more representative 21˚C demonstrating a vector competence for WNV but an 
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inability to transmit DENV or CHIKV, highlighting the specificity of the vector virus pairing 
(Blagrove et al., 2016). The first vector competence study using UK populations of Cx. pipiens 
was performed by Manley et al. (2015) demonstrating that these mosquitoes were not 
susceptible to oral infection with SBV. Both a strength and limitation of this study was the use of 
colonised mosquitoes, enabling greater control and characterisation of variables including age, 
size, lifespan, fecundity and blood feeding but colonisation can negatively affect competency 
(Gargan et al., 1983; Meegan et al., 1980) and adaption to the laboratory reduces 
representativeness to natural populations. 
 
 
Figure 1.7 Climate graph for two candidate mosquito collection sites in the UK. Graphs were 
obtained from the Met Office (2012) displaying the average maximum temperatures in two locations 
for data collected across 30 years (1981-2010). Climate stations are located 7.8miles and 3.8 miles 
from collection locations in A. Neston, Cheshire and B. Cliffe, Kent described previously (Golding et 
al., 2012; Mackenzie-Impoinvil et al., 2015). 
 
 
As the climate in Northern Europe becomes warmer and wetter mosquito numbers are 
expected to increase (Snow and Medlock, 2006), contributing to an increase in the predicted 
risk of the establishment of arboviruses including RVFV (Gale et al., 2010). It is therefore with 
increasing importance that the ability of UK populations of mosquito species, and the 
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constraints of UK temperatures, to maintain and transmit RVFV are investigated. Although 
vector competence of RVFV has been studied in European species of mosquito in Spain and the 
Netherlands demonstrating localised populations of Cx. pipiens are competent vectors of RVFV 
in the laboratory (Brustolin et al., 2017; Vloet et al., 2017), there are no data on the ability of 
mosquitoes indigenous to the UK to support RVFV, therefore limiting the ability to assess the 
risk of survival and maintenance of RVFV should it be introduced in to the UK. 
 
1.3 Aims and hypotheses 
This thesis aims to improve understanding of the survival strategies of RVFV in a 
temperate climate, focussing on factors affecting the virus within the vector host environment. 
A combination of in vitro and in vivo methods are applied to investigate the effect of relevant 
environmental temperatures on the ability of indigenous mosquitoes to vector RVFV and the 
potential for genetic adaptation to arise and promote virus transmission. 
 
In Chapter 3 RVFV detection and quantification methods will be standardised to allow 
accurate assessment of viral amplification in different host and cell systems. These will then be 
applied to study RVFV replication kinetics for two pathogenic strains of RVFV within in vitro cell 
systems across a range of temperatures in order to test the hypothesis that:  
 
Low temperatures negatively affect RVFV replication kinetics independently of its 
mosquito vector. 
 
In Chapter 4 the results generated in vitro are then applied to guide temperature selection 
of in vivo experiments on the ability of British mosquitoes to support replication and 
transmission of RVFV. Both colonised and wild-caught mosquitoes are fed artificial blood meals 
containing pathogenic strains of RVFV in order to evaluate the hypothesis that: 
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Mosquito species present in the UK are competent to transmit RVFV. 
 
Due to the numerous variables and challenges, discussed in this introduction chapter, this was 
further broken down in to more specific aims in order to determine the role of infectious dose, 
strain and temperature on the susceptibility of British mosquitoes to infection with RVFV and 
their transmission potential. Extrinsic incubation and survival are evaluated to improve 
understanding of the vectorial capacity of temperate British mosquito species.  
 
In Chapter 5 in order to improve understanding of the ability of RVFV to adapt thus 
promoting potential survival in temperate regions, RVFV samples propagated in vitro and in vivo 
are characterised by a next generation sequencing strategy. Mutations in the genome of 
alphavirus and flavivirus have been previously observed to lead to changes in fitness to replicate 
in different hosts but there is little data on RVFV genome adaptation in vivo. In order to 
understand the potential for RVFV to adapt to new hosts the aim of this chapter is to test the 
hypothesis that: 
 
Evidence of viral adaptation to the host will be detected by different consensus 
changes occurring after in vivo replication in the mosquito, compared to a 
mammalian host. 
 
 Chapter 6 summarises the thesis finding and discusses potential areas for future research. 
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2 Methods 
Unless otherwise stated, all manipulation of materials known or suspected to contain 
infectious RVFV were performed at ACDP level 3 in a Class I or III Microbiological Safety Cabinet 
(MSC) at APHA or PHE. 
 
2.1 Cells and viruses 
2.1.1 In vitro cell culture 
Cell lines were supplied by PHE’s European Collection of Authenticated Cell Cultures 
(ECACC). Vero E6 (African green monkey kidney) cells were maintained in Dulbecco’s modified 
Eagle media (DMEM) (Thermo Fisher Scientific) with 10% foetal bovine serum (FBS) (Thermo 
Fisher Scientific) incubated at 37˚C in 5% CO2 in vent cap flasks. Clone C6/36 (Ae. albopictus) 
cells were maintained in DMEM with 10% FBS and 25mM HEPES (Thermo Fisher Scientific), 
incubated at 28˚C with no supplemented CO2 in plug seal capped flasks. Both cell lines were 
routinely split at 90% confluency at a 1 in 10 ratio. Cell culture media was removed and 
mosquito cells were detached by mechanical disruption with a cell scraper, Vero E6 cells were 
washed twice in phosphate buffered saline (PBS) (Thermo Fisher Scientific) and detached in 1x 
trypsin-EDTA-0.05% (Thermo Fisher Scientific) at 37˚C for 5 minutes. 
 
2.1.2 Virus strains 
Two RVFV strains were used: ZH501 (mouse brain suspension; passage 10) isolated from a 
fatal human haemorrhagic case during the 1977 outbreak in Egypt (Meegan, 1979). Lunyo 
(mouse brain suspension; passage 11) a variant strain isolated from a pool of Aedes spp. in 1957 
(Lumley et al., 2016; Weinbren et al., 1957). Stocks were produced on Vero E6 cells at 37˚C and 
RNA and infectious titres quantified by qRT-PCR and plaque assay. 
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The downstream experiments were considered when selecting this cell culture regimen as 
the origin (vertebrate or invertebrate) of cells used to produce viral stocks can have a distinct 
effect on structural components on the surface of RVFV particles (Nfon et al., 2012; Weingartl et 
al., 2014a). Vero E6 cells were selected for virus stock propagation when performing mosquito 
infection studies as this mimics the alternate cycling between hosts that occurs in nature. 
Therefore for consistency between experiments Vero E6 cells were used to propagate viral 
stocks used throughout all experiments described in this thesis. 
 
2.1.3 In vitro virus propagation 
Propagation of RVFV was performed by inoculating a washed confluent monolayer of Vero 
E6 or C6/36 cells and incubating for one hour at 37˚C or 28˚C respectively. Virus was removed 
and growth media added (DMEM supplemented with 2% FBS, 25mM HEPES if incubated without 
CO2), Vero E6 cells were incubated at 37˚C in 5% CO2 and C6/36 cells at 28˚C without CO2. 
Supernatants were harvested at defined time points or when a cytopathic effect (CPE) was 
evident by light microscopy in Vero E6 cells. Virus (intracellular and extracellular) was harvested 
by a single freeze-thaw of the culture flasks, cell culture fluid was collected and clarified by 
centrifugation at 3,000 x g for 10 minutes. 
 
2.1.4 In vivo virus propagation in a mouse model 
Protocols were performed by the Biological Investigations Group (PHE). Four 5-8 week old 
BALB/c mice, selected due to their previous use as a mouse model of RVFV (Smith et al., 2010), 
were infected with 10 PFU of RVFV strain ZH501. Mice were challenged subcutaneously with 
40µL of virus into their left and 40µL in the right hind leg above the ankle. Additionally two 
control mice were challenged with PBS only. Mice were monitored daily for four days prior to 
challenge, clinical observations were made twice daily post infection and four times a day from 
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the first onset of clinical signs. Temperatures were recorded by indwelling temperature chips 
and weights were recorded daily. A humane clinical end point, requiring immediate euthanasia 
of mice, was defined by veterinary staff as 20% weight loss, neurological symptoms, immobility 
or abnormal vocalisation. All four infected mice succumbed to infection on day 3 post infection, 
at necropsy samples of brain, liver and blood were collected and stored at -80˚C. 
 
2.1.5 Virus concentration 
High titre viral stocks are required for competency studies to account for the dilution 
factor during blood meal preparation. Ultrafiltration had a simple, scalable setup and 
concentrated viable titres >10-fold in 40 minutes and therefore was selected for use. Virus was 
concentrated using AmiconUltra-15 centrifugal filter devices with a 100kDa molecular weight 
cut-off (Merk Millipore) adapted from (Richard et al., 2015). Up to 15mL of clarified virus was 
applied to the filter, capped and centrifuged at 3,800 x g for 40 minutes at 4˚C. Concentrated 
virus was recovered by pipetting the solution remaining on the filter with a sweeping action. 
Concentrates were pooled, stored at -80˚C and quantified by plaque assay and qRT-PCR. 
 
2.2 Quantification of virus 
2.2.1 Plaque assays 
Plaque assays were performed in 24-well plates seeded with 1x105 Vero E6 cells per well 
18-24 hours prior to use. Cells were washed with PBS and 50µL of a 10-fold dilution of virus in 
DMEM was adsorbed for 1 hour at 37˚C. An avicel (Sigma) overlay (0.5mL 0.6% avicel in MEM) 
was applied and incubated for four days at 37˚C with 5% CO2. Antibiotics and antimycotics (100 
units/mL penicillin, 100µg/mL streptomycin, 0.25µg/mL amphotericin B, 100µg/mL kanamycin, 
50µg/mL gentamicin) (Sigma) were supplemented in the overlay media for assays performed on 
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mosquito samples. Cells were fixed and virus inactivated in 10% formaldehyde for one hour, 
plaques were visualised by staining with 0.2% crystal violet in 50% methanol stain and counted. 
 
2.2.2 Production of a synthetic RVFV RNA control 
Transcript RNA was produced as a qRT-PCR control template to quantify genome 
equivalent copies (GEC). Plasmid control synthesised by GeneArt® (Thermo Fisher Scientific) was 
designed with M and S segment assay targets adjacent to one another, wild type viral sequence 
was included for regions between primer and probe but not flanking (Figure 2.1). Sequence was 
inserted into a plasmid with a T7 promoter at the 5’ end and a unique restriction site at the 3’ to 
allow linearisation. Plasmid was linearised by PacI (NEB) restriction digest at 37˚C for 1 hour, 
RNA transcripts were generated using the MEGAscript T7 transcription kit (Thermo Fisher 
Scientific) following manufacturer’s instructions. Products were DNase treated twice then 
purified by RNeasy MinElute cleanup kit (Qiagen). Transcripts were quantified on the NanoVue 
(GE Healthcare) in triplicate. Equivalent target copy numbers were calculated using molecular 
weight and target sequence length: 
 
𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐖𝐞𝐢𝐠𝐡𝐭 (𝐌𝐖) = Nucleic acid base weight × Molecular length (nt) 
 
𝐍𝐮𝐦𝐛𝐞𝐫 𝐨𝐟 𝐜𝐨𝐩𝐢𝐞𝐬 =
Quantity (g)
MW
× Avogadro’s constant (6.0223) 
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Figure 2.1 Schematic of qRT-PCR synthetic plasmid control template A. Plasmid insert design, 
coloured boxes below the sequence represent the binding sites for oligonucleotides and restriction 
enzymes. B. Circular map of plasmid manufactured by GeneArt, the red box depicts the T7 promoter 
positioned upstream of the pRVF insert. Images were generated in DNAStar, SeqBuilder v14.0. 
 
2.2.3 Extraction of viral RNA 
2.2.3.1 Cell culture and mosquito samples 
Viral RNA was extracted using the QIAamp viral RNA mini kit (Qiagen). Briefly samples 
were inactivated in an MSC III by adding sample to AVL buffer (Qiagen) at a ratio of 1:3 then 
disinfected with 5,000 ppm available chlorine solution (HazTabs) for 10 minutes and removed 
from the cabinet for downstream processing in an ACDP CL2 laboratory. Samples were extracted 
according to manufacturer’s instructions on QIAamp spin column (Qiagen) and eluted in 60µL. 
 
 
A. 
B. 
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MS2 bacteriophage (Biosafety Investigations Group, PHE) was spiked during the carrier RNA 
addition step as an extraction and inhibition control. 
 
2.2.3.2 Mice 
Tissue samples derived from mice were weighed and disrupted in 2mL tubes containing 
28mm ceramic beads (Stretton Scientific) in 0.5mL PBS (Thermo Fisher Scientific) using the 
Precellys 24 (Bertin Instruments). Six cycles of 5 seconds at 6,500 rpm with 30 seconds pause 
between cycles were performed. 100µL of blood or tissue homogenate was added to 300µL RLT 
buffer (Qiagen) and passed through a QIAshredder, RNA was extracted using the RNeasy Mini 
Extraction Kit (Qiagen). 
 
2.2.4 Quantitative (q) RT-PCRs 
Oligonucleotides were reviewed and selected from published literature targeting regions 
within the open reading frame (ORF) of the M and S segments of RVFV (Table 2.1). Selection was 
based on optimal performance of specificity and sensitivity in an international external quality 
assessment and quadraplex assay (Escadafal et al., 2013; Wilson et al., 2013). Exclusivity and 
homologies were checked by Basic Local Alignment Search Tool (BLAST, NCBI) analysis against 
the non-redundant nucleotide collection excluding RVFV. Inclusivity was checked by aligning 
oligonucleotides to all available RVFV sequences on GenBank (n= 99, 160 for the M and S 
segments accessed August 2015) by ClustalW in DNASTAR MegAlign v11. Inhibitory substances 
in RNA extracts have been reported in mosquito samples (Beckmann and Fallon, 2012; Ibrahim 
et al., 1997) and in haemolysed clinical samples such as observed in cases of viral haemorrhagic 
fever; a symptom of RVF in humans and ruminants (Drosten et al., 2002b). To account for the 
potential presence of inhibitory substances, an inhibition control was evaluated for use as a 
multiplexed assay with both RVFV targets. A published phage based internal control was 
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selected and the MS2 primers and probe (Rolfe et al., 2007) were optimised by asymmetric PCR. 
The multiplexed M PCR produced false positive results due to a non-specific increase in 
fluorescence so was performed in singleplex. The S segment assay had increased sensitivity 
when multiplexed with MS2 therefore is performed in the duplex format. Stock oligonucleotide 
premixes for these assays are detailed in Table 2.2 and Table 2.3. Assays were performed using 
the 4x TaqMan Fast Virus 1-step Master Mix kit (Thermo Fisher Scientific) interchangeably on 
the Viia 7 or 7500 platforms (Thermo Fisher Scientific) at PHE or the Mx3000P (Agilent) at APHA. 
The M segment assay was tested to confirm no loss in sensitivity or efficiency when transferring 
between Thermo and Agilent platforms. The reaction mix composition is detailed in Table 2.5 
and cycling performed as recommended for the kit detailed in Table 2.5. Results were analysed 
at baseline threshold 0.05 on the Viia 7 or 7500, and 0.1 on the Mx3000P. 
 
Table 2.1 RVFV qRT-PCR oligonucleotide sequences 
Virus Name Sequence (5’ – 3)’ Target Reference 
MS2 
MS2 Fwd TGGCACTACCCCTCTCCGTATTCACG 
MP 
(Rolfe et al., 
2007) 
MS2 Rev GTACGGGCGACCCCACGATGAC 
MS2 Probe Cy5-CACATCGATAGATCAAGGTGCCTACAAGC-BBQ 
RVFV 
RVF S Fwd TGCCACGAGTYAGAGCCA S 
segment 
(N) 
(Weidmann 
et al., 2008) 
RVF S Rev GTGGGTCCGAGAGTYTGC 
RVF S Probe FAM-TCCTTCTCCCAGTCAGCCCCAC-BHQ1 
RVF M Fwd AAAGGAACAATGGACTCTGGTCA M 
segment 
(Gn) 
(Drosten et 
al., 2002a) 
RVF M Rev CACTTCTTACTACCATGTCCTCCAAT 
RVF M Probe FAM-AAAGCTTTGATATCTCTCAGTGCCCCAA-BHQ1 
FAM: carboxyfluorescein (fluorophore), BHQ1: black hole quencher, Cy5: fluorophore, BBQ: 
blackberry quencher. Oligonucleotide ordered from MWG Eurofins. 
 
Table 2.2 RVFV M segment qRT-PCR singleplex oligonucleotide premix (100 reactions) 
Component 
Stock concentration 
(µM) 
Final  
concentration (nM) 
Volume (µL) 
Water n/a n/a 59 
RVF M Fwd 100 900 18 
RVF M Rev 100 900 18 
RVF M Probe 100 250 5 
Methods 
50 
 
Table 2.3 RVFV S segment qRT-PCR oligonucleotide premix  100 reactions), performed in duplex 
with MS2 internal control 
Component 
Stock concentration 
(µM) 
Final  
concentration (nM) 
Volume (µL) 
Water n/a n/a 23.8 
RVF S Fwd 100 900 18 
RVF S Rev 100 900 18 
RVF S Probe 100 250 5 
MS2 fwd 10 80 16 
MS2 rev 10 80 16 
MS2 probe 100 160 3.2 
 
Table 2.4 RVFV qRT-PCR master mix composition 
Component 
Stock concentration 
Final concentration Volume (μL) 
Water n/a n/a 9 
4X Reaction mix* 4x 1x 5 
Primer mix 20x 1x 1 
Template n/a n/a 5 
*Component 4x TaqMan Fast Virus 1-step Master Mix kit (Thermo Fisher Scientific). 
 
Table 2.5 RVFV qRT-PCR cycling parameters 
Step name Analysis mode 
Temperature 
(°C) 
Time 
(M:S) 
Acquisition 
mode 
Cycles 
Reverse Transcription None 50 05:00 None 1 
Denature None 95 00:20 None 1 
Amplify Quantification 
95 00:03 None 
40 
60 00:30 Single 
M: minutes, S: seconds 
 
Viral RNA was quantified in GEC/µL of extract by the PCR software using a 10-fold in-run 
standard curve of quantified transcript RNA (Section 2.2.2) for the M and S. The formula below 
was used to determine GEC/mL of sample or GEC/mosquito depending on the context of use. 
Sample and elution volumes (µL) are input into the formulae using the viral RNA extraction 
methods described in section 2.2.3.1 and 2.2.3.2. 
 
 𝐆𝐞𝐧𝐨𝐦𝐞 𝐜𝐨𝐩𝐢𝐞𝐬 /𝐦𝐋 𝐨𝐟 𝐬𝐚𝐦𝐩𝐥𝐞 =
(Quantity copies × dilution factor × elution vol in µL)
Vol of sample in µL added to lysis buffer
 × 1000 
 
𝐆𝐞𝐧𝐨𝐦𝐞 𝐜𝐨𝐩𝐢𝐞𝐬 /𝐦𝐨𝐬𝐪𝐮𝐢𝐭𝐨 = Quantity copies × (mosquito homogenate vol  in µL ÷
vol in µL added to lysis buffer) × elution vol in µL  
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2.3 Mosquitoes 
2.3.1 Maintenance of mosquitoes (uninfected) 
Mosquitoes continuously reared in the laboratory for more than two generations are 
termed colonised. General practice for the setup and maintenance of colonies and insectary 
infrastructure have been extensively reviewed (Gerberg et al., 1970). General features include 
temperature, lighting and humidity control with insect screens fitted on all openings. The 
methods described here are for Culex spp. and may require adaptation and optimisation for 
other genera. Averages are based on retrospective analysis of the Caldbeck line at APHA June 
2015 to February 2016. 
Two colony lines within the Cx. pipiens complex, donated by The Pirbright Institute, are 
maintained at APHA. The Caldbeck (CBK) line is a Cx. pipiens pipiens (~f 50 established at APHA 
in February 2015), the Brookwood (BKW) line is a mix of Cx. pipiens biotypes pipiens, molestus 
and a pipiens-molestus hybrid (~f 51 established at APHA in February 2016) characterised by 
Manley et al. (2015). 
 
2.3.1.1 Larvae 
Larval rearing trays are maintained in filtered water at 22.5˚C (+/- 3.5˚C) and fed daily on 
fish flake food (Aquarian). Trays on average are populated with 140 egg rafts (range: 15-330 
rafts) collected from mixed generation adults oviposited for 2-7 days. Trays are maintained for 
28 days (range 14-41 days) until most or all larvae have emerged and then merged or 
discontinued. On average 277 adults emerge from each tray (range 2-690, average 2.8 adults/ 
egg raft). 
 
2.3.1.2 Adults 
Adults are maintained at 25˚C (+/- 2.7˚C), 55% humidity (range 32-74%) with a 
photoperiod of 12:12 (light:dark) hours. They are contained in 30x30x30 cm white BugDorms 
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(Bugzarre, UK) and supplied with cotton wool saturated in a 10% sucrose solution as a 
carbohydrate source required by both males and females. Females additionally require a blood 
meal to oviposit and are fed twice a week on defibrinated horse blood (TCS Biosciences) by 
hemotek (Hemotek Ltd) with a Parafilm M (Sigma) membrane at 37˚C for approximately 15-18 
hours overnight. Filtered water in black cups is supplied for oviposition. Eggs and any hatched 
larvae are transferred from oviposition cups to larval rearing tray once to twice a week. 
 
2.3.2 Mosquito field collection 
Immature mosquitoes (larvae and pupae) were collected by larval dipping as described 
previously (Service, 1993; Walton, 2005). A dipper is a white pan with an approximate capacity 
of 500mL, attached to a handle. The method that follows depends on the target genus: for Culex 
the pan is dipped at a 45˚ angle and water is allowed to flow in, for Aedes a scooping action is 
used quickly dragging the dipper across the surface. Dips are transferred into a light coloured 
tray and larvae separated from other invertebrates by pipette. Collection sites were selected 
based on locations identified in surveys performed by colleagues at the University of Liverpool, 
PHE and APHA. A summary of mosquitoes and their collection sites and are listed in Table 2.6. 
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Table 2.6 Provenance of colonised and wild-caught mosquitoes 
Species Shorthand Location 
GPS coordinates 
(DMS) 
Origin 
Collection 
method 
Habitat 
Cx. pipiens 
Caldbeck 
CBK 
Caldbeck, Worcester 
Park, London 
N51°22'51.24'' 
W0°14'20.399'' 
L, P 
(colonised) 
* 1 
Cx. pipiens 
Brookwood 
BKW 
Brookwood,  
Surrey 
N51°18'23.4'' 
W0°37'58.08'' 
L, P 
(colonised) 
* 2 
Cx. pipiens s.l., 
Cx. modestus 
x 
Cliffe Pools,  
Kent 
N51°28'21.032'' 
E0°28'31.575'' 
L, P Dipping 1 
Cx. pipiens s.l.,  
Cx. modestus 
x 
Elmley National 
Nature Reserve, Kent 
N51°22'59.288'' 
E0°46'57.459'' 
L, P Dipping 1 
Cx. pipiens s.l., x 
West Byfleet,  
Surrey 
N51°20'35.084'' 
W0°29'56.664'' 
E Dipping 2 
Ae. detritus,  
Ae. caspius 
x 
Wallasea Island, 
Essex 
N51°36'55.065'' 
E0°49'22.066'' 
A CO2 traps 3 
Ae. rusticus, 
Ae. cantans/ 
Ae. annulipes 
Ae.r 
Bartley Heath, 
Hampshire 
51°16'32.568'' 
W0°57'18.207'' 
A 
Human 
landing 
4 
Ae. detritus Ae.d 
Dee Marsh,  
Cheshire 
N53°16'39.48'' 
W3°4'5.286'' 
L Dipping 3 
Habitats = 1: Freshwater pond/drainage ditch; 2: container; 3: saltmarsh; 4: Woodland/ temporary 
groundwater. E: eggs; L: larvae; P: pupae; A: adults; s.l.: sensu lato; *: Collected, colonised and 
characterised by the Pirbright Institute (Manley et al., 2015). Locations based on survey sites from 
(Golding et al., 2012; Mackenzie-Impoinvil et al., 2015; Manley et al., 2015; Medlock and Vaux, 
2013). 
 
2.3.3 Mosquito identification 
Wild-caught mosquito species were identified based on their habitat selection and 
morphological features using published keys (Cranston et al., 1987; Snow and Terzi, 1990). In 
addition molecular methods were used to support morphological identification using a 
published PCR assay targeting a 710bp region (658bp excluding primer binding regions) of the 
mitochondrial cytochrome c oxidase subunit I (COI) gene (Folmer et al., 1994). Oligonucleotides 
(MWG Eurofins) are listed in Table 2.7, reaction composition in Table 2.8 and published cycling 
conditions are detailed in Table 2.9 (Hebert et al., 2003). 
Table 2.7 COI DNA barcoding oligonucleotide sequences 
Name Sequence (5’ – 3’) Amplicon size (bp) 
LCO1490 GGTCAACAAATCATAAAGATATTGG 
710 
HCO2198 TAAACTTCAGGGTGACCAAAAAATCA 
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Table 2.8 COI DNA barcoding PCR single reaction master mix composition 
Component Stock concentration Volume (µl) 
Water n/a 14.875 
10 x PCR buffer* 10x 2.5 
dNTP* 10mM each 0.5 
LCO1490 10µM 1 
HCO2198 10µM 1 
Enzyme* n/a 0.125 
DNA Template n/a 5 
*Component of the Taq PCR core kit (Qiagen). 
 
Table 2.9 COI DNA barcoding PCR cycling parameters 
Step name Temperature (°C) Time (M:S) Cycles 
Denature 94 01:00 1 
Pre-amp 94 01:00 
5 45 01:30 
72 01:30 
Amplify 94 01:00 
35 50 01:30 
72 01:00 
Extension 72 05:00 1 
M: minutes, S: seconds 
 
Amplicons were electrophoresed on a 2% (W/V) agarose gel to confirm products of the 
correct size and the remaining PCR reaction was purified using the QIAquick PCR Purification Kit 
(Qiagen). Sequence analysis was performed by the Genomic Services and Development Unit 
(GSDU) PHE, Colindale. In brief nucleotide labelling was performed in each direction using the 
BigDye Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific), unincorporated dye 
terminator was removed using the DyeEx 96 Kit (Qiagen), samples were resuspended in Hi-Di 
formamide (Thermo Fisher Scientific), and analysed on the 3730XL DNA Analyser (Thermo Fisher 
Scientific). Sequences were compared with available sequences on GenBank by BLAST to 
determine species identity. 
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2.3.4 Mosquito host PCRs 
The prevalence and quantity of virus in mosquito samples was expected to be low (Golnar 
et al., 2014). Therefore, mosquito endogenous control PCRs were utilised targeting host actin 
for body and leg samples and mitochondrial DNA for saliva. In contrast to the spiked MS2 
internal control this provides and a control for the entire process including: dissection, storage, 
RNA extraction and PCR. Details of oligonucleotides and source information are show in Table 
2.10. Samples negative by host PCR were excluded from the population numbers used to 
determine infection rates. 
 
Table 2.10 Mosquito host PCR oligonucleotide sequences 
Assay Name Sequence 5’ – 3’ 
Amplicon 
size (bp) 
Reference 
Actin 
Act 2F ATGGTCGGYATGGGNCAGAAGGACTC 
683 
(Staley et 
al., 2010) Act 8R GATTCCATACCCAGGAAG-GADGG 
Saliva 
Saliva Fwd TTCTGATGACGGCGATATACAAATT 
100 
(Grubaugh 
et al., 2017) Saliva Rev1 GGCGGTATTTTAGTCTATTCAGAGGA 
Saliva Rev2 GGCGGTGTTTTAGTCTATTTAGAGGA 
GAPDH 
GAPDH Fwd GCTCATCTCCTGGTACGACA 
79 This study GAPDH Rev GTCCTTGCTCTGCATGTACT 
GAPDH Probe CGGCTACTCCAACCGTGTCGTCG 
 
2.3.4.1 Actin control PCR 
Master mix composition and cycling parameters derived from published literature are 
detailed in Table 2.11 and Table 2.12. Actin PCR was performed on all RVFV qRT-PCR negative 
body and leg samples. Amplicons were analysed by electrophoresis on a 2% (W/V) agarose gel 
(Sigma). 
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Table 2.11 Mosquito actin PCR master mix composition 
Component Stock concentration Volume (µl) 
Water n/a 8.5 
2 x reaction mix* 2x 12.5 
Act 2F 10µM 1 
Act 8R 10µM 1 
Enzyme* n/a 1 
cDNA Template n/a 1 
* Component of the SuperScript III One-Step RT-PCR System with Platinum Taq (Thermo Fisher 
Scientific). 
Table 2.12 Mosquito actin PCR cycling parameters 
Step name Temperature (°C) Time (M:S) Cycles 
Reverse transcription 50 15:00 1 
Denature 94 02:00 1 
Amplify 94 00:15 
40 55 00:30 
68 00:45 
Extension 68 05:00 1 
Hold 4 ∞ 1 
M: minutes, S: seconds 
 
2.3.4.2 Saliva control PCR 
Master mix composition and cycling parameters as recommended for the kit are detailed 
in Table 2.13 and Table 2.14. The PCR was performed on all saliva samples in the higher dose 
experiments (107 PFU), performed on the 7500 Fast Real-Time PCR System (Thermo Fisher 
Scientific). Grubaugh et al. (2017) developed the PCR using sequences derived from Cx. 
quinquefasciatus stating its scope for use for targeting samples derived from Cx. spp. only. Here, 
an additional reverse primer was designed based on the sequence alignment results shown in 
Figure 2.2. The PCR amplified both Aedes and Culex species used within these experiments. 
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Table 2.13 Mosquito saliva PCR master mix composition 
Component Stock concentration Volume (µl) 
Water n/a 2.75 
iTaq SYBR reaction mix* 2x 10 
Saliva Fwd 10µM 1 
Saliva Rev1 10µM 0.5 
Saliva Rev2 10µM 0.5 
iScript RT* n/a 0.25 
Template n/a 5 
* Component of the iTaq Universal SYBR Green one-step kit (Bio-Rad); RT: reverse transcriptase. 
 
Table 2.14 Mosquito saliva PCR cycling parameters 
Step name Analysis mode 
Temperature 
(°C) 
Time 
(M:S) 
Acquisition 
mode 
Cycles 
Reverse Transcription None 50 10:00 None 1 
Denature None 95 01:00 None 1 
Amplify Quantification 
95 00:15 None 
40 
60 00:30 Single 
Melt curve Melt 60-94 10 S each 0.5°C Continuous 1 
M: minutes, S: seconds. 
 
 
Figure 2.2 Sequence alignment of saliva PCR oligonucleotides to Culex and Aedes species. 
Alignment of accession numbers: MF194022, KR068634, KM676219, KP995260, EF028703, 
HQ724615, HQ724616, KT851543, KT851544, MF040162, MF040164 were performed in MegAlign, 
DNAStar. Homologous sites are represented by dots and mismatches denoted by the variant 
nucleotide letter. 
 
2.3.4.3 GAPDH control PCR 
A semi-quantitative real-time RT-PCR targeting mosquito glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) was designed for use during the optimisation of methods to detect 
nucleic acids within mosquitoes. Primers were designed targeting bases 970:1048 of the GAPDH 
T T C T G A T G A C G G C G A T A T A C A A A T T . . . . . . . . . . . . . T C C T C T G A A T A G A C T A A A A T A C C G C C
Ae. aegypti . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . C . . . . . .
Ae. albopictus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . C . . . . . .
Ae. notoscriptus . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . C . . . . . .
Ae. vilax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . .
Cx. pipiens molestus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cx. pipiens pipiens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cx. pipiens pipiens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cx. pipiens pallens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cx. tritaeniorhynchus. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cx. coronator . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cx. camposi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Methods 
58 
 
gene of Cx. quinquefasciatus accession XM_001846997, using online freeware (GenScript, 2016). 
Oligos were selected based on conserved regions using a ClustalW alignment performed in 
MegAlign (DNAStar) (Figure 2.3). Master mix and cycling parameters replicate those used for 
RVFV assays (substituting RVFV for GAPDH oligonucleotides) detailed in Table 2.2, Table 2.4 and 
Table 2.5. 
 
 
Figure 2.3 Sequence alignment of mosquito GAPDH PCR oligonucleotides. Alignment of accession 
numbers: XM_001846997, XM_011494724, GAPW01002508, KB704685.1, AXCP01000130, 
ADMH02001646.1, XM_318655.2, NM_001038847 were performed in MegAlign, DNAStar. 
Homologous sites are represented by dots and mismatches denoted by the variant nucleotide letter. 
  
G C T C A T C T C C T G G T A C G A C A . . . C G G C T A C T C C A A C C G T G T C G T C G . . . A G T A C A T G C A G A G C A A G G A C
Cx. quinque… . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ae. aegypti . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . T
Ae. albopictus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T
Ae. arabiensis . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . C . . . . . . . . . . . . . . . . . . . . . . C . . . . . . T
An. atroparvus . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . . . . . . . . . . . . . . . . . C . . . . . . .
An. darlingi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C . . . . . . T
An. gambiae . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . . . . . C . . . . . . . . . . . . . . . . . . . . . . C . . . . . . T
D. melanogaster . . . A . . . . . G . . . . . . . . . . . . . . . . T . . . . . . . . . . . C . . . A . . . . . . . . . . T . . . . . . . . . . . . . . .
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3 Results: The effect of temperature on in vitro replication kinetics 
3.1 Introduction 
RVFV is maintained in a transmission cycle between its mosquito vector and mammalian 
hosts, with the research described in this thesis predominantly focussed on the survival of RVFV 
within its vector host. Mosquitoes are poikilothermic ectotherms therefore viruses are exposed 
to environmental temperatures within the vector. It is not surprising therefore that temperature 
is one of the most studied factors affecting the ability of mosquitoes to support viral replication 
and transmission. Whilst the evaluation of European mosquito species to support replication of 
RVFV has been investigated previously, these studies did not extend analysis to the effects of 
temperature on transmission dynamics (Brustolin et al., 2017; Vloet et al., 2017). Understanding 
the effects of temperature on virus survival, replication and transmission within its vector is 
fundamental when considering the expansion of an arbovirus, predominantly found in arid or 
tropical regions of Africa, to temperate regions in Europe experiencing mild summers and cold 
winters (Kottek et al., 2006). Furthermore, establishing the temperature thresholds required to 
support replication and transmission is considered key to guide prediction models for arbovirus 
emergence and persistence (Johnson et al., 2015; Thomas and Blanford, 2003), as temperature 
has been predicted to limit the geographic distribution of arboviruses in Europe (D. Fischer et 
al., 2013; Tilston et al., 2009). 
However, the optimal temperature for the virus is not necessarily the same for the vector. 
A high rate of viral replication is of mixed advantage and disadvantage for vector transmission. 
Increased rates of replication will reduce the time from a mosquito acquiring virus to the time it 
is proficient to transmit virus when taking its next blood meal, termed the extrinsic incubation 
period (EIP). A short EIP maximises the likelihood the vector can pass virus on with each 
subsequent blood feed; however, rapid viral amplification can produce cytopathic effects within 
the mosquito (Girard et al., 2005) and has been linked to reduced transmission of WNV (Girard 
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et al., 2007). Additionally, the susceptibility of mosquitoes to infection by virus is dose 
dependent; therefore, low viraemia titres raised within the mammalian host can limit the 
transmission potential (Chamberlain and Sudia, 1961; Franz et al., 2015). The requirement for 
virus to then replicate to a threshold titre within the mosquito in order to enter or egress tissues 
such as the midgut and salivary glands has also been reported for a number of arboviruses 
including RVFV, WNV and WEEV (Gargan et al., 1983; Girard et al., 2004; Kramer et al., 1981). 
Therefore factors that have an adverse effect on viral titre, including temperature in the 
mosquito, could limit the ability of the vector host to support onward transmission. This is 
further complicated by the multitude of vector traits that are affected by temperature including 
the vector’s development time, longevity, fecundity, size, biting rate, metabolic rate, pathogen 
defence mechanisms and stress responses (Adelman et al., 2013; Johnson et al., 2015; Muturi et 
al., 2012, 2011; Reiskind and Zarrabi, 2012; Smith, 1975). 
Simplifying the processes by studying the effect of temperature on the mosquito and virus 
independently of one another is an important first step to assess the relative influences on 
replication. In vitro cell culture is a useful tool to improve understanding of the effect 
temperature has on viral replication kinetics. Although the focus of the project is on vector-virus 
interactions, it is important to consider viral growth kinetics in mammalian cells as RVFV must 
retain the ability to replicate in both vertebrate and invertebrate environments. The well 
characterised mammalian Vero E6 cell line and mosquito Clone C6/36 cell line, derived from 
Aedes albopictus, a mosquito species capable of transmitting RVFV at 26˚C in laboratory studies 
(Turell et al., 1988a), are commonly used tools to propagate RVFV and define viral replication 
dynamics. These cell lines are both deficient in innate immune pathways (interferon deficient 
Vero E6 cells and RNAi deficient C6/36 cells) (Brackney et al., 2010; Emeny and Morgan, 1979) 
resulting in cells highly permissive to viral infection and whilst not fully replicating the in vivo 
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environment this allows easy manipulation and preliminary assessment of viral replication 
dynamics. 
As quantitative molecular and virological assays demonstrating good inter and intra assay 
reproducibility and sensitivity are key for accurately detecting viral amplification in vitro and 
potentially low quantities of virus within mosquito samples in downstream experiments, the 
initial aim of this chapter is: 
To establish standardised methods of RVFV quantification 
These standardised methods of quantification are then applied to measure the effect of 
temperature on RVFV replication kinetics (change in titre over time) in a mosquito and 
mammalian cell line in order to test the hypothesis that: 
 
Low temperatures negatively affect RVFV replication kinetics independently of its 
mosquito vector. 
 
As it is reasonable to predict that the rate of RVFV replication will be reduced or cease at low 
temperatures, the ability of replication rates to ensue when thermal conditions are returned to 
optimal higher temperatures for viral replication, simulating a seasonal shift in temperatures in 
temperate regions, will be investigated. 
The results generated and discussed in this chapter were used to guide temperature 
selection in the downstream in vivo experiments in mosquitoes, discussed in Chapter 4. 
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3.2 Methods 
3.2.1 Virus quantification 
In order to accurately measure changes in viral titre in response to temperature over 
time, two methods of viral quantification were evaluated. Defining the assays’ efficiency, 
sensitivity and reproducibility was essential as these techniques were implemented for use 
throughout the project; in cell culture in this chapter and in downstream in vivo experiments 
assessing vector competence and viral adaptation in temperate mosquitoes (Chapter 4 and 5). 
 
3.2.1.1 Establishing a plaque assay 
Plaque assays are a functional measure of viral particles capable of infecting the cell 
monolayer. Standard methods from the literature were performed on a monolayer of the Vero 
E6 cell line derived from kidney cells of an African green monkey (Cercopithecus aethiops) (Baer 
and Kehn-Hall, 2014) to calculate infectious titres in plaque forming units (PFU). Virus inocula 
volume, cell seeding density and incubation times were assessed and parameters selected based 
on appearance and ease of counting the resultant plaques (data not shown). The optimised 
protocol is described in Methods Section 2.2.1. 
 
3.2.1.2 Establishing a PCR 
Quantitative reverse transcription (qRT)-PCR allows quantification of RNA titres expressed 
in genome equivalent copies (GEC). It offers a more rapid and sensitive method than the plaque 
assay, however, it does not distinguish between infective and non-infective virions. Two 
published qRT-PCR assays targeting nucleotides within the open reading frame (ORF) of the 
glycoprotein (GP) and nucleoprotein (N) on the M and S segments respectively were utilised 
(Drosten et al., 2002a; Weidmann et al., 2008), using a synthetic plasmid control as template 
detailed in Methods Sections 2.2.2 and 2.2.4. 
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Quantification by qRT-PCR targeting the M and S segments was compared using a 10-fold 
dilution of synthetic control and reported in GEC across a 7-log range. To define the assay limit 
of detections (LOD) and assay efficiency, three replicates were performed on three days (n=9), 
the LOD was considered the lowest dilution at which all replicates were detected. Linear 
regression was used to test change in cycle threshold (Ct) (y) by titre in GEC (x) and assays were 
compared by comparison of the slopes generated by t-test. 
Reproducibility and versatility are important criteria for quantification assays in order to 
gain confidence for data generated. These factors typically focus on the intrinsic capability for 
an assay to produce similar data when performed on different days; however as data for this 
study was generated at two institutes using different equipment and analysis platforms, 
additional validation was required to ensure assay robustness. A single replicate was performed 
using the M segment qRT-PCR on three days on the Mx3000P platform (Agilent) at APHA and 
compared to performance on the Viia 7 or 7500 platforms (Thermo Fisher Scientific) at PHE to 
confirm no loss in sensitivity or efficiency. 
 
3.2.2 Measuring the effect of temperature on RVFV replication kinetics 
To study the effect of temperature on RVFV replication; T25 flasks containing confluent 
Vero E6 or C6/36 cells were infected in triplicate with RVFV strain Lunyo or ZH501 at an MOI of 
0.1 as described in Methods Section 2.1.3. Technical replicates were setup in parallel in a single 
experiment. Although performing a one step-growth curve using a high multiplicity of infection 
(MOI) designed to infect all cells simultaneously is typically used to characterise viral replication, 
this method was not selected here as was not considered as physiologically relevant when 
applying the results generated to predict potential results in mosquitoes. Preliminary studies, 
performed to optimise titres for creating viral stocks in Vero E6 cells at a single collection time 
point, showed no difference between the titre yielded from an MOI of 0.1 or 0.01 (data not 
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shown). Multi-cycle growth curves were therefore determined in C6/36 and Vero E6 cells 
infected with RVFV at an MOI of 0.1. 
Vero E6 cells were incubated for 7 days at 28˚C or 37˚C with 5% CO2. This mammalian 
Vero E6 cell system was selected as a baseline rate for comparison of replication at high 
temperatures. It was also considered a core cell line within the project, used to propagate viral 
stocks used throughout the study for consistency between experiments, therefore important to 
characterise replication kinetics within. These cells were not incubated at lower temperatures as 
incubation of mammalian cells below 24˚C results in detachment and pausing (Hunt et al., 
2005). Additionally the study of these cells at temperatures well below that of the 
homeothermic host would not be biologically relevant. 
C6/36 cells were incubated for 10 days at regular temperature intervals: 12˚C, 20˚C, 28˚C 
or 37˚C. Temperature selection was based on UK averages reviewed in Chapter 1 Section 1.2.8 
and the temperature thresholds of Ae. caspius, 11.5˚C-36˚C (Reviewed in: Milankov et al., 2009). 
Total virus (intracellular and extracellular) was harvested at 0, 3, and 8 hours post 
infection (h.p.i) then daily for 7 or 10 days by placing flasks at -80˚C. RVFV was quantified in 
duplicate by plaque assay and by two qRT-PCR assays (targeting the M and S segments), the 
mean titres for each time point were used to generate growth curves. 
 
3.2.2.1 Measuring replication rates at 28˚C following a low temperature passage 
In order to investigate the potential for rates of RVFV replication to return when 
temperature is raised to more optimal conditions for viral replication, RVFV harvested at 10 dpi 
in cells incubated at 12˚C was passaged in C6/36 cells at 28˚C. The mosquito cell line was 
selected here to simulate the scenario where virus had overwintered within the mosquito but 
needs to replicate first within this same mosquito to initiate a potential horizontal transmission 
event whilst blood feeding. 
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3.2.3 Measuring the effect of temperature on uninfected cells 
As viral replication requires use of the host cell replication system, any effect of 
temperature on the host cells’ ability to replicate will also affect the potential for viral 
replication. Uninfected controls were set up in parallel to understand the effect of study 
temperature on the viability of cells independently of virus. At the time of analysis, techniques 
were not established to perform viability counts on infected cells so uninfected cells were also 
used as a proxy. Cells at 85% confluency were mock infected with DMEM and incubated for 1 
hour to replicate viral absorption, inoculum was then removed and replaced with maintenance 
media. Vero E6 cells were maintained at 28˚C or 37˚C for 7 days, C6/36 cells at 12˚C, 20˚C, 28˚C 
or 37˚C for 10 days. Viability was recorded periodically by vital staining with trypan blue 
(Thermo Fisher Scientific) after 3, 7 and 10 days and cell morphology observed daily by light 
microscopy to assess the overall health of cultures, looking for signs of overcrowding, rounding 
and detachment. 
 
3.2.4 Statistical analyses 
Statistical analyses were performed in GraphPad Prism version 5.04 for Windows, 
GraphPad Software, San Diego California USA, www.graphpad.com. Analyses are described in 
detail in all graphical representations of data but are described in brief here. 
The efficiency of the qRT-PCR assays was determined by linear regression, a PCR with an 
efficiency of 90-110% will have a slope within the range of -3.58 to -3.10. Comparison of the two 
assays was performed by t-test of the resultant slopes. Titres expressed in GEC by PCR and PFU 
by plaque assay were compared by Pearson’s correlation, to determine the relationship 
between quantification methods. 
Live cell counts and viability of uninfected controls were assessed by a two-way analysis of 
variance (ANOVA) with Bonferroni corrected threshold for multiple comparisons over time. 
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Because the ANOVA test treats time as any other parameter, alternative statistical analyses 
were selected to test the relationship with titre over time across different temperatures. The 
core parameters tested were rate of replication applying a linear regression model comparing 
the exponential growth phases for each condition as performed by Wang et al. (2006) and peak 
titre, the resultant slopes and titres were then compared by Mann Whitney test to compare two 
variables or Kruskal-Wallis to test multiple variables with Dunn’s post-test for multiple 
comparisons. Descriptive statistics of the average time to peak and exponential phase were also 
compared. 
 
3.3 Results 
3.3.1 Comparability of the qRT-PCR and plaque assay 
The limit of detection of the qRT-PCRs were 10 and 100 GEC/µL of extract for the M and S 
segments respectively. The slopes generated from a 10-fold dilution of synthetic control 
demonstrated good assay efficiency (M segment: slope=-3.379 ±0.09672, S segment: slope=-
3.551 ±0.09672) and did not differ significantly (p=2.01) when compared by t-test (Figure 3.1; 
Panel A). 
Quantification of RVFV strain ZH501 by plaque assay was compared in triplicate to mean 
titres determined by the M and S segment qRT-PCRs (Figure 3.1; Panel B) demonstrating the 
expected linear relationship (slope=1.040 ±0.04360; R2= 0.9776). The limit of detection of the 
plaque assay was 10 PFU/mL equivalent to 105.2 GEC. The titres quantified by these two 
methods demonstrated good correlation (p=<0.0001), with a Pearson’s correlation coefficient of 
(r) 0.9824. On average, titres calculated in GEC were 4.1-log (range: 3.7-5.0) higher than titres 
reported in PFU. 
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Figure 3.1 Comparison of viral quantification methods. Serial 10-fold dilution of A. RVFV synthetic 
transcript control was used to compare two qRT-PCR assays targeting the M and S segments 
performed in triplicate on three days B. RVFV strain ZH501 was quantified by qRT-PCR or plaque 
assay in triplicate to compare the molecular and virological assays. GEC: genome equivalent copies 
calculated by qRT-PCR; PFU: plaque forming units. Data were log10 transformed and a linear 
regression model applied represented by solid lines, dotted lines; 95% confidence band; error bars: 
95% CI, calculated in GraphPad Prism. 
 
3.3.1.1 PCR assay robustness 
The results presented in Figure 3.2 demonstrate compatibility between Thermo and 
Agilent platforms (PCR performed at APHA on Agilent platform: slope=-3.202 ±0.08762), with no 
significant difference between the slopes generated by 10-fold dilution of synthetic template 
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(t-test: p=0.2854). Therefore, where required, the M segment qRT-PCR assay was performed 
interchangeably at both institutes. 
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Figure 3.2 qPCR assay robustness. The RVFV M segment qRT-PCR was performed using standardised 
reaction setup and cycling conditions on two PCR platforms to test assay robustness. Assays were 
performed in triplicate on the Mx3000P platform (Agilent) in comparison to the Viia 7 or 7500 
platforms (Thermo Fisher Scientific). Results show no loss in sensitivity or efficiency compared to 
performance on at PHE, there was no significant differences between the slopes (t-test: p=0.2854), 
data points represent the mean of 3 replicates, error bars: 95% confidence interval. 
 
3.3.2 Effect of temperature on the viability of uninfected cells 
There were no observable differences in morphology between the highest and lowest 
monitored temperatures in either cell line. However, by later time points, day 7 for Vero E6 and 
day 10 for C6/36, cells appeared smaller and rounder with Vero E6 cells commencing growth in 
multi-layers and C6/36 cells beginning to detach. Live cell counts and viability were compared by 
two-way ANOVA with Bonferroni post-test in GraphPad Prism, demonstrating a significant 
interaction between time and temperature. No significant difference was recorded in viability or 
count between the monitored temperatures in Vero E6 (Figure 3.3; Panel B and D) or between 
12˚C and 28˚C in C6/36 (Figure 3.3; Panel A and C), demonstrating both cell lines tolerate a 
range of temperature environments. However, C6/36 incubated at 37˚C had significantly 
reduced live cell counts (0.3-0.5 log reduction) and viability (6-12% reduction) compared to all 
temperatures at days 7 and 10. 
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These data show that both cell lines are capable of replicating at temperatures lower than 
the considered optimal levels, and any differences observed in virus replication between 12˚C 
and 28˚C in mosquito cells and 28˚C and 37˚C in mammalian cells are not exclusively due to the 
effect of temperature on the cells. 
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Figure 3.3 Viability of uninfected cells. C6/36 cells were propagated at 28˚C and Vero E6 cells at 
37˚C until 85% confluent, media was removed and cells were mock infected with 0.5mL DMEM for 1 
hour. Inoculum was removed and 6mL maintenance media added, live cells were counted and 
viability calculated by vital staining at the indicated time points. A and C: C6/36 cells incubated at 
12˚C, 20˚C, 28˚C or 37˚C B and D: Vero E6 cells incubated at 28˚C or 37˚C. Data points represent the 
mean of three technical replicates collected in a single experiment, analysed by two-way ANOVA 
with Bonferroni post-test; α: value significantly different from all temperatures; β: value significantly 
different from data collected at 28˚C; error bars: 95% CI, calculated in GraphPad Prism. 
 
3.3.3 Effect of temperature on RVFV replication kinetics 
With results in Section 3.3.2 demonstrating a minimal difference between viability and 
live counts of uninfected cells throughout the time course of the experiment, the effect of 
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temperature on RVFV in vitro replication was next examined. A two-way repeated ANOVA was 
considered for result analysis but rejected on the grounds of violating test assumptions. Because 
the ANOVA test treats time as any other parameter, the order is not accounted for. Instead, 
alternative methods to better define the relationship with time were selected, including 
replication rate, peak titres and time to peak. The result and the relevance of measuring each is 
presented in turn in this section. 
 
3.3.3.1 Rates of replication 
The growth curves generated from experiments described above are shown in Figure 3.4. 
Rates were compared applying a linear regression model comparing the exponential growth 
phases for each condition as performed by Wang et al. (2006). In brief, data points outside of 
the exponential phase, which are defined in Table 3.1, were excluded and change in titre (y) as a 
function of time (x) was determined by linear regression for each replicate. The resultant slopes 
were then compared across conditions using the Mann Whitney test to compare two variables 
or Kruskal-Wallis to test multiple variables with Dunn’s post-test for multiple comparisons. 
In mosquito cells, replication rates for both strains were significantly higher at 37˚C 
compared to at 12˚C (p=<0.0005) and 20˚C (p=<0.05), and at 28˚C compared to 12˚C (ZH501 
p=<0.05, Lunyo p=<0.005), when observing titres expressed in GEC. However, the replication 
rate measuring infectious virions was only significantly higher at 37˚C compared to 12˚C, again 
observed for both strains (p=0.0027). Rates in Vero E6 cells were significantly higher at 37˚C 
compared to 28˚C for both strains expressed in GEC (Lunyo p=0.0050, ZH501 p=0.0022) but only 
for Lunyo determined in PFU (Lunyo p=0.0294, ZH501 p=0.3429). 
In all cases, the rates were higher when calculating slopes in GEC compared to PFU; in 
most cases this increased rate was statistically significant, with the exceptions of both strains at 
28˚C in Vero E6 cells and ZH501 at 20°C in C6/36 cells. Rates were significantly higher in all cases 
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in Vero E6 cells compared to C6/36 cells when comparing matched strains and temperatures. 
The implications of these observations will be discussed within in the context of all the observed 
parameters in Section 3.4. 
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Figure 3.4 Effect of temperatures on Rift Valley fever virus replication in C6/36 and Vero E6 cells. 
RVFV strains ZH501 and Lunyo were propagated at 12˚C, 20˚C, 28˚C or 37˚C in C6/36 and Vero E6 
cells. Cells were infected at an MOI of 0.1. Data points represent the mean of three technical 
replicates collected in a single experiment at the indicated time points. Infectious viral particles were 
quantified by plaque assays in duplicate on Vero E6 cells and genome copies quantified by two qRT-
PCRs targeting each genome segment. Data points represent the mean for the M and S segments. 
Error bars: 95% CI, GraphPad Prism. 
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Table 3.1 Average time and duration of the exponential growth phase 
Cell line Strain 
Temperature 
(˚C) 
Exponential growth phase 
(hours) 
PFU GEC 
C6/36 
ZH501 
12 24 - 240* 144 - 240 
20 24 - 72 24 - 72 
28 8 - 24 8 - 24 
37 8 - 24 3 - 8 
Lunyo 
12 24 - 240* 120 - 240 
20 48 - 120 24 - 72 
28 8 - 120 8 - 24 
37 8 - 48 3 - 24 
Vero E6 
ZH501 
28 8 - 24 8 - 24 
37 3 - 24 0 - 8 
Lunyo 
28 8 - 24 3 - 24 
37 8 - 24 3 - 8 
Numbers are based on the mean between replicates of infectious titres (PFU) and RNA titres (GEC). 
*: no increase in titre observed therefore values indicate times used to perform linear regression to 
calculate slope only. 
 
3.3.3.2 Peak titres 
The titres generated within both the mammalian and mosquito host can have a significant 
effect on whether virus can be subsequently transmitted, with potential dose dependencies for 
entry and egression of sites within the mosquito requiring replication to high titres within both 
hosts to support onward transmission. Therefore peak RVFV titres were measured in cells 
incubated at a range of temperatures between 12˚C and 37˚C to better understand potential 
transmission dynamics in the UK. 
Peak titres are compared in Figure 3.5, with ZH501 titres marginally higher under optimal 
conditions for each cell line (37˚C for Vero E6 and 28˚C for C6/36 cells) and infectious titres of 
Lunyo slightly higher in both cell lines at 28˚C, though this latter observation was not statistically 
significant. These results corroborate the finding in 3.3.3.1 comparing replication rates; 
demonstrating significantly higher titres in GEC at 37˚C and 28˚C compared to 12˚C by both 
strains in C6/36 cells. Despite the highest rates of infectious particle replication recorded at 
37˚C, PFU titres were only significantly higher at 28˚C versus 12˚C. Taken together, these data 
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confirm that while viral replication can occur at temperatures below the considered optimum, 
peaks titres can be significantly lowered. Such a reduction in viral titre could have a marked 
impact on the ability of the virus to cross barriers within the mosquito host and establish an 
infection in the salivary glands, thereby limiting the potential for onward transmission. 
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Figure 3.5 Comparison of peak viral titres following replication at 12˚C to 37˚C. Bars represent the 
mean peak RVFV titres across two replicates, quantified in duplicate in C6/36 cells or Vero E6 cells 
infected with RVFV strain Lunyo or ZH501 at an MOI 0.1, following incubation at 12˚C to 37˚C. 
Infectious titres at 12˚C did not increase during the time course so peak titres represent the 
maintenance of input infectious virion titres. Mann Whitney test was used to compare between two 
temperatures in Vero E6 cells and Kruskal-Wallis test to compare four temperatures in C6/36 cells 
with Dunn’s post-test for multiple comparisons. Error bars: 95% CI; solid lines: comparison of GEC 
titres calculated by qRT-PCR; dotted lines: comparison of infectious titres in PFU. 
 
3.3.3.3 Time to peak titres 
A delay in producing peak titres (3.3.3.2) that support progression of virus through its 
vector host could increase the EIP, thereby, affecting the potential for onward transmission. Any 
effect on the temporal dynamics of transmission leading to an increase in time may cause delay, 
reduce or even prevent the occurrence of transmission events. The time required to attain these 
Results: The effect of temperature on in vitro replication kinetics 
74 
 
peak titres is summarised in Table 3.2. Peak titres in GEC were generally recorded at later time 
points than in PFU, with RNA titres continuing to increase after infectious titres plateaued; this 
was particularly prominent in the mosquito cells. Further still, in the mosquito cells, time to 
maximal yields decreased as temperature increased, but was slower overall compared to Vero 
E6 cells. Differences between strains were minimal, with Lunyo slower to reach maximal yields 
at 20˚C in C6/36 cells and at 28˚C in Vero E6 cells compared to ZH501. 
Table 3.2 Average time to peak titres 
Cell line Strain 
Temperature 
(˚C) 
Hours to peak titre 
PFU GEC 
C6/36 
ZH501 
12 >240 240 
20  96 168 
28 120 120 
37  72 104 
Lunyo 
12 >240 240 
20 240 240 
28 114 144 
37  72  88 
Vero E6 
ZH501 
28  42  48 
37  48  48 
Lunyo 
28  90  88 
37  48  48 
Numbers are based on the mean between replicates recorded of infectious titres recorded in plaque 
forming units (PFU) and RNA titres recorded in genome equivalent copies (GEC). 
 
3.3.3.4 Comparing the difference in infectious particle to RNA titres 
Comparison of the two measures of viral titre, genome copies and infectious virus, prior 
to exponential growth offers insights into the eclipse phase (where virus has entered the cell 
and uncoating has begun but progeny virions have not been produced) with this stage of the 
replication cycle demonstrating the greatest variability. The measure of time recorded here is a 
simplification of the events occurring: encompassing viral attachment, entry, uncoating, and 
transcription/replication, in order to measure an increase in GEC, and further includes assembly 
and maturation to occur in order for the functional measure of PFU to increase. These are 
Results: The effect of temperature on in vitro replication kinetics 
75 
 
recorded in the final column of Table 3.1 on page 72; however, in most cases the time points did 
not capture a discernible difference between onset of replication and maturation, except at 
37˚C under all conditions and Lunyo at 20˚C in C6/36 cells. 
The difference between the two distinct measures of early (genome transcription and 
replication) and late phases (packaging of mature progeny virions) of replication can be further 
exploited to give insights into the processes. The relative difference between levels of infectious 
and genome copy titres were calculated for each time point by subtracting PFU from GEC. On 
average, RNA titres were 3.84 logs higher than PFU, peaking at 5.63 logs at the end of the 
eclipse phase, with the most pronounced differences recorded in Vero E6 cells infected with 
ZH501. These values are presented in Table 3.3, with values shaded from high to low for each 
temperature variable. This highlights the peak increase in differences are occurring at the end of 
the eclipse phase at a stage when transcription/replication has occurred but virus is yet to be 
assembled at the Golgi complex and mature into infectious particles; further showing the 
extension in the eclipse phase as temperatures decrease. Additional time points in which 
differences between the two measures are high are at the late time points demonstrating the 
potential relative stability of genomic content compared to infectious virions. These results 
further illustrate the benefit of multiple methods to quantify viral titres. 
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Table 3.3 Temporal differences in the ratio of infectious viral particles to viral RNA titres 
Hours 
post 
infection 
C6/36 Vero E6 
ZH501 Lunyo ZH501 Lunyo 
12˚C 20˚C 28˚C 37˚C 12˚C 20˚C 28˚C 37˚C 28˚C 37˚C 28˚C 37˚C 
0 4.17 3.58 3.87 3.84 2.52 2.80 2.95 2.93 4.51 4.12 3.34 3.37 
3 4.00 3.54 3.75 3.72 3.14 3.43 3.18 2.54 4.03 5.03 3.26 3.19 
8 4.20 3.68 3.98 5.07 3.29 3.10 3.49 4.40 4.18 5.63 3.70 5.40 
24 3.98 4.06 3.70 3.41 3.35 3.14 4.00 4.16 4.50 3.70 3.82 3.66 
48 3.84 4.26 3.55 3.37 3.22 4.12 4.76 3.60 4.68 3.84 3.45 3.83 
72 3.78 4.13 3.58 2.99 2.98 4.66 4.43 3.34 4.89 3.60 3.55 3.74 
96 3.77 4.05 3.49 3.07 3.88 4.81 4.34 3.51 5.00 3.92 3.52 3.48 
120 3.77 4.14 3.55 3.08 2.42 4.39 3.82 3.45 4.85 3.86 3.25 3.89 
144 3.66 4.16 3.40 3.22 3.60 4.19 4.25 3.47 4.94 3.90 3.23 3.54 
168 3.99 4.32 3.39 3.56 3.89 4.36 4.13 3.47 4.80 4.43 3.77 3.65 
240 5.50 4.36 3.47 4.05 4.65 4.63 3.71 3.84 x x x x 
Differences in the quantity of functional infectious titres (PFU) and total viral RNA (GEC) titres were 
calculated, subtracting log 10 titres expressed in PFU from GEC. Values are shaded darkest from high 
to low within each column to highlight temporal changes in relative abundance of infectious virions 
and RNA are affected by temperature and cell line. 
 
3.3.3.5 Analysis of replication at 28˚C after passage at 12˚C 
The results presented have demonstrated RVFV has only limited ability to transcribe or 
replicate its genome and did not produce mature packaged virions in C6/36 cells at 12˚C across 
the course of 10 days. Despite this, the infectious titres of RVFV were stable throughout the 10 
day experiments. The potential for virus to survive cold conditions in overwintering adult female 
mosquitoes or remain viable after potential vertical transmission to the egg or progeny would 
be significant if replication rates ensue when environmental conditions become favourable to 
support transmission. 
The replication rate at 28˚C in mosquito cells after passage at 12˚C is compared in Figure 3.6 to 
the original rates recorded at the constant temperature of 28˚C (which were presented 
previously in Figure 3.4). Results demonstrate both the rate of replication and titres of RVFV 
strain ZH501 and Lunyo return after a slightly increased eclipse period when temperatures are 
increased to 28˚C. The peak titres recorded in each case were within one log of the original titre 
resulting from a single passage at the constant temperature of 28˚C. These titres were, 
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however, significantly lower in Lunyo after the single passage at 12˚C (PFU: p= 0.0265, GEC: 
p=0.0238). For ZH501 the reverse was true, with no significant difference between the titres 
recorded in GEC (p=0.2619) but significantly higher titres in PFU recorded at 28˚C after prior 
passage at 12˚C (p=0.0294). No differences in the time to peak titres were recorded in either 
strain when comparing the temperature regimens. 
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Figure 3.6 Viral replication rates at 28˚C after propagation at 12˚C. RVFV strains ZH501 and Lunyo 
harvested after replication at 12˚C for 10 days were passaged on fresh C6/36 at 85% confluency and 
incubated at 28˚C for 10 days. Blue data points represent the previously presented replication data 
at 28˚C in C6/36 cells for reference. Data points represent the mean of three technical replicates 
collected in a single experiment at the indicated time points. Infectious viral particles were 
quantified by plaque assays in duplicate on Vero E6 cells and genome copies quantified by two qRT-
PCRs targeting each genome segment. Data points represent the mean for the M and S segments. 
Error bars: 95% CI, GraphPad Prism. 
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The rates of replication were compared as performed previously in Section 3.3.3.1, the 
exponential growth phases were compared by linear regression and the resultant slope 
compared by Mann Whitney test (Wang and Bushman, 2006). The exponential phases recorded 
by PFU occurred between 24 and 48 hpi (GEC: 8-48 hpi) for ZH501 and 24 and 96 hpi (GEC: 8-72 
hpi) for strain Lunyo. The rates of infectious particle production were not significantly different 
for strain ZH501 (p=0.6857) but rates of RNA amplification were significantly reduced in the 12˚C 
to 28˚C compared to the constant 28˚C setup (p= 0.0238). The rates of replicating strain Lunyo 
infectious particles and genome were both significantly reduced after passage at 12˚C (PFU: 
p=0.0294, GEC: p=0.0238). 
 
3.4 Discussion 
In this chapter quantitative molecular and virological assays were standardised and 
applied to investigate the effect of temperature on RVFV replication kinetics independently of 
its mosquito vector. This has been delivered using cell culture systems to mimic the potential 
temperatures encountered by the virus within its vector host. The data presented in this chapter 
showed a reduction in both replication rate and titres yielded of RVFV as temperature 
decreased from 28˚C to 20˚C and cessation of the full replication cycle at 12˚C. The data 
generated provide useful information in predicting how RVFV will replicate in mammalian and 
mosquito cells, setting a conservative estimate of the minimum temperature required to 
support replication at 20˚C. However, it is acknowledge that there is an 8˚C gap between the 
temperatures investigated, requiring further work to determine a more accurate lower 
threshold for RVFV replication. 
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3.4.1 Strengths and limitations of the cell lines 
Before inferences can be made based on the data presented, it is important to evaluate 
the relevance of methods and the cell culture systems used to generate these results in order to 
use them to predict responses in vivo. Cell cultures represent a model system; they do not 
replicate the exact physiological environment within the host but provide an environment to 
produce preliminary results in. 
The optimal temperature for virus replication is not necessarily the same as that for cell 
growth. This is the case whether studying cell systems or the whole organism, the question is 
whether the response observed in the cell system is representative of the cellular response to 
temperature within the whole organism. The direct effect of studying cells outside of their 
temperature optima on viral replication is challenging, therefore uninfected controls were set 
up to observe the effect of temperature on the viability of cells independently of the virus 
demonstrated the robustness of the mosquito cells to tolerate a range of temperature from 
12˚C to 37˚C. Overheating is considered more detrimental, pertinent here to the mosquito cells, 
so determining the upper temperature threshold has been the focus of previous research (Kuno 
and Oliver, 1989). These findings were supported here with C6/36 cells held at 37˚C showing 
significantly reduced viability at late time points; however, the impact of this on viral replication 
was likely limited as changes in morphology and loss of viability occurred after peak titres of 
RVFV replication were recorded. Although data are available on the upper temperature 
thresholds in insect cells, there are limited data on low temperatures. Presumably, the ability of 
C6/36 cells to support the full replication cycle of Salmonid alphavirus (SAV; Alphavirus) at its 
natural environmental temperature of 15˚C (Hikke et al., 2014) and replication of Tahyña virus 
(TAHV; Orthobunyavirus) albeit at reduced rates and titres at 10˚C and 15˚C (Danielová, 1975), is 
evidence that host cellular processes required for viral replication do occur at low temperatures. 
It has been proposed that optimal temperatures for arthropod cell cultures may reflect their 
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optima in nature (Rothblat and Cristofalo, 1972). Whether this relationship can be extrapolated 
to environmental temperatures encountered by a virus within its vector is explored in vivo in 
Chapter 4. 
Uninfected controls demonstrated temperatures were also tolerated by the mammalian 
Vero E6 cells with no significant difference between viability at 28˚C or 37˚C, and changes in 
morphology indicating cellular stress were again recorded in non-infected controls after the 
peak titres were recorded in infected cells. However, this basic characterisation of cell counts 
and morphology in both cell systems relied upon viability assessed by proxy in uninfected cells 
as decontamination of counting chambers, in order to perform cell counts manually by light 
microscopy outside of the MSC III, was not possible without negatively affecting the cells. Future 
studies could utilise a countess automated cell counter (Thermo Fisher Scientific) that would fit 
within the MSC III using disposable counting chambers in order to assess the effect of virus on 
viability in infected cells in addition to the controls; however, the equipment was not available 
for use in either ACDP CL3 facility at the commencement of these studies. 
One limitation of the results presented is the cell lines themselves, both are deficient in 
innate immune response pathways (Brackney et al., 2010; Emeny and Morgan, 1979). The 
impact of these deficiencies on the temperature response was predicted to be low due to 
previous studies having observed comparable rates of RVFV replication in immunocompetent 
and compromised mosquito and mammalian cells (Brennan et al., 2011b; Welch, 2014). 
However, these previous experiments cannot be fully extrapolated as they were performed at 
the single optimal temperature for each cell line and higher titres were obtained from the 
immune deficient cells. Further still, the RNAi response was impaired in Ae. aegypti, reared at 
low temperatures of 18˚C compared to 28˚C, during infection with YFV and CHIKV (Adelman et 
al., 2013). This finding raises the possibility that innate immune responses may be 
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downregulated at suboptimal environmental temperatures thereby limiting their involvement at 
the temperatures studied in cell lines here. 
Acquiring mosquito cell lines from other research establishments in addition to efforts to 
generate a cell line from the Cx. pipiens colony lines were unsuccessful. An alternative that could 
have been utilised is the U4.4 cell line also derived from Ae. albopictus (Condreay and Brown, 
1986) with a competent RNAi pathway. However, acquiring this cell line before the 
commencement of these studies was not feasible and reproducing these data in additional cell 
lines, within the course of this project, was deemed of low priority having established the 
chapter objective to observe the effect of temperature on RVFV independently of its vector. 
 
3.4.2 The effect of temperature on peak titres 
RVFV alternates its replication cycle between disparate mammalian and mosquito hosts 
and the viral titres attained in each can have a pronounced effect on the survival of the 
arbovirus. The acquisition of virus by the vector to support onward replication is dose 
dependent, therefore reliant upon titres in the mammalian host and the volume of blood meal 
imbibed (Chamberlain and Sudia, 1961; Turell et al., 1988b). The subsequent potential for virus, 
once acquired, to progress through the vector for onward transmission can also depend on 
replication to a threshold level (Gad et al., 1987; Gargan et al., 1983; Hardy et al., 1983; Kramer 
et al., 1981). Differences in titres in response to temperature were studied in cells prior to 
performing experiments in mosquitoes (Figure 3.4). Comparable viral titres were observed in 
mammalian and mosquito cells at 28˚C and 37˚C, with maximal titres generally produced at the 
optimal temperature of each: 37˚C for Vero E6 and 28˚C for C6/36 cells. As temperature 
decreased from 28˚C, the titre reduced with a 100-fold decrease recorded at 20˚C compared to 
28° C (Figure 3.5). RNA titres continued to rise for a short period after PFU titres plateaued; 
whether this reflects the relative stability of viral RNA compared to infectious virions or if host 
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cell processes leading to virion packaging and maturation cease whilst maintaining limited 
support of RNA synthesis requires further experimental investigation. At 12˚C the production of 
infectious particles fell below detectable levels but importantly, after 10 days, both strains of 
RVFV studied showed an increase in RNA titres demonstrating survival at 12˚C. These results 
suggest low temperatures (of 20˚C or below) may limit the ability of RVFV to replicate to titres 
that would support progression of virus to the salivary glands limiting transmission in temperate 
climates. The ability of virus to replicate in vivo in the mosquito host at 20˚C is investigated in 
Chapter 4. 
 
3.4.3 Rate of replication in cells and implications for replication in mosquitoes 
Rapid rates of viral replication confer a mixed benefit in terms of vector transmission of an 
arbovirus. Increased rates of replication will likely reduce the EIP and increase transmission 
rates; however, survival of the virus is reliant upon survival of the host and high viral titres have 
been linked with tissue damage or resource depletion (Girard et al., 2005; Romoser et al., 1992) 
and increased mortality of RVFV infected mosquitoes (Faran et al., 1987). The balance between 
survival and EIP is fine, assuming the mosquito lives beyond the EIP to bite a susceptible host, 
the viral lifecycle will continue (Smith, 1975). The gradual rise in titre observed at 20˚C 
compared to rapid amplification at higher temperatures, therefore, may prove beneficial to 
transmission, reducing virus induced cell death whilst promoting mosquito longevity. 
Despite the slowed growth rate previously observed in mammalian cell lines as 
temperature decreases from 37˚C to 28˚C (Watanabe and Okada, 1967), the rates of viral 
replication (comparing the constant exponential phase of growth) were not affected by 
temperature in Vero E6 cells. The rates of viral replication in mammalian cell lines were faster 
than in mosquito cells at the two temperatures measured, even at the optimal 28˚C for C6/36, 
consistent with previous findings (Vaughn et al., 2010). Whilst it is feasible that virus adopting a 
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steady rate of replication to generate persistent infection in the vector compared to rapid 
replication in the mammalian host leading to haemorrhagic fever would be advantageous for 
viral maintenance, these factors are likely modulated by host factors that were outside the 
scope of this project and largely removed from this model using innate immune pathway 
deficient cell lines. Alternatively, and perhaps more likely, this observation could be an artefact 
of the provenance of the virus strains having been propagated in mice and Vero E6 cells. This 
hypothesis is supported by Moutailler et al. (2011) with closely related strain ZH548 (99.8%, 
99.8% and 99.9% nucleotide identities in the L, M, and S segments, DQ375403, DQ380206, 
DQ380151 to strain ZH501), demonstrating a steady rate of replication in mosquito cells 
compared to mammalian cells that was overcome by persistent passage within the mosquito 
cell line. Whilst the authors demonstrate the extreme effects of 30 serial passages in an 
individual cell line, far beyond the passage history of strains used here (maximum p11), care 
should be taken when extrapolating cell culture results. Genomic analysis of the consensus 
sequence, further discussed in Chapter 5, confirmed any replicative advantage due to virus 
progeny does not result from consensus sequence adaptation in cell culture, suggesting minimal 
adaptation. 
At 28˚C and 37˚C infectious particles were typically detected after 8 hours with the time 
required to detect an increase in virion production increasing by over 24 hours when 
temperature was decreased to 20˚C, demonstrating a steady rate of replication with titres still 
increasing at day 7. At 12˚C there was no increase in infectious viral titres. Studies of the effect 
of low temperatures on the early stages of the replication cycle of Semliki Forest virus (SFV; 
Alphavirus) concur with the results reported in this chapter; with reduced titres and increased 
time to shedding observed as temperatures decreased (by 3 hours for every 1˚C decrease) 
(Vallan et al., 1994). The authors also observed cessation of virion shedding at 12˚C 
hypothesising the restricted transport of proteins at these low temperatures as the cause. It is 
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possible that similar mechanisms were at play in the attenuation of RVFV in Cx. pipiens at 13˚C 
(Turell et al., 1985), though the underlying mechanisms were not evaluated. Results reported in 
this chapter also measured the whole process, measuring the overall production and rate of 
RNA (GEC) and virions (PFU), whilst the exact mechanism cannot be pinpointed, the increased 
GEC without increased PFU shows a process downstream of RNA replication including protein 
transport. Further work is needed to fully elucidate what the temperature-sensitive rate limiting 
factors are in the replication cycle and the extent to which they are affected in different 
environments. 
These results generated from monitoring RVFV growth dynamics at varying temperatures 
facilitated the selection of temperatures to apply to mosquitoes in vector competence studies 
discussed in subsequent chapters. 
 
3.4.4 Implications of higher qPCR than infectious titres 
The qRT-PCR assays utilised measure all genetic material present in the sample, both 
functional and non-functional unpackaged genomic content, including the transcribed mRNA 
and replicated genomic RNA, therefore RNA titres measured by RT-PCR will be higher than 
functional titres measured by plaque assays. The 3-5 log difference in RNA titres compared to 
infectious titres by plaque assay (Table 3.3) is supported by previous findings. Weidmann et al. 
(2011) used electron microscopy to quantify the number of viral particles (for a range of highly 
pathogenic viruses) in comparison to genomic and infectious content, demonstrating that RVFV 
over produces its genome compared to particles, in addition to the multiple virions required to 
produce infectious foci in virological assays. The surplus of genome or particles observed by 
Weidmann et al. (2011), varied between virus, indicative of different packaging strategies or 
efficiencies. It is feasible, therefore, that strain differences may also occur and RVFV ZH501 in 
this study typically had a higher ratio of GEC:PFU than strain Lunyo. In the case of RVFV, the 
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excess of genomic content may stem from the stochastic packaging strategy of genome 
segments observed by Wichgers Schreur and Kortekass (2016) using fluorescent in situ 
hybridisation (FISH) technology. The results presented in this chapter demonstrated the rate of 
RNA amplification was greater than virion production with a peak five log difference in GEC and 
PFU produced at 37˚C. This may in part be due to the non-selective packaging strategy but also 
reflects a difference in the efficiencies in the two processes (RNA transcription and replication 
versus protein production and packaging) as the differential ratio typically returned to the base 
level of three to four logs in the following 24 hours. It is feasible that differences in the reports 
of persistent infections that do not cause harm to the vector (Reviewed by: Chamberlain and 
Sudia, 1961; and Clements, 2011) versus reports of viral induced damage within the vector 
(Faran et al., 1987; Girard et al., 2007; Weaver et al., 1992) may be a factor linked to the 
replication and packaging strategies employed by different viruses or even strains. Further work 
could extend the findings reported here to include assessing the expression of host proteins in 
response to stress induced by replication and temperature and some potential molecular 
markers are presented by Muturi et al. in larvae (2012, 2011). However, gaps in knowledge on 
the basic ability of mosquitoes to support replication are first required before the underlying 
mechanisms can be addressed. 
Despite differing titres by the two methods, the pattern of replication correlated well for 
plaque assay and qRT-PCR data and exploiting the differences between detecting functional 
virions and the sensitive detection of total RNA gave insights into the eclipse phase. These 
results confirm the value of determining both PFU and PCR in in vivo mosquito experiments as 
highlighted by Vloet et al. (2017) and therefore both assays were used to study replication in the 
mosquito host discussed in Chapter 4. 
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3.4.5 Replication ensues when virus maintained at 12˚C is returned to 28˚C 
The theoretical ability of RVFV to survive at low temperatures (that are sub-optimal for 
viral replication) in the UK until local conditions are favourable to support viral replication 
horizontal transmission is necessary for its potential establishment. The stability of infectious 
viral titres at 12˚C is important for potential RVFV maintenance within temperate regions where 
average temperatures in winter are too low to support viral replication and vector activity. 
When virus passaged at 12˚C was returned to 28˚C (Figure 3.6), the rates of replication (albeit a 
decreased rate in the case of Lunyo) and viral titres returned to within one log of those yielded 
from cells maintained at a constant temperature of 28˚C. Despite a slightly increased eclipse 
period, this result is significant as it simulates a potential scenario in which virus survives within 
an overwintering mosquito with viral replication supported once temperatures are increased in 
spring or summer as demonstrated in laboratory studies of WNV (Kramer et al., 2011). This 
finding is supported by results in Egyptian Cx. pipiens showing lower infection rates and titres of 
RVFV in mosquitoes held at 13˚C compared to 26˚C, but this was also reversible with titres and 
infection rates returning when specimens were transferred to 26˚C (Turell et al., 1985). Based 
on a thorough literature search these data, on the maintenance of infectious RVFV and RNA 
replication at low temperatures, have not been shown in cell culture systems for RVFV 
previously. Whilst it is conceded that these data would need to be replicated in in vivo 
mosquitoes to infer any overwintering capability supporting RVFV maintenance in British 
species, the power of in vitro cell lines to generate data exploring replication at prolonged low 
temperatures relevant to the UK was a useful tool to demonstrate a potential survival strategy. 
 
3.5 Summary 
The aim of this chapter was to test the hypothesis that low temperatures negatively affect 
RVFV replication kinetics independently of its mosquito vector. This has been achieved utilising 
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in vitro cell culture systems to demonstrate that temperatures below 20˚C adversely affect RVFV 
replication kinetics independently of its vector. The key findings are summarised below: 
 
Quantitative molecular and virological assays to detect RVFV were standardised 
demonstrating good reproducibility, efficiency and sensitivity, providing confidence in the 
results generated by these methods utilised throughout this research. 
 
Based on these in vitro data, a conservative minimum threshold for replication was set at 
20˚C, which will be applied to assess the ability of wild-caught British mosquitoes to support 
transmission of RVFV. 
 
At 12˚C infectious virions were not produced, however, evidence of RNA transcription or 
replication was demonstrated by increased genomic titres after 10 days. Despite prolonged 
exposure to low temperature, cell associated virus remained stable and infectious with 
replication rates and increases in titres occurring when temperatures were raised to 28˚C, 
providing the means for potential overwintering strategies. 
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4 Results: Vector competence of British mosquitoes 
4.1 Introduction 
The introduction of RVFV to Europe would have severe consequences for the health of 
humans, livestock and the economy. Vector competence is the ability of a susceptible vector to 
acquire an organism from one host and transmit it to another. An understanding of this 
competence for local vectors to support transmission is essential to assess the risk of 
establishment and guide control programmes, should an introduction occur. Compatibility 
between a vector and virus is dependent on the vector species, virus strain and the 
environment. Candidate vectors of RVFV in the UK were reviewed in Chapter 1 but localised 
adaptation means extrapolating the known competency of a vector-virus pairs in endemic 
regions, is inadequate to infer competency in UK populations. Therefore the overarching aim of 
the research described in this chapter is to evaluate the hypothesis that: 
 
Mosquito species present in the UK are competent to transmit RVFV. 
 
Vector competence, however, is a single component of a multi-factorial relationship between a 
disease vector and its host, known as vectorial capacity. This accounts for the interplay of 
environmental and behavioural traits such as vector density, lifespan, biting rate, flight distance 
and host feeding preferences. Therefore, in order to improve the understanding of factors 
affecting the competence and capacity of temperate British mosquitoes to transmit RVFV, 
additional objectives were: 
 
 Determine if there is an infectious dose threshold for the susceptibility of British 
mosquitoes to infection with RVFV and their subsequent ability to transmit (Section 
4.3.3.1). 
 
 To study the effect of viral strain on vector competence (Section 4.3.3.2). 
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 To analyse titres within the bodies, legs and saliva of mosquitoes to improve 
understanding of replication and the dose-dependency of virus spread to localised 
tissue sites within the vector (Section 4.3.3.3). 
 
 To study the effect of temperature on the ability of British mosquitoes to transmit 
RVFV (Section 4.3.4.1) guided by in vitro results. 
 
 To evaluate factors affecting mosquito survival (Section 4.3.4.1 and 4.3.4.2). 
 
 To determine the time required for virus to replicate, progress through the vector and to 
then be expectorated in the saliva (extrinsic incubation period: EIP) (Section 4.3.4.3). 
 
4.2 Methods 
While the fundamental hypothesis of this chapter assesses the transmission potential of 
UK mosquitoes, it was first necessary to develop in vivo methods that would provide robust and 
reproducible data. In vivo mosquito experiments are technically and logistically challenging and 
prone to high variability, especially when performed within a microbiological safety cabinet 
(MSC). Methods were developed suitable for working with both wild-caught mosquitoes and for 
RVFV which requires conformance with ACDP CL3 practices and procedures. The development 
and optimisation of methods are detailed in Appendix Section A4.1, including optimising: 
sample collection, homogenisation, extraction and storage parameters to limit the effects of 
virus degradation during mosquito processing; use of endogenous host and spiked internal PCR 
controls to confirm sample integrity and removal of PCR inhibitors; optimising factors affecting 
blood feeding including nutrient deprivation, blood type, feeding matrix, phagostimulant and 
duration; and comparison of methods to collect saliva. 
The methods detailed here are within the final optimised format, all experiments were 
performed in an ACDP containment level 3 laboratory at APHA in an MSC I. 
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4.2.1 Infecting mosquitoes by blood feeding 
Methods used here replicate those used for infecting mosquitoes with Usutu virus (USUV) 
at APHA and described previously (Mackenzie-Impoinvil et al., 2015). 1-3 days prior to 
experimental feeding, female mosquitoes that had not previously blood fed were separated and 
counted into 17.5x17.5x17.5 cm BugDorms (Bugzarre). Mosquitoes were deprived of sucrose for 
approximately 16-22 hours, and both water and sucrose for 2-3 hours prior to feeding. A blood 
meal was prepared containing defibrinated horse blood (TCS Biosciences), dATP (Thermo Fisher 
Scientific) as a phagostimulant at a final concentration of 1µM and virus at the desired 
concentration. Viral stocks were produced as described in Methods Section 2.1.2 and added at 
no greater than 1:2 ratio of media containing virus to blood. For non-infected controls virus was 
substituted with DMEM. Mosquitoes, 4-10 days old, were fed by hemotek with a parafilm 
membrane at 37˚C for approximately 15-18 hours (overnight) in a BugDorm darkened with foil. 
Pre-feed and post-feed blood meal samples were collected and stored at -80˚C to quantify the 
viral titre ingested. 
 
4.2.2 Maintaining infected mosquitoes 
Post-feeding, BugDorms were placed in a sealed bag with FlyNap (triethylamine) (Carolina 
Biological Supply) for 5 to 15 minutes until all mosquitoes were visibly anaesthetised. Using 
forceps engorged mosquitoes were separated from unfed and placed in groups of 10-15 in 
73mm x 118mm microhabitat pots fitted with a fine mesh vent within the white screw-top lid 
(Bugzarre). Mosquitoes were left in the microhabitat pots in the MSC I to revive from 
anaesthetic for 1-2 hours. Unfed mosquitoes were discarded. All mosquito numbers were 
accounted for and monitored every 24-72 hours for survival. Mosquitoes were maintained on a 
carbohydrate meal delivered by filter paper discs soaked in mānuka honey on the mesh vent 
(Figure 4.1). In addition water soaked cotton wool was positioned adjacent but not touching the 
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filter allowing enough gap for air exchange through the mesh. Honey-filters were collected, and 
water topped up or replaced, every 24-72 hours and stored at -80˚C to assess for the presence 
of virus by qRT-PCR (Hall-Mendelin et al., 2010). 
 
4.2.3 Harvesting mosquito samples 
Three core parameters were then measured throughout the course of these experiments 
to assess the potential for mosquitoes to support replication and transmission of RVFV. 
Mosquitoes were assessed for viral infection, dissemination (spread of virus from the primary 
site of infection, in this case the midgut) and transmission potential by detecting viral RNA and 
infectious virus within their bodies, legs and saliva at weekly intervals for up to 21 days. 
At designated collection points microhabitat pots were selected (based on the required 
numbers at the time of collection) and mosquitoes anaesthetised using FlyNap as described 
previously in Section 4.2.2. Mosquito processing was performed on white filter paper in petri 
dishes. Ensuring the mosquito was not killed during the process, legs and wings were removed 
using fine point forceps and placed into 2mL tubes containing 14mm ceramic beads (Stretton 
Scientific) and 300µL mosquito buffer (Eagle’s minimum essential medium (EMEM) 
supplemented with 20% FBS and 100 units/mL penicillin, 100 µg/mL streptomycin, 0.25 µg/mL 
amphotericin B) (Sigma). The proboscis was inserted into a 200µL micropipette tip with the end 
removed containing 20µL mosquito buffer supplemented with 50% sucrose (Sigma). To 
encourage salivation 5µL of pilocarpine mix was placed on the abdomen (1% pilocarpine 
hydrochlorides, 0.1% Tween 80 in PBS) (Alfa Aesar) (Sigma). Active movement of palps, 
engorgement and bubbles are all signs of salivation, the mosquitoes were left to salivate for 30-
45 minutes and saliva collected by expelling liquid in the tip into 280µL mosquito buffer in a 
screw cap 1.5mL tube. Heads were removed and discarded and the body (abdomen and thorax) 
placed in a 2mL tube containing 14mm ceramic beads and 300µL mosquito buffer. Forceps were 
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cleaned with 70% ethanol between specimens. All tubes were stored at -80˚C prior to shipping 
on dry ice to PHE for processing. Body and leg samples were then disrupted by two 20 seconds 
cycles of 4,000 rpm with a 30 second pause between cycles on the Precellys 24 homogeniser 
(Precellys). All samples including saliva were then centrifuged at 3,000 x g for 10 minutes and 
processed in the first instance for virus by qRT-PCR. The remaining sample was stored at -80˚C 
and plaque assays were performed on positive samples only. Viral quantification and 
endogenous control assays are detailed in Methods Section 2.2.4 and 2.3.4. A schematic of the 
process is shown in Figure 4.1. 
 
Figure 4.1 Schematic of vector competence experiment methods. 
 
1. Mosquitoes are blood-fed RVFV overnight 
Hemotek 
2. Mosquitoes are anaesthetised with FlyNap for 10 minutes 
3. Engorged mosquitoes are sorted into groups of 10-15 
4. Mosquitoes are anaesthetised and dissected to 
ascertain infection status 
Bodies Saliva and honey filters  Legs 
Honey filter 
Water soaked 
cotton 
(Infection) (Dissemination) (Transmission potential) 
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4.2.4 RNA in situ hybridisation 
RNAscope (Advanced Cell Diagnostics: ACD) is a commercially available novel RNA in situ 
hybridisation (RNA-ISH) technology applied here to study RVFV replication and localisation by 
light microscopy of the whole host following oral infection of RVFV. Strain ZH501 and Cx. pipiens 
(Caldbeck) were used as the archetypal character species and strain to develop this method. 
Novel probes targeting the nucleoprotein of RVFV strain ZH501 (nucleotides 915-1652 of 
accession DQ380148.1) and host GAPDH (Cx. quinquefasciatus; nucleotide 54-810 of the 
accession XM_001846997.1) were designed in the chromogenic assay format, selected based on 
the production of preliminary images of uninfected Cx. pipiens (Caldbeck) by standard 
haematoxylin and eosin staining, detailed in Appendix Section A4.1.6. 
Cx. pipiens (Caldbeck) were prepared for microscopy on day 7 post infection with 107 
PFU/mL RVFV ZH501, in parallel to the collection of bodies, legs and saliva samples to assess 
vector competence. Formaldehyde (FA) was used to preserve tissue architecture, prevent tissue 
degradation and inactivate virus allowing the safe handling of samples outside of primary 
containment. Whole mosquitoes were dipped in 70% ethanol to remove hydrophobicity and 
then immersed in 0.5mL 4.5% formaldehyde (10% buffered-formalin) in screw-cap tubes for 5 
days at room temperature. Mosquitoes were paraffin embedded, sectioned and mounted by 
the Histology Department at APHA described in Appendix A4.1.6. RNAscope procedures were 
performed by the Histology Department at PHE following manufacturer’s instructions using the 
custom designed positive control probe targeting host GAPDH (Cq-GAPDH targeting 54-810 of 
XM_001846997.1) or the RVFV specific probe (V-RVFV-ZH501-NP targeting 4-738 of 
complementary of 915-1652 of DQ380148.1) within the RNAscope 2.5 HD red detection kit 
(Advanced Cell Diagnostics: ACD). Probe binding sites were stained with fast red and 
counterstained with haematoxylin. A negative control, supplied with the kit, was performed on 
parallel sections targeting the bacterial dihydrodipicolinate reductase (DapB) gene that is not 
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present in the sample; any observed staining to this negative probe is due to non-specific 
background binding. 
 
4.2.5 Experimental design for investigating vector competence 
Details of the collection and routine maintenance of colonised and wild-caught 
populations of mosquitoes are detailed in Methods Section 2.3.1. Colonised lines of Cx. pipiens 
and wild-caught Aedes species were fed infectious blood meals, as described in section 4.2.1, to 
mimic feeding on a viraemic ruminant host. To ascertain the dose threshold at which 
transmission can be supported in the UK, mosquitoes were fed a blood meal containing RVFV 
strain ZH501 or Lunyo at two doses, 106 or 107 PFU/mL, that fall within the natural livestock 
viraemia range (Bird et al., 2009). A summary of the vector competence experiments 
performed, including strain, dose and temperature parameters tested is shown in Table 4.1. 
Table 4.1 Summary of vector competence experiments performed 
Mosquito species 
106 PFU 107 PFU 
ZH501 Lunyo ZH501 Lunyo 
Cx. pipiens  
(Caldbeck colony)   
-   -  
25˚C 25˚C 
Cx. pipiens  
(Brookwood colony) 
-      
25˚C 
  
25˚C 25˚C 
Ae. detritus 
(Wild-caught)         
20˚C 25˚C 20˚C 25˚C 20˚C 20˚C 
Ae. rusticus 
(Wild-caught)   
-    -  
25˚C 20˚C 
The infectious viral titres within the blood meal offered to mosquitoes are written in plaque forming 
units/mL (PFU). A mosquito represents a vector competence experiment was performed under the 
conditions listed with the incubation temperature written below, -: denotes experiment condition 
not tested. Mosquito cohorts were tested in single experiments, comparison of temperature and 
virus strain data were collected in parallel for each cohort (from a single population of mosquitoes). 
Data collected at the 106 PFU infectious dose were performed throughout the summer of 2016, and 
the 107 PFU dose in 2017. 
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The results presented in chapter 3 demonstrated that under optimal conditions for the 
host cells, rapid rates of replication and production of high titres of RVFV were supported. 
Therefore 25°C was selected as the baseline temperature corresponding to the routine rearing 
environment for the Cx. pipiens colonies. Other temperatures were not evaluated in colony 
mosquitoes as they were considered adapted to this environment. For consistency with colony 
lines, wild-caught Aedes spp. were challenged initially at 25˚C, and where numbers permitted 
also at 20˚C. This secondary temperature was selected as in vitro mosquito cells supported RVFV 
replication, albeit at a reduced rate and titre, at 20˚C representing peak average temperatures 
recorded during summer months at the mosquito collection sites (recorded 1981-2010 by Met 
Office, 2012). While a range of additional temperatures were also considered for analysis, the 
technical and resource challenges involved in performing these studies precluded inclusion of 
additional cohorts. 
Additional competence experiments were performed with wild-caught species of Cx. 
pipiens s.l. (sensu lato), Cx. modestus and Ae. caspius but due to poor feeding rates these 
species are excluded from analysis. The feeding rates are reported in Appendix Figure A 4. 8 in 
comparison to feeding rates of mosquitoes included in analysis for reference. 
 
4.2.6 Statistical analyses 
Mosquito infection, dissemination and transmission rates were calculated as the 
percentage of the population tested (i.e blood fed and survived until a collection point), 
containing virus in their bodies, legs and saliva respectively. 95% confidence intervals (CI) were 
calculated by a modified Wald method (Agresti and Coull, 1998). To provide confidence in the 
validity of negative results reported (mosquito groups deemed refractory to infection, 
dissemination or transmission), sample sizes (mosquito numbers) were guided by the results of 
the herd sensitivity model for an infinite population size (DiGiacomo and Koepsell, 1986). This 
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determined a required sample size of 29 in order to detect a single positive specimen, with 95% 
confidence, from a population with 10% transmission capability; sample sizes below this were 
interpreted with caution. 
The significance threshold for all hypothesis testing was set at 0.05 with Bonferroni 
corrected thresholds (or Dunn’s post-test when applied to confidence intervals) for multiple 
comparisons. In general non-parametric tests were selected due to low sample numbers. 
Numerical data such as viral titres were compared using non-parametric comparison of 
medians; Mann Whitney for two variables or Kruskal Wallis for multiple variables. Categorical 
data including the proportion of mosquitoes infected between: populations, time points, doses 
and virus strains were compared by Fisher’s exact test (McDonald, 2014). 
Survival was analysed by a Kaplan-Meier plot, mosquitoes processed for virus detection 
were censored and groups compared by Log-Rank test. 
 
4.3 Results 
4.3.1 Vector competence 
Three out of the four populations of British mosquitoes offered a blood meal containing 
107 PFU/mL RVFV demonstrated a potential to transmit virus under laboratory conditions. The 
proportion of mosquitoes that tested positive for RVFV RNA within the bodies, legs and saliva, 
thereby, demonstrating the ability to support viral infection, dissemination from the midgut and 
a transmission potential are presented in Figure 4.2. Infectious viral particles were detected in 
the body and leg samples but not the saliva. The limit for consistent detection of infectivity 
(PFU) was 105.3 GEC per mosquito supported by the in vitro LOD determined in Chapter 3, vRNA 
titres within the saliva fell below this limit. Accordingly some of the body and leg samples with 
titres below this limit of detection were therefore also negative by plaque assay. The results 
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described here are therefore based on qRT-PCR data and the plaque assay titres are in Appendix 
Figure A 4. 9 for reference. 
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Figure 4.2 Percentage of mosquitoes infected with Rift Valley fever virus. Mosquitoes were fed a 
blood meal containing 107 PFU/mL RVFV strain ZH501 or Lunyo and maintained for up to 21 days. 
Results are based on the proportion of mosquitoes positive for RVFV by qRT-PCR results. Day 0 was 
excluded from the totals; n.t: not tested; numbers: number tested (subtracting any endogenous 
control negatives from population); Error bars: 95% CI calculated by a modified Wald method. 
Fisher’s exact test was used to compare between species using a Bonferroni corrected threshold for 
multiple comparisons, depicted by solid bars. CBK: Caldbeck colony; BKW: Brookwood colony. 
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Both of the Cx. pipiens colony lines and a wild-caught population of Ae. detritus had RVFV 
RNA within their saliva after ingesting blood containing 107 PFU/mL RVFV; demonstrating a 
transmission potential. Ae. rusticus were susceptible to infection but did not demonstrate a 
transmission potential, though only 27 were tested in total. The transmission rates at this 
infectious dose did not differ significantly between species except Ae. detritus (18%) versus Ae. 
rusticus (0%) infected with ZH501 (p=0.0345). These data are analysed further and presented 
again within the context of factors that affect this competence potential in Section 0. 
 
4.3.2 Viral tropism in the mosquito by RNA in situ hybridisation 
RNA in situ hybridisation (RNA-ISH) using an RNAscope protocol provided visual 
confirmation of the results presented (Section 4.3.1), demonstrating support of widespread 
replication and dissemination of RVFV strain ZH501 within Cx. pipiens (Caldbeck). This is the first 
known application of this previously described commercial method (Wang et al., 2012) to detect 
virus localisation within the mosquito host. Results of the controls are presented in Figure 4.3; 
demonstrating the method works by targeting the ubiquitously expressed host GAPDH positive 
control to validate the integrity of RNA in tissue samples (Figure 4.3; Panel B), and the DapB 
negative control demonstrated little to no background staining (Figure 4.3; Panel A). Non-
specific red staining around the cornea of the ommatidia (compound eye) was observed in the 
negative, therefore any staining localised in this site in RVFV stained sections cannot be used to 
infer infection. 
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Figure 4.3 RNA in situ hybridisation positive and negative controls. Whole Cx. pipiens (Caldbeck) 
were fixed in 4.5% formaldehyde and were embedded in paraffin 0.5µm sections mounted and 
stained by A. negative control probe targeting absent bacterial DapB. B. positive control probe 
targeting host GAPDH Probe binding sites are stained with fast red and counterstained with 
haematoxylin, non-specific staining can be seen around the cornea of the compound in panel A. 
Images were taken on the Pannoramic 250 Flash II slide scanner (3D HISTECH) and image selection 
performed on digitised images in Pannoramic Viewer (1.15.2 SP 2, 3D HISTECH). 
 
Five Cx. pipiens (Caldbeck) fed a blood meal containing RVFV strain ZH501 at a dose 
107 PFU/mL were fixed at day 7 post infection, then prepped and stained by the RNAscope 
method using the RVFV specific probe and counterstained with haematoxylin. Results showed 
one out of the five mosquitoes were infected (20%), comparable to the infection rate of 27% 
(4/15 bodies infected at 7 dpi) observed in the bodies of mosquitoes infected and processed in 
parallel by qRT-PCR and plaque assay. Whole mosquitoes are presented in Figure 4.4, with red 
staining indicating probe binding to RVFV. Image labelling follows Christophers (1960) and 
Romoser and Stoffolano (1998). 
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Figure 4.4 RNA in situ hybridisation of an uninfected and infected whole mosquito. Cx. pipiens 
(Caldbeck) were infected with 107 PFU/mL RVFV strain ZH501 and whole mosquitoes fixed in 4.5% 
formaldehyde at day 7 post infection. Specimens were paraffin embedded and 0.5µm sections 
mounted and stained by RNAscope. The RVFV specific probe targeting RNA of the nucleoprotein is 
stained red. A: negative specimen; B: positive specimen. CG: cerebral ganglion; JO: Johnston’s organ; 
O: ommatidia (compound eye); L: legs; FG: foregut; DLM: dorsal longitudinal muscle; MG: midgut; 
OF: ovarian follicle. 
 
Individual tissue images are presented in Figure 4.5, the images on the left show a 
representative RNAscope image of one of the four negative mosquitoes. The principal findings 
and implications for RVFV tropism within each of these tissues are presented in Table 4.2. Three 
section levels were performed, however, further work is necessary to increase the number of 
section levels to locate the salivary glands, a key site to infer transmission potential or the 
presence of barriers to viral entry. Taken together with the vector competence data (Section 
4.3.1), these data offer robust support of the ability of Cx. pipiens to support viral escape from 
the midgut and infer replication is supported at secondary sites within the mosquito. These 
images provide proof of concept for the application of RNAscope in mosquito competence 
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studies, demonstrating a novel highly sensitive method to detect wild-type virus localisation 
within the mosquito. 
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Figure 4.5 Detection of viral RNA in mosquitoes tissues using RNA in situ hybridisation. Paraffin 
embedded formalin fixed Cx. pipiens at day 7 post infection with 107 PFU/mL strain ZH501, stained 
by RNAscope. The RVFV probe targeting the nucleoprotein is stained red. Left (odd numbers): 
negative specimens; Right (even numbers): positive specimens. The tissues with reference to scale 
bar in the top left of each image are: 1-4: midgut (50µm); 5 and 6: legs (50µm); 7 and 8: thorax 
(500µm); 9 and 10: head (200µm); 11 and 12: Johnston’s organ (50µm), second segment of 
antennae containing sensory cells; 13 and 14 ommatidia, compound eye showing non-specific 
staining around cornea (50µm); 15 and 16: ovarian follicle (100µm). 
AMG: anterior midgut; BM: basement membrane; Ch: chorion; CL: corneal lens; DLM: dorsal 
longitudinal muscle; FB: fat body; FE: follicular epithelium; G: ganglion; JO: Johnston’s organ; L: 
lumen; O: ommatidia (compound eye); PPM: pharyngeal pump muscle; Pr: proventriculus; OF: 
ovarian follicle; R: rhabdom surrounded by retinular cells; Sc: scolopophores; YG: yolk granules. 
Results: Vector competence of British mosquitoes 
103 
 
Table 4.2 Summary of virus localisation within an orally infected Cx. pipiens 
Tissue  
(Figure 4.5 panel) 
RVFV localisation Implication 
Midgut  
Posterior (1 & 2) 
Anterior (3 & 4) 
 
No virus present in the negative 
mosquitoes  
 
 
RVFV localised on the apical side 
of the midgut epithelium 
 
RVFV is also localised in the 
proventriculus of foregut 
Suggests a barrier to viral entry to midgut, 
virus within the midgut lumen (L) was 
cleared by day 7 post infection 
 
RVFV entering the midgut epithelium on 
the apical side is localised by day 7 on the 
basal side and quantity is suggestive of 
replication. The proventriculus was 
previously associated with RVFV 
dissemination (Romoser et al., 2004) 
Legs (5 & 6) RVFV present in infected but 
absent in negative mosquito 
Supports the method used to determine 
virus escape and spread from the midgut 
Thorax (7 &8) Trace levels of RVFV within 
thoracic ganglia (G) and dorsal 
longitudinal flight muscles (DLM). 
High levels relative to other sites 
within the coxa of the legs and 
the fat body (FB) 
Suggestive of secondary viral amplification 
sites that may support entry to the 
salivary glands located proximally 
Salivary glands Could not be located Further sections required to locate salivary 
glands in this area of thorax 
Head (9 & 10) Trace levels of RVFV in cerebral 
ganglion (G) relative to rest of 
head and thorax. Differential 
permissiveness of sensory organs 
located in head below:  
Previously suggested that infection of 
ganglia negatively affects the mosquitoes 
regulatory functions (Higgs, 2004) but 
limited evidence of RVFV localised in these 
sites here. 
Johnston’s 
organ (11&12) 
RVFV localised within the sensory 
scolopophores (Sc) with trace 
amounts located at the cell 
bodies of the neurones (G) 
The Johnston’s organ (JO) (second 
segment of antennae) shows high levels of 
RVFV. This is not thought to infer a benefit 
in terms of transmission but further 
demonstrates widespread RVFV dispersal. 
Ommatidia  
(13 & 14) 
Non-specific staining present on 
the cornea (CL) in negative, 
positive and controls. 
RVFV appears refractory to enter the 
optical rod-like rhabdom or retinular cells 
(R) and is localised on the basal side of the 
ommatidia (O) where basement 
membrane and nerve fibres are located. 
Ovarian follicles  
(15 & 16) 
RVFV located on the exterior of 
the follicular epithelium. 
 
Trace levels of GAPDH can be 
seen within the chorion and 
follicles of the control Figure 4.3, 
though sensitivity may be lower 
in this site due to the dark 
staining of follicles.  
This infected mosquito would not pass 
virus vertically to its progeny in this 
gonotrophic cycle. This is not entirely 
surprising given the relatively rare 
occurrence of arbovirus vertical 
transmission events by mosquitoes and 
this ability is unknown for RVFV in Culex 
species (reviewed by: Lumley et al., 2017; 
Romoser, 2011). 
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4.3.3 Factors limiting vector competence 
The complex interplay of multiple factors affect the ability, and likelihood, of mosquitoes 
to transmit a virus, these include: infectious dose ingested by the mosquito, viral strain, 
temporal dynamics and survival. The ability of British mosquitoes to support RVFV replication 
and a transmission potential has been demonstrated, in this section factors affecting this 
transmission potential are analysed. 
 
4.3.3.1 Role of infectious dose on vector competence 
A linear relationship between infectious dose ingested and onward transmission rate has 
been observed for a number of arboviruses including RVFV (Chamberlain and Sudia, 1961; 
Kramer et al., 1981; Turell et al., 1988b). As the proposed viraemia range to challenge 
mosquitoes with was narrow (ranging by one log), confidence in the titre of infected blood meal 
and uniformity between experiments was paramount. Viral titres were calculated within the 
blood meal pre and post-feeding (18-22 hours later) as well as within the ingested blood meal in 
4-20 engorged mosquitoes post-feed (day 0), by qRT-PCR (genome equivalent copies: GEC) and 
plaque assays (plaque forming units: PFU). These data, presented in Appendix Figure A 4. 7, 
showed highly reproducible titres of the infectious blood meal and the viral titre ingested. Mean 
titres of RVFV in the blood were 106.0 and 107.2 PFU/mL matching the predicted viraemia 
anticipated in infected livestock. 
Decreasing the infectious dose 10-fold from 107 to 106 PFU/mL reduced the rates of 
infection, dissemination and transmission (Figure 4.6). Rates between species were compared 
by Fisher’s exact test with Bonferroni’s corrected threshold for multiple comparisons. Ae. 
rusticus was not compared statistically due to low sample numbers. Infection rates were 
significantly lower for all groups at the lower dose of 106 except Cx. pipiens (Caldbeck) and 
dissemination for all but the Cx. pipiens (Brookwood) infected with Lunyo. 
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Figure 4.6 The effect of infectious dose on the percentage of mosquitoes infected. Mosquitoes 
were fed a blood meal containing 106 or 107 PFU/mL RVFV strain ZH501 or Lunyo and maintained for 
up to 21 days. Results are based on the proportion of mosquitoes positive for RVFV by qRT-PCR 
results. Data sets collected on day 7, 14 and 21 have been pooled for analysis; n.t: not tested; 
numbers: number tested (subtracting any endogenous control negatives from population); Error 
bars: 95% CI calculated by a modified Wald method. Fisher’s exact test was used to compare 
between doses using a Bonferroni corrected threshold for multiple comparisons, depicted by solid 
bars. 
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A decrease or cessation of transmission was observed in all species compared to their higher 
dose counterparts: 9% versus 0% in Cx. pipiens (Caldbeck) strain ZH501; 7% versus 0% in Cx. 
pipiens (Brookwood) strain Lunyo; and 18% versus 3% and 23% versus 0% in Ae. detritus 
infected with ZH501 and Lunyo respectively. All honey-filter papers from mosquitoes infected 
with 106 PFU/mL were negative for RVFV, supporting these observations. Despite this, only 
transmission rates (determined by forced salivation) in Ae. detritus infected with Lunyo were 
significantly different between doses (p=0.0115); likely due to the low overall number of 
mosquitoes with viral RNA detected in their saliva. Based on these data the dose threshold for 
the competent mosquitoes was 107 PFU/mL for both Cx. pipiens colonies and 106 PFU/mL for Ae. 
detritus. 
 
4.3.3.2 Effect of RVFV strain 
Infection, dissemination and transmission rates (Figure 4.6) did not differ significantly 
between viral strains in either mosquito species challenged with both ZH501 and Lunyo; Ae. 
detritus (p=1.0000, p=1.0000, p=1.000) and Cx. pipiens (Brookwood) (p=0.2910, p=0.1176, 
p=0.7139). 
 
4.3.3.3 Comparison of intra-host viral titres 
The results presented thus far are an analysis of the proportion of infected mosquitoes, 
using results from the qRT-PCR to evaluate the presence and absence of virus within the tissues 
sampled. Here these same results are analysed using the quantitative data generated by the 
qRT-PCR to evaluate the titres in genome equivalent copies within the mosquito (PFU data are 
in Appendix Figure A 4. 9 for reference). Ultimately the titres generated within the mosquito will 
directly affect the potential for virus to be transmitted horizontally. 
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Comparison of viral titres quantified within different mosquito tissues can be further 
utilised to indicate viral replication and used to evaluate the potential dose dependency of viral 
infection or egress from tissues (Hardy et al., 1983; Kramer et al., 1981). This pertains 
specifically to the progression of the virus through the mosquito. Mosquitoes capable of 
transmitting RVFV have been shown previously to have significantly higher titres in their 
midguts than their non-transmitting counterparts (Gad et al., 1987; Gargan et al., 1983); 
suggesting the underlying mechanism in these species was the dose dependency of egression 
from the midgut. Here viral titres between tissues in British mosquitoes were compared to 
determine if a relationship exists between virus titre in one tissue with the presence and titre 
within another. 
Positive sample numbers were too low to compare temporal differences in titres so data 
collected across time points were pooled for analysis. The titres within the tissues of individual 
positive mosquitoes are shown in Figure 4.7. Titres within the mosquitoes did not differ 
statistically between the strains or dose ingested (Figure 4.7). The titres did not differ between 
the species’ bodies or saliva but disseminated viral titres were significantly higher in Cx. pipiens 
(Brookwood) compared to other species challenged with the same dose and strain. 
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Figure 4.7 Titres of Rift Valley fever virus within the mosquito host. Data-points represent single 
positive mosquito samples by qRT-PCR. Samples were collected weekly for up to 21 days after 
ingestion of infected blood. Time points and temperatures were pooled for analysis. Solid and 
hollow data-points represent mosquitoes ingesting 106 and 107 PFU/mL respectively, total numbers 
tested are written in parentheses (n). Dotted lines: limit of detection; solid lines: geometric mean; 
n.s: p>0.05; *: p<0.05, **:p<0.005; ***:p<0.0005, Mann Whitney or Kruskal Wallis. CBK: Cx. pipiens 
(Caldbeck colony); BKW: Cx. pipiens (Brookwood colony); Ae.d: Ae. detritus; Ae.r: Ae. rusticus. 
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To further understand whether there is a relationship between the titre generated within 
the host and the transmission ability, titres were compared as performed previously (Gad et al., 
1987; Gargan et al., 1983). Titres of RVFV RNA in bodies of positive mosquitoes (negative 
mosquitoes were excluded) were grouped into one of two categories: mosquitoes with RVFV 
RNA detected within their saliva were termed ‘transmitters’ and saliva negative mosquitoes 
termed ‘non-transmitters’. Non-parametric comparison of the median titres was performed 
using the Mann Whitney test (Table 4.3). Average titres in the bodies of mosquitoes 
transmitting virus are presented in Table 4.3, demonstrating significantly higher titres in Cx. 
pipiens (Brookwood) transmitters compared to non-transmitters (ZH501 p=0.0401, Lunyo 
p=0.0070). These results suggest that different mechanisms may be at play between the species 
studied and are discussed further in Section 4.4. 
 
Table 4.3 Comparison of viral titres in mosquitoes demonstrating a transmission potential 
“Transmitters” were defined here as mosquitoes displaying a transmission potential by detecting 
RVFV RNA in their saliva by qRT-PCR. The Mann Whitney test was applied to compare viral titres in 
the bodies of mosquitoes deemed to be ‘transmitters’ or ‘non-transmitters’ in order to test the 
potential dose dependency of tissues. Negative results were excluded for calculating average titres. 
 
The titre required to cause disease in the ruminant is not known and the susceptibility to 
doses will be further varied between species and age of the ruminant host. These factors were 
not studied in this project that uses saliva collection as a model of transmission potential as a 
proxy for in vivo animal experiments. Comparison of the method to collect saliva showed no 
significant difference in titre detected by honey-filter or capillary method: Cx. pipiens (Caldbeck) 
Species Strain 
Log10 viral titres in mosquitoes Mann Whitney 
(p=) n Mean Min Max n Mean Min Max 
Bodies Transmitters Non-transmitters  
Cx. pipiens (Caldbeck) ZH501 4 5.84 2.92 7.68 23 4.55 2.78 8.08 0.314 
Cx. pipiens 
(Brookwood) 
ZH501 4 7.18 4.76 9.51 10 4.01 2.39 7.10 0.0401 
Lunyo 3 7.95 7.52 8.60 10 4.72 2.47 6.92 0.0070 
Ae. detritus 
ZH501 3 4.55 3.58 5.69 15 4.44 2.58 6.39 0.7839 
Lunyo 5 5.51 4.79 6.54 17 4.32 2.58 6.03 0.1096 
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(ZH501 p=0.2648) Cx. pipiens (Brookwood) (ZH501 p=0.3429, Lunyo p=1.0000) Ae. detritus 
(p=0.1580, Lunyo p=0.8286); validating and corroborating the methods and observations of 
each. The results from the honey-filter method for detecting nucleic acid in saliva are presented 
in Figure 4.7. The standard titre observed between species presumably demonstrates the equal 
capability of each to transmit. 
 
4.3.4 Factors limiting vectorial capacity 
4.3.4.1 Effect of temperature 
Although the aim set out to study the effect of temperature on competence, factors 
affecting survival meant that analysis of the infection rates between the two temperatures 
performed in Ae. detritus at 106 PFU/mL was restricted by high mortality limiting sample 
numbers. Baseline rates of the susceptibility and transmission potential of UK populations must 
precede comparison of parameters that affect these rates, such as temperature. Therefore 
generating data to evaluate the single variable of vector competence was prioritised. In order to 
increase the endpoint mosquito numbers by promoting survival, subsequent experiments with 
Aedes, challenged with 107 PFU/mL, were performed at 20˚C only. Analysis of temperature was 
therefore analysed exclusively in relation to survival. 
Mosquito survival is a critical component of a vector’s capacity to transmit a pathogen, 
with mortality interrupting the transmission cycle. A relatively small reduction in survival can 
result in a big reduction in a vector’s capacity to transmit. Survival rates of the Aedes species at 
20˚C and 25˚C, under experimental conditions infected with RVFV, were compared by Log-Rank 
test using Kaplan Meier survival plots to censor the mosquitoes processed for end-point virus 
detection from the population (Figure 4.6). Higher temperature had a negative effect on survival 
with significantly higher mortality rates in Ae. detritus at 25˚C compared to 20˚C infected with 
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106 PFU ZH501 (Figure 4.8; Panels A), Lunyo (Figure 4.8; Panels B) or uninfected controls (Figure 
4.8; Panels C). 
Due to low starting numbers the effect of temperature on Ae. rusticus was not studied 
under equal dose conditions. Mosquitoes were exposed to 106 PFU at 25˚C and 107PFU at 20˚C 
therefore the effect of virus as a confounding variable cannot be fully accounted for. However, 
significantly reduced survival at 25˚C at the lower dose titre was also observed in this population 
(Figure 4.8; Panel D), offering limited additional support that wild mosquitoes in the UK suffer 
increased mortality at higher temperatures in the laboratory environment. 
This result is not entirely unexpected; UK mosquitoes will be adapted to local 
temperatures which are rarely above 25°C; the marked increase in mortality rate therefore 
shows that any benefit that can be shown in terms of infectivity or transmission rate at high 
temperatures, such as increased replication rates and titres attained in vitro, must be 
considered alongside the increased overall mortality that such temperatures impose. 
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Figure 4.8 Effect of temperature on the survival of wild-caught Aedes species. A-C: Ae. detritus 
infected with 106 PFU A. ZH501, B. Lunyo, C. control. D. Ae. rusticus infected with ZH501 at 106 PFU 
at 25˚C or 107 PFU at 20˚C. Kaplan-Meier plots were generated, bars represent the 95% CI, numbers 
tested are written within parentheses (N). Statistical analysis: Log-Rank test. 
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4.3.4.2 Effect of viral strain and dose 
The effect of viral strain and dose are also analysed in terms of survival affecting vectorial 
capacity. Survival of mosquitoes exposed to equal doses did not differ significantly between 
infection with either strain ZH501 or Lunyo (Figure 4.9). However, mortality increased in groups 
exposed to higher doses of virus; recording a significant increase in Cx. pipiens (Caldbeck) 
infected with ZH501 (Figure 4.9; Panel A), Ae. detritus infected with both strains (Figure 4.9; 
Panel C) and Ae. rusticus infected with ZH501 (Figure 4.9; Panel D) compared to controls or their 
lower dose counterparts. Mortality rates between doses in the Cx. pipiens (Brookwood) were 
not statistically different (Figure 4.9; Panel B). 
In summary these data show mosquito mortality was greater under increased 
temperature and dose but was not affected by strain. The mosquitoes often showed signs of 
fatigue such as a reduced ability to fly and crawl on the base of pots, in the 24 hours prior to 
death. This reduction in mosquito survival would thereby reduce their potential to transmit 
pathogens. However, it also had the knock-on affect for downstream analysis of experiment by 
negatively affecting the cohort size for analysing the vector competence. 
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Figure 4.9 Effect of infectious dose on mosquito survival. A. Cx. pipiens (Caldbeck colony), B. Cx. 
pipiens (Brookwood colony), C. Ae. detritus, D. Ae. rusticus. Data generated for Aedes species were 
performed at 20˚C and the Culex colony species at 25˚C. Survival was monitored periodically for up 
to 21 days. Kaplan-Meier plots were generated, bars: 95% CI, numbers tested are written within 
parentheses (N). Statistical differences were tested by Log-Rank test with Bonferroni-corrected 
thresholds, dotted lines compare strain Lunyo and solid lines ZH501. 
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4.3.4.3 Temporal dynamics 
Low numbers of positive samples, in part due to mortality limiting numbers, meant that 
temporal differences between vector competence and viral titres at different time points could 
not be analysed. The extrinsic incubation period of all transmitting species was ≤7 days. 
However, earlier time points were not analysed. 
 
4.4 Discussion 
This chapter offers substantiating data identifying three populations of temperate 
mosquitoes present in the UK as potential vectors of two pathogenic strains of RVFV. 
The first of which was a wild-caught population of Ae. detritus relevant to potential 
maintenance of RVFV in the UK due to: its abundance; its coastal habitat placing it in proximity 
to ports where RVFV could be introduced; and its reported aggressive biting behaviour on 
mammals. These data add to the previous findings of UK Ae. detritus as a potential vector of 
WNV and JEV (Blagrove et al., 2016; Mackenzie-Impoinvil et al., 2015). In addition two 
temperate populations of the Cx. pipiens complex demonstrated vector competence. Culex 
pipiens sensu lato is a pivotal vector of RVFV during many epidemics in Africa (Hoogstraal et al., 
1979; Meegan et al., 1980) and several populations from non-endemic regions have 
demonstrated their competence in laboratory studies (Brustolin et al., 2017; Turell et al., 2010; 
Vloet et al., 2017). Despite only occasionally biting humans, colonised UK populations of the 
predominantly ornithophagic Cx. pipiens pipiens were tested alongside a Cx. pipiens hybrid, 
characterised previously (Manley et al., 2015). These populations are relevant to the potential 
maintenance of RVFV, were it introduced to the UK, due to their: abundance and widespread 
distribution across the UK; proximity to humans; homology to vectors in endemic regions and 
the co-occurrence of biotypes and hybrids. 
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Vector competence is one component of vectorial capacity; some of the factors 
contributing to the potential for transmission to occur are discussed below. 
 
4.4.1 Vector competence and the role of dose 
Infectious viral dose had the greatest impact on the competence of UK mosquito species 
to transmit RVFV, supporting the previously observed linear relationship with infection and 
transmission rates with dose (Chamberlain and Sudia, 1961; Golnar et al., 2014; Turell et al., 
1988b; Vloet et al., 2017). Natural livestock viraemia range between 106-108 PFU/mL (Bird et al., 
2009; Golnar et al., 2014). The dose required to infect or support onward transmission is 
affected by the mosquito species and virus strain but has been shown to be as low as 104 -
104.8 PFU/mL with RVFV (Turell et al., 2013; Vloet et al., 2017). To determine the lower dose 
threshold at which infection, dissemination and transmission can be supported in British 
species; mosquitoes were challenged with 106 or 107 PFU/mL. 
Owing to the importance of this dose relationship, titres were calculated in both the blood 
meal and engorged mosquitoes directly after feeding. Blood meal analysis confirmed the 
uniformity in dose between experiments, with ingested doses as varied within a species as they 
were between species. The reduction in virus titre from blood to engorged mosquitoes was 
consistent with previous reports that mosquitoes ingest 1-10µL (Clements, 1992). Differences in 
the log reduction (Appendix Figure A 4. 7), from blood to mosquito titre, were significant in PFU 
but not GEC; likely due to the higher variability of viral infectivity assays compared to molecular 
methods. Although virus was stable within the blood meal, the effect of a mosquito feeding 
within the first hour compared to 18 hours later cannot be excluded as a factor that may reduce 
infectious titres in earlier feeding mosquitoes, affected by an increased exposure to midgut 
enzymes or viral uncoating during the eclipse phase of replication. In the absence of 
standardised methods for studying competency, analysing both meal and mosquito allows 
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direct comparison with a broader range of studies. With the importance of dose universally 
reported these observations could support the use of a crude conversion rate of three logs from 
dose in blood to dose ingested. 
 
4.4.2 Viral replication and the effect of titres 
Viral titres within the vector host change throughout the course of an infection. The low 
number of positive specimens recorded within experiments here limited the ability to compare 
titres between time points and temperatures. However, previous studies with WNV have shown 
temporal differences in titres within mosquitoes do exist (Richards et al., 2012a). The initial 
titres are due to ingested virus within the blood; in this study the blood meal in the mosquito 
was visible for three to four days post-feeding. Following this an eclipse phase can occur, where 
viral titres drop below the detectable level (Higgs, 2004). The requirement for viral replication in 
the midgut of competent vectors, accompanies an increase in titres. In some cases secondary 
amplification occurs after virus exits the midgut but prior to entering the salivary gland (Kramer 
et al., 1981; Romoser et al., 1992), with then further amplification occurring within the salivary 
glands (Hardy et al., 1983). Analysing the presence and titre of virus within the body, legs and 
saliva of mosquitoes as performed here, can give insights into viral replication and factors 
affecting the progression of a virus through its vector host and the dose dependency of any 
barriers encountered. 
Neither Cx. pipiens colony line could support dissemination from the midgut or 
transmission at the lower dose of 106 PFU/mL. Cx. pipiens (Caldbeck) moderately supported 
replication within the midgut but the Cx. pipiens (Brookwood) could not, suggesting the 
presence of barriers to escape and infect the midgut respectively. This supports previous 
observations of both the presence and dose dependency of these barriers (Chamberlain and 
Sudia, 1961; Turell et al., 1988b). Multiple mechanisms have been postulated, including physical 
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barriers to virus or incompatibility with host receptors or antiviral responses including RNA 
interference and degradation by midgut enzymes (Hardy et al., 1983; Higgs, 2004). At the 
increased dose of 107 PFU/mL the aforementioned barriers within the midgut were generally 
overcome in both colony lines; virus infected a moderate number and escaped the midgut of a 
large proportion of infected specimens. This observation was confirmed by RNA-ISH 
(RNAscope), although only five of the Cx. pipiens (Caldbeck) line were assessed for presence of 
RVFV ZH501, the single infected mosquito showed widespread distribution of virus throughout 
the mosquito. Once infected, the Cx. pipiens (Brookwood) had significantly higher titres in the 
bodies of those transmitting compared to their refractory non-transmitting counterparts, as 
observed previously (Gad et al., 1987; Gargan et al., 1983). This was not reproduced in any other 
species, suggesting a dose dependency for the midgut escape barrier in Cx. pipiens 
(Brookwood). Although limited inferences can be made from a single positive Caldbeck 
specimen by RNA-ISH and further samples are required to form robust correlations between 
viral localisation with dissemination and transmission mechanisms, future research could apply 
this technique to test the hypothesis that a dose dependant midgut escape barrier is present in 
the Brookwood mosquito line. 
Ae. detritus however, once infected, supported high proportions of disseminated 
infections regardless of the infectious dose. At the low dose of 106 PFU, RVFV RNA was detected 
in the saliva of a single mosquito with all rates increasing with dose. Ae. detritus had high 
infection and dissemination rates compared to other species but did not differ in their ability to 
transmit compared to Culex; suggestive of a salivary gland barrier as observed by Gargan et al. in 
Cx. pipiens (1983). Whilst secondary amplification prior to entry into the salivary glands was 
evident in WNV infected Cx. pipiens (Girard et al., 2004) the titres detected in the legs and body 
here were not significantly different in transmitting or non-transmitting specimens. The 
methods in this project cannot differentiate between a salivary gland infection or escape 
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barrier. Using microscopy, such as the ultrastructural studies performed by Romoser et al. 
(2005) to implicate the basal lamina as an extracellular barrier to host cell surface receptors in 
salivary glands, could increase understanding of the underlying mechanisms. The salivary glands 
could not be located within the RNA-ISH sections performed (in colonised Cx. pipiens) and 
further work should focus on locating this important site within the mosquito and the method 
extended to confirm its application to wild-caught species. 
The population of Aedes rusticus from southern England was unable to transmit RVFV 
demonstrating only a limited potential to disseminate virus in early time points after ingesting 
107 PFU/mL RVFV. However, more numbers are needed to support this finding and differences 
between the species could not be determined. 
 
4.4.3 Transmission dynamics 
The EIP is the time from a mosquito acquiring virus when feeding upon a viraemic host to 
the time it is proficient to transmit when taking its next blood meal and is a key factor of 
vectorial capacity. As EIP decreases the potential for transmission events to occur in subsequent 
blood feeds increases; here the EIP was ≤7 days in all transmitting mosquitoes. To avoid 
detecting false positives from the blood meal, samples were collected from day seven onwards 
by which point viral RNA was detected in the saliva of all transmitting species. Further studies 
using earlier time points, to capture the eclipse phase and the increase in midgut titres, could 
facilitate determining the exact EIP and evaluating the rates of replication within the mosquito. 
This latter point will be discussed within the context of survival Section 4.4.4. Transmission has 
been suggested to occur as early as 2 dpi in previous studies (Romoser et al., 1992). The 
development of the honey-filter methods may be useful in facilitating the collection of data at 
these earlier time points. The time between seeking blood meals in the populations is not 
known, however, the presence of blood meal in the abdomen for three days coupled with 
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observations from feeding colonies suggests an EIP of seven days would be ample to support 
transmission in several subsequent blood feeds in these species. 
Viral titres in the saliva did not differ between species, strain or method of collection 
regardless of the infective dose ingested, agreeing with the previous findings (Gargan et al., 
1983). It is not known if the RNA titres detected here, 102.8 and 103.6 GEC ZH501 and Lunyo, are 
sufficient to cause disease; presumably the uniformity among species signifies their equal 
capability to pass virus horizontally to vertebrates. Failure to detect infectious virus in the saliva 
is likely due to the limit of detection of the plaque assay as observed previously (Nepomichene 
et al., 2018). Diluting the samples to screen by sensitive molecular methods increased through-
put but introduced a freeze-thaw, potentiating virus degradation. Previous reports have 
suggested that in vitro collection of saliva underestimate titres and local inflammatory 
responses in the vertebrate may facilitate viral infection (Le Coupanec et al., 2013; Pingen et al., 
2016; Styer et al., 2007; Vloet et al., 2017). Therefore, important next steps are demonstrating 
this ability to transmit to an animal model as a more natural mode of transmission. 
Additionally, lower rates of infection and transmission have been observed when 
comparing mosquitoes infected with an artificial blood meal prepared using frozen versus 
freshly harvested flaviviruses and RVFV stocks (Richards et al., 2007; Turell, 1988; Weger-
Lucarelli et al., 2016). Rates further decreased when comparing infection from a viraemic 
hamster or lamb compared to an artificial blood meal (Turell, 1988; Vloet et al., 2017). 
Therefore, the rates reported here may further underestimate rates in the field and the 
feasibility of using fresh stocks or an animal model for infection should be considered in future 
experiments. 
Peak viraemia in young ruminants is transient, typically occurring two to three days post 
infection and lasting less than 24 hours. The dose dependency observed here, limits the period 
that blood feeding mosquitoes could support acquire infection the field, to the short duration of 
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the peak viraemia. Mosquitoes feeding outside of this window would not contribute to 
transmission of RVFV. A single Ae. detritus was able to transmit at the lower dose, suggesting an 
increased capacity to transmit after ingestion of a broader range of doses in comparison to Cx. 
pipiens but further numbers are required to support this hypothesis. 
 
4.4.4 Effect of viral dose and temperature on vector survival 
Survival of the virus, and ultimately transmission, is reliant on survival of the vector host. 
The longer a mosquito survives, the more opportunity it has to feed upon vertebrate hosts 
facilitating horizontal acquisition or transmission of a virus. High mosquito mortality was 
observed at 25˚C compared to 20˚C in the wild-caught Aedes species; the concurrent mortality 
of controls and infected mosquitoes suggests a virus independent factor. It is conceivable that 
both Aedes populations have adapted to cooler (temperate) climes in their coastal and 
woodland habitats. The peak average temperatures recorded at climate stations located in close 
proximity to the collection sites ranged between 19-21˚C during June to August, 1981-2010 (Met 
Office, 2012). Therefore, studying these species at 20˚C is of relevance but the effect of natural 
diurnal temperature fluctuations should be considered; as previous studies with tropical species 
have shown altered survival and vector competence for DENV and malaria when compared to 
maintenance at constant temperatures (Davies et al., 2016; Lambrechts et al., 2011). 
Mosquito survival was observed as a factor of vectorial capacity in this study but the 
thermal sensitivity of vector host factors were not measured. The previously observed shorter 
eclipse phase of JEV in this population of Ae. detritus at 28˚C compared to 23˚C, is suggestive of 
an increased metabolism at higher temperatures (Mackenzie-Impoinvil et al., 2015). It has been 
shown that stress and immune responses triggered by higher temperatures come with high 
energetic-costs to the vector, perhaps with a trade-off for survival rates (Murdock et al., 2012; 
Muturi et al., 2012). Analysing differences in vector host expression levels in response to 
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temperature and virus would extend the observation here in order to better understand the 
relationship with survival. Further work is required to determine the lower temperature 
tolerance of temperate Ae. detritus; pairing these data with in vitro findings of Chapter 3, 
demonstrating the stability of RVFV at 12˚C. 
To increase sample numbers, repetitions of experiments infecting mosquitoes at the 
higher dose of 107 PFU/mL were performed at 20˚C for Aedes spp. However, increased mortality 
was observed in both Ae. detritus and Cx. pipiens (Caldbeck) at this dose, consistent with 
previous reports (Faran et al., 1987). This virus dependant factor occurred exclusively in the 
infected (not control) groups and was not affected by strain. Despite higher disseminated titres 
within Cx. pipiens (Brookwood), survival did not differ significantly between dose groups, 
thereby increasing its capacity as a vector. Tissue damage and resource depletion, as a result of 
rapid viral amplification, have been postulated as causes of cytopathic effects observed in 
flavivirus infected mosquitoes (Girard et al., 2005). Mosquitoes in this study were often 
observed to be fatigued at the bottom of microhabitat pots 24 hours prior to death. Romoser et 
al. (1992) postulated that the energy resources required to support viral infection can cause 
physiological changes, such as reduced re-feeding and fecundity reported by Turell et al. (1984), 
and could be a contributing factor in the reduced survival observed here. RNA-ISH 
demonstrated high titres of RVFV were localised within the thorax of a Cx. pipiens (Caldbeck), 
suggestive of high rates of replication. Ultrastructural studies as executed by Girard et al. (2005) 
and Romoser et al. (1992) could be performed, or RNA-ISH methods could be further developed 
to enable performance on a larger cohort of samples in order to compare high mortality groups 
to the lower mortality Brookwood group and improve understanding of the underlying 
mechanisms. However these methods should be done in parallel to comparing intra-host viral 
titres. The RNAscope method applied here has been previously used as a semi-quantitative 
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method so further work could also focus on developing a quantitative RNAscope application for 
mosquitoes (Grabinski et al., 2015). 
 
4.5 Summary 
The aim of this chapter was to evaluate the hypothesis that mosquito species present in 
the UK are competent to transmit RVFV. This has been achieved demonstrating three UK 
mosquito populations were capable of laboratory transmission of two pathogenic strains of 
RVFV, by 7 days post infection, by detecting viral RNA within their saliva by two methods. These 
findings were substantiated by the novel application of an RNA in situ hybridisation method 
showing high levels of RVFV RNA disseminated throughout Cx. pipiens at day 7 post infection. 
Key factors that affected this transmission potential were: 
 
The dose dependency observed would limit the period that blood feeding mosquitoes 
could support transmission in the field, to the short duration of the peak livestock viraemia. 
Both Cx. pipiens colonies required a dose of 107 PFU/mL in order to detect RVFV within their 
saliva. The lower dose threshold of 106 PFU/mL for Ae. detritus, albeit at a low transmission 
efficiency, increases its capacity as a vector compared to the Culex. 
 
Infecting mosquitoes with strain ZH501 or Lunyo produced no observable differences in 
infectivity rates, intra host titres or survival within these experiments. 
 
The effect of temperature on vector competence could not be evaluated due to high 
mortality rates, instead it was analysed in relation to survival as a factor of vectorial capacity. 
Wild-caught Ae. detritus demonstrated potential to transmit RVFV at temperatures relevant to 
the UK (20˚C) but its low survival at the higher temperature (25˚C) may limit its capacity in the 
field. This finding supports the data presented in Chapter 3 demonstrating optimal temperature 
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for virus is not necessarily the same as that for cell growth or the mosquito. Blagrove et al. 
(2017) propose that in terms of transmission fitness, the vectors’ optimal temperature precedes 
that of the virus and this hypothesis is supported by the in vitro and in vivo data presented 
within this thesis. 
 
Reduced survival was observed in Cx. pipiens (Caldbeck) and Ae. detritus infected at 107 
PFU/mL but not in the Cx. pipiens (Brookwood) suggesting the latter would be a better vector in 
the field. This concurs with previous observations of differences between localised Cx. pipiens 
populations’ capacity to vector RVFV (Brustolin et al., 2017, 2016; Turell et al., 2014; Vogels et 
al., 2016). 
 
Vector competence is one component of vectorial capacity so these data must be paired 
with behavioural and life-history traits in the field including: biting rate, feeding preferences and 
longevity. Considering the feeding preferences of the Cx. pipiens (Brookwood) and Ae. detritus, 
and their competence to transmit two pathogenic strains of RVFV within their saliva in the 
laboratory, it can be concluded that these temperate UK mosquito species demonstrate a 
potential to infect susceptible vertebrate hosts but at low efficiency. Factors affecting the ability 
of RVFV to adapt to the host are considered within Chapter 5, assessing changes in the 
consensus and sub-consensus genome after replication within the mosquito host. 
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5 Results: Inter- and intra-host sequence variation of RVFV 
5.1 Introduction 
Genomic mutations within the viral population provide the potential for adaptation to 
promote survival in new hosts or environments. The plasticity of RNA genomes is largely due to 
the low fidelity of the RNA-dependent RNA polymerase (RdRp) but is also affected by rapid viral 
replication rates and large viral population sizes (Duffy et al., 2008). The contribution of genetic 
mutations leading to arboviral emergence in new geographic locations and hosts has been 
demonstrated previously for several arboviruses including CHIKV, VEEV and WNV (Brault et al., 
2004; Davis et al., 2003; Ebel et al., 2004; Moudy et al., 2007; Rezza et al., 2007; Tsetsarkin et al., 
2007). These examples each demonstrate the dramatic effect a small number of nucleotide 
changes in the consensus sequence can have on the phenotype and the course of viral 
transmission and pathogenicity. 
Current understanding of RVFV genetic variation is largely based on data generated in cell 
culture assessing sequence at the consensus level (Bird et al., 2007). However, the use of in vitro 
cell culture to investigate adaptation can dilute genetic variation in comparison to in vivo 
models due to the absence of pressures arising from the host immune response and 
requirement to enter multiple cell types (Coffey et al., 2013, 2008). In vivo experiments 
performed to assess adaptation of flaviviruses and alphaviruses demonstrated consensus level 
mutations occur when switching between disparate hosts (Dridi et al., 2015; Grubaugh et al., 
2017; Lequime et al., 2016). These changes rarely become fixed within the population, as a gain 
in fitness in one host can be deleterious in the other resulting in a purifying selection that limits 
adaptation during alternate cycling between the disparate hosts in nature (Ciota et al., 2007; 
Coffey et al., 2008; Vasilakis et al., 2009). This is reflected in the evolutionary stability reported 
for arboviruses (Coffey et al., 2008; Forrester et al., 2014; Woolhouse et al., 2001) and has been 
demonstrated within in vitro experiments of RVFV (Moutailler et al., 2011). Whilst Moutailler et 
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al. (2011) observed adaptation occurring in vitro after a high number of consecutive passages in 
a single cell line (>10 passages), consensus mutations were not observed in the initial or 
alternate passages in either mosquito or mammalian derived cell lines. Studies of RVFV, based 
on data generated in vitro, suggest that adaptation at the consensus sequence level does not 
routinely occur when switching between hosts (Moutailler et al., 2011; Weingartl et al., 2014c) 
which conflicts with the aforementioned adaptation observed for flaviviruses and alphavirus in 
vivo (Dridi et al., 2015; Grubaugh et al., 2017; Lequime et al., 2016). Studies determining the 
presence or absence of consensus changes within in vivo mammalian and mosquito models 
would therefore improve understanding of potential adaptation, mimicking more natural 
transmission dynamics. 
The consensus sequence, however, represents the genetic average of the population 
(Isakov et al., 2015) and therefore is a simplified determinant of potential adaptation of RNA 
viruses that exist in dynamic heterogeneous populations of variants (Holmes and Moya, 2002; 
Lauring and Andino, 2010). A genetically diverse population presents a greater adaptive 
potential, more likely to be equipped with a minority variant that is suited to a new 
environment compared to a homogenous population that may be less equipped to survive in a 
rapidly changing host environment (Coffey et al., 2013). Multiple parallel reads generated by 
next generation sequencing (NGS) facilitate the characterisation of minority variants in viral 
populations in comparison to traditional sequencing methods. However, despite these 
technological advances, the majority of available data are consensus sequences generated by 
Sanger sequencing which does not provide sequence data for the low abundance variants which 
can result in phenotypic changes without alteration of the consensus, as has been demonstrated 
with VEEV (Coffey et al., 2008). Despite a lack of data utilising the optimal technique, minority 
variants have been indirectly detected within in vitro populations of RVFV with reports of 
abnormal phenotypes arising from characterised strains such as plaque variants of strain ZH501 
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(Rossi and Turell, 1988), the naturally-attenuated Clone 13 containing a 549bp deletion in the 
NSs protein (Muller et al., 1995), and a single nucleotide substitution demonstrating reduced 
virulence in mice (Morrill et al., 2010). While the phenotypic variants arising from in vitro 
adaptation have been identified, data regarding to proportion of minor variance is absent. 
Similarly, analysis of minor variants in strains cycling between mammalian and mosquito hosts 
in vivo is absent. 
In addition to a dearth of information relating to minority variants for RVFV, investigation 
of intra-host genetic diversity is limited to a single study characterising the MP-12 vaccine strain 
(Lokugamage et al., 2012). Studies of intra-host variability in mosquitoes infected with WNV, 
VEE and CHIKV with a focus on Sanger sequence data demonstrated that variability is restricted 
at anatomical barriers within the vector correlating with a reduction in population size (Coffey et 
al., 2013; Forrester et al., 2014). These findings have been recently extended using deep 
sequence data to measure sequence heterogeneity of flaviviruses (Dridi et al., 2015; Grubaugh 
et al., 2017) and alphaviruses (Patterson et al., 2018) in vivo demonstrating heterogeneity is 
restored downstream of bottlenecks following replication. 
As genomic mutations present a mechanism for adaptation to new hosts promoting 
survival, next generation sequencing techniques were applied to assess adaptation occurring at 
the consensus level within in vitro and in vivo sample sets in order to test the hypothesis that: 
 
Evidence of viral adaptation to the host will be detected by different consensus 
changes occurring after in vivo replication in the mosquito, compared to a 
mammalian host. 
 
As it is reasonable to predict that consensus changes will occur in vivo based on similar 
investigation with other arboviruses such as DENV, WNV and VEEV, the occurrence of minority 
variants and intra-host genetic diversity will be evaluated, in addition to consensus level 
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changes, to measure the potential for RVFV adaptation within its vector host and a model 
vertebrate host. 
 
5.2 Methods 
5.2.1 Sample cohorts analysed 
Strain ZH501, the virulent strain used throughout this project, was selected for further 
characterisation by the optimised deep sequencing method described by Quick et al. (2017). 
Use of this strain permitted comparison to the limited RVFV sequence analysis performed 
previously and submitted to the public sequence repository GenBank (NCBI). RVFV propagated 
in vitro (in Vero E6 and C6/36 cell lines) and in vivo (in mosquitoes and BalbC mice) as part of the 
preceding chapters was used as source material. The sample cohorts were RVFV propagated in: 
1) Cx. pipiens Caldbeck bodies; 2) Cx. pipiens Brookwood bodies; 3) Cx. pipiens Brookwood legs; 
4) BalbC mouse livers; 5) C6/36 cells at 20˚C-37˚C; 6) Vero E6 cells at 28˚C-37˚C. A schematic of 
the NGS development and sequencing strategy are presented in Figure 5.1. 
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Figure 5.1 Schematic of next generation sequencing experiments 
 
5.2.2 Multiplexed amplicon NGS (primal scheme) 
To evaluate genetic diversity at both the consensus and sub-consensus level from 
mosquito samples predicted to contain low RVFV titres, it was first necessary to develop a 
sensitive NGS approach to attain a high sequence read depth. The development and 
optimisation of methods are detailed in Appendix Section A5.1 using RVFV ZH501 RNA stocks to 
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evaluate metagenomic, amplicon and multiplexed-amplicon (primal scheme) sequencing 
strategies. 
The methods detailed here are within the final optimised format using a novel published 
multiplex amplicon approach developed by Quick et al. (2017). Primer pairs were designed to 
generate overlapping amplicons (400 nucleotides in length) across the entire genome using an 
online primer design tool (https://primal.zibraproject.org), using reference sequences from 
GenBank (accession numbers detailed in Appendix Table A5. 4). The method was trialled 
following the published protocol (Quick et al., 2017) using strain ZH501. Primer pairs were 
assessed using the resultant sequence coverage and were manually redesigned for regions of 
low or missing coverage, using online freeware (GenScript, 2016). In addition to redesigning 
primers, the cycling and reaction chemistry parameters were optimised due to low yields in 
regions of the genome associated with high GC content and significant secondary structures. 
This included the addition of dithiothreitol (DTT) and dimethyl sulfoxide (DMSO) (both Thermo 
Fisher Scientific) to the reaction mix and extended cycling parameters. The optimised protocol 
used to amplify, then sequence, from in vitro and in vivo samples is detailed below. 
The initial cDNA synthesis step was performed using the published protocol as follows: 
7µL template RNA and 2.5µM random hexamers (Thermo Fisher Scientific) were incubated at 
65˚C for 5 minutes and then immediately placed on ice. This was used as template for the cDNA 
synthesis step performed in a 20µL reaction using the Protoscript II First Strand cDNA Synthesis 
Kit (NEB) under the following conditions: 25˚C for 5 minutes (1 cycle), 48˚C for 15 minutes (1 
cycle) and 80˚C for 5 minutes (1 cycle). Amplification was performed using oligonucleotides 
listed in Appendix Table A5. 5, with redesigned sequences written in bold typeface: in total 6, 11 
and 22 primer pairs were designed for the S, M and L segments respectively. Alternate primer 
pairs (10µL of each 100µM stock) were pooled (designated primer pool A or B) to create a stock 
then used in the reaction master mix detailed in Table 5.1 and cycling in Table 5.2. 
Results: Inter- and intra-host sequence variation of RVFV 
131 
 
Amplicons were electrophoresed on a 2% (W/V) agarose gel and PCR reactions containing bands 
between 300-500nt in size were sequenced. Amplicon pools designated A and B were 
sequenced separately as detailed in Sections 5.2.3 and 5.2.4. 
 
Table 5.1 Multiplexed amplicon (primal scheme) reaction mix composition 
Component Stock concentration Volume (µl) 
Water n/a Up to 25 
Q5 reaction buffer* 5x 12.5 
dNTP* 10 mM 0.5 
Primer mix: Pool A 
or Pool B  
2.27µM 
2.5µM 
0.22 
0.2 
DTT 100 mM 0.6 
DMSO 100% 1.25 
Q5 DNA polymerase* n/a 0.25 
cDNA n/a 3 
* Component of the Q5 Hot Start High-Fidelity DNA Polymerase (New England BioLabs). 
 
Table 5.2 Primal scheme PCR cycling parameters 
Step name Temperature (˚C) Time (M:S) Cycles 
Pre-denaturation 98 °C 05:00 1 
Denature 98 °C 00:30 
40 
Anneal and extend 65 °C 06:00 
Final extension 68 °C 10:00 1 
 
5.2.3 Sequencing 
Sequencing steps were performed by the Genomic Services and Development Unit (PHE) 
or the Sequencing Facility (APHA). Double stranded-cDNA was purified using Agencourt AMPure 
XP system (Beckman Coulter), purified genomic DNA was tagged and multiplexed with the 
Nextera XT DNA library preparation kit (Illumina) and sequenced on the Illumina Mi-Seq 
platform following standard Illumina protocols with paired-end read lengths of 150bp. The 
quality of raw data was assessed by FASTQC. 
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5.2.4 NGS data analysis 
5.2.4.1 Sequence mapping to a reference genome 
The mapping method decribed in this section was performed by Specialist Scientific 
Support Department (APHA). Primer trimming, prior to performing standard mapping pipelines, 
was a prerequisite for sequence data generated by the Primal Scheme method. This was 
achieved in a primer sequence targeted manner using Trimmomatic; a tool designed to remove 
Illumina sequence adapters (Bolger et al., 2014) as described previously (Quick et al., 2017). The 
trimmed run 1 sequences for pools A and B were concatenated as were the run 2 pool A and B 
sequences. Downstream protocols were performed as standard on all sequence data. 
Standard read trimming was performed on raw data to exclude data falling below a 
quality score (Q-score) threshold of 30 (equivalent to an error probability of 0.001, generated by 
the Illumina MiSeq Reporter software) and read length threshold of 50 after quality trimming. 
Total reads were mapped to a concatenated reference sequence for the entire 11,979bp 
genome of RVFV strain ZH501 (Accession numbers: DQ380149; DQ380200; DQ375406 for the S, 
M, and L segments respectively) using BWA version 0.75a-r405 (Li and Durbin, 2010) and 
visualised in Tablet (Milne et al., 2013). Consensus sequence was generated using a modified 
SAMtools/vcfutils script (Li et al., 2009), the intermediate sequence generated was then used as 
a reference to iteratively map and call the consensus, the fourth repeated iteration of this 
process was used (Marston et al., 2015). 
 
5.2.4.2 Data analysis of consensus sequence 
Alignments of the consensus sequence were performed in MegAlign (Version 14.0, 
DNASTAR) using RVFV ZH501 sequence on GenBank as a reference (Accession numbers: 
DQ380149; DQ380200; DQ375406 for the S, M, and L segments respectively). Mapping statistics 
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were extracted (from the mapped BAM file) using the SAMtools_FlagStat script and coverage 
statistics generated in Tablet visualisation software. 
 
5.2.4.3 Data analysis of sub-consensus diversity 
In the first instance, minority variant analysis of the RVFV population was performed using 
the variant call format (.VCF) file generated by the SAMtools_Mpileup script. The number of 
variant sites occurring in >1% of the population relative to the nucleotide coverage was counted 
and normalised to calculate variant frequency across the entire genome. Heterogeneity was 
calculated by the Specialist Scientific Support Department (APHA) using an in-house developed 
Heterogeneity Index (H-Index) method described previously (Marston et al., 2017) and the 
pipeline is available at https://github.com/JaviNunez/ViralVariantAnalysis. Unlike the variant 
frequency measure, H-index accounts for the proportion of the population carrying a variant 
and is defined as the ratio between the number of sequenced calls that differs from the 
reference genome (in this case the consensus sequence) and the total number of sequence calls. 
This index calculates a comparable measurement of heterogeneity between samples, based on 
the number of alternative nucleotide calls per million sequenced, rather than an absolute 
measure, permitting comparison between samples despite any differences in coverage: the 
higher the genetic diversity, the higher the H-index will be. If fewer variant sites are present 
within the population but at a higher frequency then the complexity measure will remain high, 
whilst variant rate will decrease. 
To provide further confidence, these analyses were repeated using the web-based 
pipeline ViVan developed by Isakov et al. (2015) and results of each are compared. Variant 
frequency was calculated per nucleotide then multiplied by the coverage so measures were 
comparable between samples regardless of coverage, with a cut-off of >90% genome coverage 
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applied. Shannon entropy was calculated as a measure of sequence complexity instead of H-
index. 
 
5.2.5 Statistical analyses 
Each sample derived from mosquito or mouse was considered a biological replicate, but 
because cell lines were derived from the same origin, different flasks of cells were considered 
technical replicates. Comparisons of consensus variation across the genome between sample 
cohorts and protein coding regions within sample cohorts were compared by Chi square test. 
Selective pressures occurring within the consensus sequence derived from mosquito samples 
were assessed by significance testing of the hypothesis of neutrality, using the codon based Z-
test based on the methods of Nei and Gojobori (1986) in MEGA7. Comparison of sequence 
complexity and variance indices in the sub-consensus were compared between sample cohorts 
using non-parametric comparison of medians using the Kruskall Wallis test with Dunn’s post-test 
for multiple comparisons. 
 
5.3 Results 
5.3.1 Depth of coverage obtained in NGS datasets 
The sensitivity of the multiplexed amplicon method was 105 genome equivalent 
copies/sequencing reaction (equivalent to around Ct 24), facilitating the generation of deep 
sequence data for 27 samples summarised in Table 5.3. Coverage across the genome for 
individual samples is presented in Appendix Figure A 5. 4. To prevent the introduction of bias 
due to insufficient viral reads and coverage, a cut-off was applied after quality, length and 
duplicate filtering: >25,000 reads and a minimum depth of x100 reads across >90% of the 
genome (Marston et al., 2017; Patterson et al., 2018). The omitted samples are provided in 
Appendix Table A5. 7. Due to insufficient viral reads, only one sample sequenced from virus 
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propagated at 20˚C was analysed. The low quantity of viral RNA detected in saliva samples was 
below the limit of detection of the amplicon RT-PCR, and only paired body and leg samples from 
Cx. pipiens Brookwood had sufficient vRNA titres to generate sequencing data. 
 
Table 5.3 Summary of samples analysed for consensus and sub-consensus variation 
# Host Site DPI 
Genome equivalent copies Viral 
reads 
Coverage 
(%) Infected Disseminated Transmitted 
4 Cx. pipiens (Caldbeck) Body 7 7.72 3.61 Neg 214,231 98.4 
5 Cx. pipiens (Caldbeck) Body 7 7.03 3.37 2.84 163,711 98.5 
6 Cx. pipiens (Caldbeck) Body 7 7.11 3.05 Neg 229,158 98.5 
7 Cx. pipiens (Caldbeck) Body 7 7.72 3.61 Neg 225,484 98.4 
9 Cx. pipiens (Caldbeck) Body 21 8.08 3.66 Neg 257,716 98.4 
10 Cx. pipiens (Caldbeck) Body 21 7.68 4.12 2.50 259,002 98.4 
11 Cx. pipiens (Brookwood) Body 21 9.34 8.45 Neg 317,511 99.1 
12 Cx. pipiens (Brookwood) Body 21 9.51 8.68 1.76 275,354 98.9 
13 Cx. pipiens (Brookwood) Body 21 9.49 8.30 4.12 335,067 99.0 
14 Cx. pipiens (Brookwood) Body 21 9.54 8.16 Neg 360,024 99.3 
16 Cx. pipiens (Brookwood) Legs 21 9.34 8.45 Neg 182,832 98.9 
17 Cx. pipiens (Brookwood) Legs 21 9.51 8.68 1.76 338,195 99.0 
18 Cx. pipiens (Brookwood) Legs 21 9.49 8.30 4.12 306,420 99.1 
19 Cx. pipiens (Brookwood) Legs 21 9.54 8.16 Neg 275,520 99.1 
20 BalbC mouse Liver 3 8.69 n/a n/a 186,670 99.2 
21 BalbC mouse Liver 3 8.79 n/a n/a 259,416 99.4 
22 BalbC mouse Liver 3 8.78 n/a n/a 308,125 99.1 
23 BalbC mouse Liver 3 8.69 n/a n/a 186,929 98.8 
24 C6/36 20˚C 10 8.19 n/a n/a 304,786 99.0 
25 C6/36 28˚C 3 8.98 n/a n/a 326,306 99.0 
26 C6/36 28˚C 3 8.78 n/a n/a 304,114 99.2 
27 C6/36 37˚C 3 8.94 n/a n/a 312,689 99.1 
28 C6/36 37˚C 3 8.59 n/a n/a 263,392 98.9 
33 Vero E6 28˚C 3 9.88 n/a n/a 141,219 97.8 
34 Vero E6 28˚C 3 9.46 n/a n/a 143,708 96.5 
35 Vero E6 37˚C 3 9.79 n/a n/a 127,760 98.2 
36 Vero E6 37˚C 3 9.23 n/a n/a 350,762 99.9 
Genome equivalent copies (GEC) are presented /mL for mouse and in vitro samples and /mosquito 
for the body, legs and saliva; samples in bold typeface were sequenced. DPI: days post infection. 
Viral reads are listed post quality filtering and removal of duplicates, representing the population 
analysed. 
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5.3.2 In vitro sequence variation at the consensus level 
No consensus changes were detected in RVFV propagated in vitro. This sample cohort 
included strain ZH501 propagated in duplicate at 28˚C and 37˚C in the mammalian Vero E6 and 
the mosquito C6/36 cell lines, in addition to a single replicate at 20˚C in C6/36 cells. The 
consensus sequences were identical to both the reference sequence for ZH501 in GenBank 
(accessions DQ380149; DQ380200; DQ375406) and the preliminary data generated by the 
metagenomic approach that was used to confirm strain identity. 
 
5.3.3 In vivo sequence variation at the consensus level 
Changes to the consensus sequence were detected in RVFV propagated in vivo, a 
schematic of the location of consensus changes are presented in Figure 5.2 and a summary of 
individual samples and amino acid changes in Table 5.4. Five nucleotide substitutions were 
detected in samples of two or more biological replicates. The same non-synonymous 
substitution within the M segment T843C (GP-Y275H) occurred in three out of the four mice and 
a single Cx. pipiens. A second non-synonymous consensus substitution within the M segment 
A1303G (Y428R), occurred within both Cx. pipiens lines but not within the mouse samples. The 
remaining three reproducible consensus changes were synonymous, occurring within the L 
segment of RVFV derived from mosquito samples: C2904T; A5598G; T5793C. 
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Table 5.4 Consensus sequence changes within infected Cx. pipiens mosquitoes and BalbC mice 
Genome 
position 
Input 
nt 
Cx. pipiens CBK 
body 
Cx. pipiens 
BKW body 
Cx. pipiens 
BKW legs 
Mouse 
BalbC Coding 
region 
Amino acid 
change 
7 dpi 21 dpi 21 dpi 21 dpi 3 dpi 
S Segment 
                     
115 T  C              
 
  NSs S 
208 T                C   NSs S 
1580 C   T                N V25I 
M Segment 
                     
843 T     C          C C 
 
C GP Y275H 
1201 T        C   
 
C       GP L394P 
1303 A     
 
G G  G G G  G G     GP Y428R 
1312 A   G 
   
            GP N431S 
1315 C  T                 GP A432V 
1598 T  
 
     C    C       GP S 
1678 T   C                GP V553A 
1913 A          G    G     GP I631M 
1944 A       
 
C    C  
 
    GP N642H 
2497 T  A          
 
      GP F826Y 
3406 A 
  
       G  
 
 G     GP E1129G 
L Segment 
           
 
   
    
  
1118 A          G   
 
G     L N367S 
2904 C      T   T T 
 
 T T     L S 
5011 G      
 
A    A        L V1665I 
5502 C          T    T     L S 
5598 A      G   G G 
 
 G G     L S 
5739 T 
 
C C  C 
 
C    C 
 
      L S 
6199 G 
  
A                L V2061I 
Consensus changes and nucleotide positions are reported relative to accession numbers DQ380149; 
DQ380200; DQ375406 for the S, M, and L segments respectively; dpi: day post infection; letters 
represent the nucleotide change within the consensus sequence; S: synonymous mutation; amino 
acid changes within the M segment are reported relative to the glycoprotein polyprotein. CBK: Cx. 
pipiens Caldbeck colony; BKW Cx. pipiens Brookwood colony. Sequence data from Brookwood line 
was determined on paired samples from the bodies and legs, these datasets are shown in the same 
order in the table demonstrating 100% homology between the two tissue sites within individual 
mosquitoes. In vitro data have been omitted as no changes to the consensus were detected. 
 
The proportion of nucleotides that differed from the input sequence, and between sample 
cohorts, was calculated as performed previously for WNV (Ebel et al., 2004) and statistical 
significance tested by Chi-square test (Appendix Table A5. 8). There were no significant 
differences between consensus changes between coding regions within groups (Chi-square test 
with a Bonferroni corrected significance threshold for multiple comparisons set at >0.0166). 
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There was also no significant difference between consensus diversity for the mosquito species 
(p=0.4335). However, genome-wide comparison of consensus diversity was significantly higher 
for both mosquito species compared to mouse samples (Caldbeck p=0.0124, Brookwood 
p=0.0010) and the input in vitro samples (Caldbeck p=0.0006, Brookwood p=<0.0001). 
Using a codon based test of neutrality, the consensus sequences of glycoprotein were 
compared to predict whether consensus changes in the mosquitoes arise as a result of adaptive 
selection or stochastic events (Nei and Gojobori, 1986). The results were not significant for the 
Brookwood (p=0.648) or Caldbeck (p=0.458) lines, therefore the assumption of neutrality cannot 
be rejected. 
 
5.3.4 In vivo minority variants within the sub-consensus 
The consensus changes reported within Table 5.4 were analysed to ascertain whether the 
substitutions existed within the population as minority variants in all the samples tested. These 
same data (as presented in Table 5.4) are repeated in Table 5.5 reporting the percentage of the 
nucleotide substitution that resulted in a consensus change in parallel to its frequency within 
the minority population of the remaining samples. 
The five nucleotide substitutions (reported in Section 5.3.2 and 5.3.3) that occurred 
reproducibly (in two or more biological replicates) in the consensus were each present at 
varying minority frequencies within the input Vero E6 viral population. Analysing the sub-
consensus revealed the substitution reported in three out of the four mice (GP-Y275H) was 
present in a high proportion (47%) of the sub-population in the fourth mouse and was present 
in a third of the in vitro populations. The reproducible consensus substitution within the M 
segment (Y428R) of RVFV propagated in Cx. pipiens was present within 14% of Vero E6 viral 
populations and an average of 20% within the mice. 
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Table 5.5 Frequency of minority variants within the population (at genome locations giving rise to 
a consensus level change in at least one sample) 
Genome 
position 
nt 
change 
Cx. pipiens CBK 
Body 
Cx. pipiens BKW 
body 
Cx. pipiens BKW 
legs 
Mouse BalbC 
Cells 
C6/36 
Cells 
Vero E6 Coding 
region 
7 dpi 21 dpi 21 dpi 21 dpi 3 dpi 3 dpi 3 dpi 
S Segment 
                      
115 TC 12 99 * x * * * * * * * * * * * * * * 3 * NSs 
208 TC * * * x * * * * 1 * * * * * * 53 * * * 9 NSs 
1580 CT 0 * 97 0 0 * * * * * 0 * * * * * * 2 3 2 N 
M Segment 
                      
843 TC 47 * * x 99 * 25 32 * * 37 11 * * 86 53 48 64 31 27 GP 
1201 TC 1 * * 0 1 * 4 60 * * 9 85 1 1 8 1 48 2 25 26 GP 
1303 AG 46 * * 26 * 99 72 * 98 99 55 * 97 99 3 44 1 32 8 14 GP 
1312 AG * 2 99 0 * * * * * * * * * * * * * * 1 2 GP 
1315 CT 7 99 2 7 * * * * * * * * * * 5 * * 4 14 14 GP 
1598 TC 0 0 0 * * 0 * 63 * * * 86 * * * 0 * * * * GP 
1678 TC * * 99 * 0 0 * * * * 0 * 0 * * x * * * * GP 
1913 AG * * * 0 * * * * * 99 * * * 99 * * * * * 4 GP 
1944 AC * * * 0 * * * 60 * * * 84 * * * * * 0 * 0 GP 
2497 TA 0 99 0 x 0 0 0 0 0 0 0 0 * 0 0 0 0 0 * 1 GP 
3406 AG 0 0 * 0 0 0 * * * 99 0 * * 99 * * * * * * GP 
L Segment 
           
 
          
1118 AG * * * * * * * * * 58 0 * * 53 * * * * * * L 
2904 CT 45 2 * 0 * 99 * 1 99 99 * * 99 98 * 1 * * * 3 L 
5011 GA 0 0 0 0 * * 71 * * * 54 * * * * * * * * * L 
5502 CT 0 0 0 0 0 0 * 
 
* 56 * * * 56 * 0 * * * * L 
5598 AG 45 0 0 0 * 79 * * 99 99 0 * 99 99 2 * * 0 2 * L 
5739 TC 2 99 99 * 99 * 80 * * * 78 0 * * 0 9 40 31 20 7 L 
6199 GA 0 * 94 * * * * * * * 0 * * * * * * * * * L 
Numbers represent the percentage of the population carrying the reported consensus change 
nucleotide. Substitutions occurring in >50% of the population resulting in a consensus change are 
highlighted in bold typeface. * variant present in <1% of population; 0: variant absent or below 
detectable level in population; x: data point excluded as <100 reads coverage. Nucleotide positions 
are reported relative to accession numbers DQ380149; DQ380200; DQ375406 for the S, M, and L 
segments respectively; dpi: day post infection. CBK: Cx. pipiens Caldbeck colony; BKW Cx. pipiens 
Brookwood colony, sequence data from this latter mosquito population was determined on paired 
samples from the bodies and legs, these datasets are shown in the same order in the table 
demonstrating 100% homology between the two tissue sites within individual mosquitoes. The 
presence of variants in the sub-populations for in vitro data is based on the concatenated results of 
replicates. 
 
Common variants occurring within all samples within a cohort are presented in Appendix 
Figure A 5. 8, showing minority variants scattered across the genome with no obvious pattern of 
localisation. 
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5.3.5 Sub-consensus diversity 
5.3.5.1 Comparison of in-house and published measures of sub-consensus diversity 
The in-house and published methods used to calculate variant frequency correlated well 
(Pearson’s correlation: r=0.9498, p=<0.0001) (Appendix Figure A 5. 5; Panel B). The in-house 
H-index measure of genetic complexity also yielded comparable results to the Shannon entropy 
as observed previously (Marston et al., 2017) with a significant correlation between the two 
measures (Pearson’s correlation: r=0.7262, p=<0.0001) (Appendix Figure A 5. 5; Panel A). The 
only discrepant result between the two measures of genetic complexity was observed in the Cx. 
pipiens Caldbeck line and are presented in Appendix Figure A 5. 6. Shannon entropy and variant 
frequency calculated by the ViVan pipeline (Isakov et al., 2015) are presented in the main body 
of this chapter as the more widely cited method within the literature, permitting reproducibility 
and comparison. Additionally, these are thought to be more robust with more stringent 
inclusion criteria based on statistical probability of true variance. 
Shannon entropy and variant frequency were plotted as a function of viral reads to 
determine if measures were skewed by read depth, showing no (Pearson’s) correlation 
(Shannon entropy r=0.1919, p=0.3580; variant frequency r=0.0741, p=0.7250) (Figure A 5. 7; 
Panel A and C). However, a significant positive correlation was observed between diversity and 
viral titre (Shannon entropy r=0.8082, p=<0.0001; variant frequency r=0.7966, p=<0.0001) 
(Figure A 5. 7; Panel B and D). 
 
5.3.5.2 Comparison of diversity relative to the input in vitro population 
Genetic diversity of the viral populations in the mosquitoes (Cx. pipiens Caldbeck n=6, 
Brookwood n=4), mice (n=4) and C6/36 cells (n=4) were compared to the diversity recorded in 
Vero E6 cells (representing the input viral population used to infect hosts, n=4) by the Kruskall 
Wallis test (Figure 5.4). A significant decrease in RVFV diversity, by both measures (entropy and 
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frequency), was recorded in the Cx. pipiens Caldbeck line compared to in the Vero E6 cells but 
not within other sample cohorts (Shannon entropy: p=0.0016, variant frequency: p=0.0013, with 
Dunn’s post-test results presented in Figure 5.4). As viral titre correlated with the genetic 
diversity indices (Section 5.3.5.1 and Appendix Figure A 5. 7), mean viral titres were compared 
between cohorts. A significantly higher titre in Vero E6 cells and Brookwood mosquito samples 
tested was observed compared to the Caldbeck line by Kruskall Wallis with Dunn’s post-test 
(p=0.0016). 
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Figure 5.3 Comparison of sub-consensus genetic diversity in mosquitoes, mice and in vitro cell 
lines. The genetic diversity of RVFV propagated in different host environments was compared by 
published methods (Isakov et al., 2015). Using A. Shannon entropy as a measure of complexity and 
B. variant frequency to understand if complexity arises from a low number of mutations at high 
abundance within the population or high number at low abundance. Cx. pipiens Caldbeck (CBK) n=6; 
Cx. pipiens Brookwood (BKW) n=4; BalbC mouse n=3; C6/36 cells n=5; Vero E6 cells n=3 were 
compared by Kruskall Wallis test with * indicating a significant difference by Dunn’s post-test; bars 
represent the 95% CI calculated in GraphPad prism. 
 
5.3.5.3 In vivo comparison of diversity between mosquito and mammalian hosts 
Genetic diversity of the viral population in the BalbC mice (n=3) did not differ significantly 
compared to that in Cx. pipiens Brookwood (n=4) or Caldbeck (n=6) mosquitoes, but there was a 
significantly higher diversity in the Brookwood line compared to Caldbeck by both diversity 
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measures (Kruskall Wallis with Dunn’s post-test: Shannon Entropy p= 0.0069, ns; variant 
frequency p=0.0069, ns) (Figure 5.3). 
A confounding variable in the comparison of these sample cohorts was the time elapsed 
since infection: all Brookwood mosquitoes were tested on day 21 post infection whereas for the 
Caldbeck line four were sampled on day 7 and two on day 21. Although sample numbers were 
too low to compare statistically, the entropy and variant values attained on day 21 were within 
the range of values yielded on day 7. Additionally, there were the aforementioned significant 
difference between titres in the Caldbeck compared with Brookwood lines but not between 
either of the mosquito lines and mouse. 
 
5.3.5.4 Comparison of diversity between viral populations in mosquito bodies and legs 
Genetic diversity in Cx. pipiens Brookwood was compared in paired samples collected 
from the bodies and legs of four mosquitoes collected at 21 dpi. Both measures demonstrated 
significantly higher diversity in the legs compared to the bodies (Mann Whitney test: Shannon 
entropy p=0.0286; variant frequency p=0.0286) shown in Figure 5.4. 
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Figure 5.4 Comparison of viral heterogeneity and variants in paired mosquito bodies and legs. A. 
Complexity measured by Shannon entropy and B. Variant frequency in Cx. pipiens Brookwood colony 
compared by Mann whitney U test at day 21 post infection with RVFV strain ZH501. Bars represent 
the 95% CI calculated in GraphPad Prism. 
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5.4 Discussion 
In this chapter, an NGS strategy was developed and performed on virus harvested from 
mosquitoes and BalbC mice to improve understanding of genetic variation arising within in vivo 
model hosts. Data generated from in vitro propagated samples showed no change in the 
consensus sequence as previously reported (Moutailler et al., 2011; Weingartl et al., 2014c). 
However, the results generated here demonstrate that consensus sequence changes do occur 
after in vivo replication marking the first confirmation of this phenomenon for RVFV. These 
changes occurred in both hosts, although at a greater frequency in the mosquito compared to 
the mouse. To permit comparison to previous knowledge of RVFV, results are primarily 
discussed within the context of sequence variation arising at the consensus level. The potential 
implications of events occurring in the underlying sub-consensus population are then also 
discussed. 
 
5.4.1 Method evaluation 
The high coverage attained by the multiplexed amplicon approach (average read depth 
across all samples of 3,043) allowed the evaluation of viral sequence diversity within 27 samples 
to investigate intra- and inter-host differences, which would not have been feasible within this 
project using a metagenomic approach. However, it is acknowledged that using PCR to amplify 
sequences can introduce errors via the imperfect polymerase fidelity by much the same 
mechanism as the errors introduced during in vivo viral replication (Duffy et al., 2008) and 
variant frequency can be led by PCR bias (Beerenwinkel and Zagordi, 2011; Isakov et al., 2015). 
As distinguishing PCR artefacts from the true base calls under evaluation is challenging, methods 
were selected to limit these effects (Aird et al., 2011), including: the use of a high fidelity 
polymerase; PCR optimisation to recover sequence from GC-rich regions of the genome; and 
computational removal of duplicates within the sequence data generated to mitigate against 
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PCR bias. A number of additional steps were undertaken to limit the errors introduced within 
the sequencing reads; in the first instance read quality and length filtering were applied as 
standard, followed by utilising methods previously described to evaluate both consensus and 
sub-consensus diversity (Marston et al., 2017, 2013) in parallel to a web-based pipeline 
developed by Isakov et al. (2015) reporting a robust error correction process with integrated 
false-discovery rate and significance testing. Whilst these measures will limit the effect of errors 
introduced by this experimental method, they will not remove them entirely. However, these 
effects are predicted to affect all samples (with sufficient reads) uniformly, particularly as the 
same PCR and sequencing equipment and methods were used for each. Relative diversity levels 
between sample cohorts reported within this chapter are discussed using the online pipeline 
metrics (Isakov et al., 2015) in comparison to relative observations within other studies. 
However, the direct comparison to diversity metrics obtained in other studies would be 
misleading due to inherent differences between sequence strategies. 
 
5.4.2 Adaptation is not observed at the consensus level in vitro 
No changes to the consensus were detected in sequences propagated in either cell line 
replicating previous in vitro findings for RVFV (Moutailler et al., 2011; Weingartl et al., 2014c). 
The validity of the NGS strategy is supported by the reproducibility of this consensus sequence 
showing 100% homology to the published sequence on GenBank (NCBI) (Vero E6 cells n=4, 
C6/36 cells n=5, presented in Table 5.4). Furthermore, changes were not expected to arise in 
vitro with previous research demonstrating that 10-15 consecutive single cell line passages were 
performed before sequence changes were observed (Moutailler et al., 2011; Weingartl et al., 
2014c). Additionally, no changes in the consensus were detected across different in vitro 
incubation temperatures; however, the evaluation of the effect of temperature was limited by 
the low number of samples and may be further restricted by the use of an in vitro model of 
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replication. Next steps will be to extend these observations in vivo using RVFV propagated in 
mosquitoes across a range of temperatures. 
 
5.4.3 Adaptation is observed at the consensus level in vivo 
Distinct populations of RVFV were observed at the consensus level between the mosquito 
and mouse hosts (Table 5.4). These results suggest adaptation occurs when cycling between 
disparate hosts when using in vivo models, albeit with unknown function. Taken together these 
data provide support of the previously reported limitation of using in vitro systems to study 
genetic variation (Coffey et al., 2008); with the requirement to enter and replicate in a range of 
cell types and the evasion of the host immune responses in vivo driving adaptation by 
bottlenecks and selective pressures. 
 
5.4.3.1 Consensus changes observed in the mosquito 
Two genome sequences are available on GenBank for strain ZH501 after oral infection of 
Ae. taeniorhynchus (Accessions: DQ380147; DQ380199; DQ375405 for the S, M and L segments) 
and Cx. pipiens (Accessions: DQ380150; DQ380201; DQ375407 for the S, M and L segments), 
however, to the best of my knowledge these data have not been the subject of peer-reviewed 
analysis. Each of these genome sequences (derived from previous data on GenBank) had a single 
substitution at two different sites within the M segment compared to reference strain ZH501 
(unique to sites observed in this chapter), supporting the finding that consensus changes do 
occur in the mosquito host. However, limited comparison to frequency can be made as only a 
single specimen of each species was available and results in this chapter showed the number of 
consensus changes varied from 0-7 positions (mean 3.2) per mosquito, in addition to unknown 
factors on the dose, day post infection and tissue sample from which these sequences were 
generated. Comparison of consensus changes observed in the saliva of WNV infected 
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mosquitoes showed a similar range of consensus substitutions (0-7, mean 1.9) across three time 
points in six mosquitoes and for DENV at 11 sites across the genome in the salivary glands of Ae. 
aegypti (Grubaugh et al., 2017; Lequime et al., 2016) substantiating the observations of this 
chapter with RVFV. Further work is required to investigate if a gain in fitness occurs due to the 
convergent non-synonymous consensus substitution within the RVFV M segment (A1303G), as 
was performed by Grubaugh et al. (2017) with substitutions observed in WNV; this was not 
possible within the timeframe of these studies. 
The overall frequency of substitutions occurring in the consensus sequence was 
significantly higher in the mosquito model compared to the mouse model (Table 5.4 and Table 
A5. 8), suggestive of different selective pressures or stochastic events within each host. Similar 
findings were reported previously with observations with WNV (Grubaugh et al., 2017; Jerzak et 
al., 2007) showing increased diversity arising in mosquitoes compared to vertebrates. These 
previous findings were associated with a purifying selection in the vertebrate host (Coffey et al., 
2008; Grubaugh et al., 2017) but further work is required performing alternate cycling between 
in vivo hosts to confirm if this is the case for RVFV. 
 
5.4.3.2 Consensus changes observed in the mouse model 
Adaptation of RVFV in the mouse model was characterised by a single convergent non-
synonymous substitution at position 843 of the M segment. This led to a switch from a tyrosine 
to a histidine in three out of the four mice and was present within a high proportion of the sub-
population of the fourth mouse. A similar observation had been seen previously with RVFV 
(although substitution at position 843 has not been reported in populations of strain ZH501) 
with Morrill et al. (2010) observing a switch from a glutamic acid to a glycine occurring in the 
adjacent amino acid position (nucleotide position 847) to the substitution reported in this 
chapter. The implications of this are discussed within the context of minority variants below. 
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5.4.4 Minority variants detected in vivo 
The findings by Morrill et al. (2010) were furthered within this project by using deep 
sequence data to investigate the frequency of minority variation occurring at consensus change 
sites (Table 5.4 and Appendix Figure A 5. 8). These analyses showed that the previously reported 
single nucleotide polymorphism (SNP) (present at a 1:1 ratio) at position 847 (Morrill et al., 
2010) was present in all samples tested in this chapter but at a frequency of <1%. Conversely, 
the novel data regarding the substitution at position 843 occurred at an approximate 2:1 ratio 
(T:C) within the input sub-population, with the dominant input nucleotide remaining in the 
mouse population at an average frequency of 25% (1:3 ratio). Whether a phenotypic difference 
resulting from a tyrosine or histidine residue at this site occurs is unknown. It is feasible that the 
proximity of these two (published and reported in this chapter) non-synonymous substitutions 
infer a functional domain within the glycoprotein. The results by Morrill et al. (2010) report a 
change in RVFV fitness within mice resulting in attenuation when infected with ZH501 carrying 
the substitution (G at position 847) compared to the wild-type. All mice reported in this chapter 
succumbed to infection by day 3 post infection. However, fitness assays using two cloned 
populations could further our understanding as to whether a selective advantage may cause the 
observed changes in frequency in position 843. The significance of observing this SNP at the 
consensus level in a single Cx. pipiens is not known but using mice to infect mosquitoes in future 
studies could be used to investigate whether it is maintained at the consensus level in the 
vector. 
 
5.4.5 Intra-host diversity between mosquito populations 
In addition to analysis of specific variants that occurred in the consensus of replicate 
samples, sequence diversity of the intra-host viral population was calculated by two previously 
reported indices: Shannon entropy and variant frequency (Isakov et al., 2015). The observed 
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sub-consensus diversity was significantly lower in the Caldbeck population compared to the 
Brookwood, as observed previously with different genotypes of Ae. aegypti infected with DENV 
(Lequime et al., 2016). However, a significant confounding factor in the diversity measured 
between mosquito lines in this chapter is the viral titre. Whilst the comparison of titres in the 
original datasets for infected Caldbeck versus Brookwood mosquitoes were not statistically 
significant (Chapter 4 Figure 4.7), sampling bias was introduced by the amplicon PCR limit of 
detection. This resulted in the sequence data being collected from Caldbeck mosquitoes with 
significantly lower titres (mean 107.6 GEC/mosquito) compared to the Brookwood (mean 109.4 
GEC/mosquito). Whilst diversity is known to be affected by large viral population sizes (Duffy et 
al., 2008), there will be a limit to the application of the diversity measures based on the amount 
of viral particles present, therefore the cause and effect of diversity and titre within these 
mosquito populations cannot be deciphered based on these data alone (correlation between 
diversity and viral titre presented in Figure A 5. 7). Differences in population phenotypes were 
observed within in vivo competency studies (Chapter 4), namely the higher titres in transmitting 
Brookwood mosquitoes compared to their non-transmitting counter-parts, but this was not 
observed for the Caldbeck line. It is plausible that population bottlenecks (due to dramatic 
reduction in the titres at localised sites within the mosquito) as a result of the postulated 
differences between midgut entry and escape in these lines (based on the in vivo Chapter 4) 
could alter genetic diversity as seen previously (Forrester et al., 2012). Forrester et al. (2012) 
demonstrated viral dose in the blood meal affected these bottlenecks but this factor is excluded 
within the Caldbeck and Brookwood lines shown to ingest a uniform dose (Appendix Figure A 4. 
7). An increased sample number is required, across a range of titres and collection points, to 
understand early events during infection and dissemination in order to determine if differences 
in genetic variation in the sub-consensus arise (due to factors other than titre) between these 
populations. 
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The consensus changes detected in the mosquito cohorts (for all except one) were 
present in the sub-population of the input sequence suggesting that selective or stochastic 
events on the existing population were drivers of change to the dominant population (Table 
5.4). The collective observations of: no statistically significant difference between frequency of 
consensus variants within protein coding regions (Table A5. 8); no obvious pattern of common 
sub-population variants (Figure A 5. 8); and no evidence of selection in the glycoprotein at 
consensus level in mosquitoes (codon-based Z-test) suggest that genetic drift is the principal 
driver of variation in mosquitoes rather than selection. Whilst this agrees with findings with 
WNV and VEEV (Forrester et al., 2012; Grubaugh et al., 2017), more samples will strengthen this 
observation. Although the role of a high level of variants at low frequency derived from the in 
vitro population cannot be excluded as a factor, future analysis comparing these data using an 
animal model for mosquito feeding would further the understanding of more natural dynamics. 
 
5.4.5.1 Diversity between mosquito legs and bodies 
The consensus changes observed within the legs were 100% homologous to their paired 
mosquito bodies (Brookwood line) demonstrating good reproducibility of data at the consensus 
level. Whilst studying the bodies has been described as a good proxy for the midguts (Forrester 
et al., 2012; Lequime et al., 2016), the body will contain both midgut and disseminated 
populations of virus, whereas the leg will contain only virus that has disseminated from the 
midgut. This is supported by RNAish (using RNAscope technology) of a single positive Caldbeck 
line mosquito in the previous chapter showing RVFV was present throughout the body and 
localised within regions of the thorax, which may limit the ability to compare disseminated 
sequence diversity compared to non-disseminated. An unexpected result at the sub-consensus 
level was that sequence diversity was greater in the legs compared to the bodies, in contrast 
with previous findings of DENV and VEEV (Lequime et al., 2016; Patterson et al., 2018). Viral 
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titres within the bodies were one log higher than the legs, therefore the results observed here 
can be distinguished from the trend of increased diversity with titre that confounded previous 
discussion between the two mosquito lines. The reasons leading to these differences between 
sites are likely complex, including the role of bottlenecks which will have been missed by 
studying time points (>day 7 post infection) now known to be after virus has disseminated 
throughout the mosquito, and further replicates and sample time points may help decipher the 
mechanism. It is feasible that the body samples representing both escaped and non-escaped 
(from the midgut) viral particles may reduce diversity and differences between measuring 
multiple cell types in the body may affect results  
To the best of my knowledge, these baseline analyses of the sub-consensus have not been 
published for RVFV, limiting the ability to make strong inferences based on the sub-consensus 
data. This is further confounded by the sensitivity of low-frequency variant analysis to any 
background error within the datasets, although the two measures of complexity and variant 
frequency correlated well (Appendix Figure A 5. 5). The only discrepancy between the measures 
was reported within the Cx. pipiens Caldbeck cohort, thought to be due to increased sample to 
sample variance measured by H-index (highlighted by higher confidence interval range in Figure 
A 5. 6) resulting from the less stringent inclusion criteria compared to the method described by 
Isakov et al. (2015) and was observed previously by Marston et al. (2017). 
A limitation of this study was the inability to obtain sequence data from saliva as RNA 
titres were too low in this sample cohort, as has been observed previously for VEEV (Patterson 
et al., 2018). Studies that have successfully analysed viral sequences in saliva required higher 
input doses utilising the higher read quantity generated by the Illumina HiSeq platform 
(Grubaugh et al., 2017) or applying an amplicon approach to extracted salivary glands (Lequime 
et al., 2016). Whether the consensus changes detected in bodies and legs of mosquitoes would 
be passed on within the saliva is not known. Further work is required to see if the findings of 
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Grubaugh et al. (2017) for WNV, showing that variants arising in the mosquito were not 
preserved when placed in the vertebrate host, is also true of RVFV. The comparative differences 
observing less consensus variants in the mouse than mosquito predict this would be the case; 
supporting current knowledge of the stability of RVFV during outbreaks (Bird et al., 2007) and 
after alternate host passaging in vitro (Moutailler et al., 2011) but this cannot be categorically 
concluded from these data. 
 
5.5 Summary 
The aim of this chapter was to evaluate the hypothesis that evidence of viral adaptation to 
the host will be detected by different consensus changes occurring after in vivo replication in 
the mosquito, compared to a mammalian host. This has been achieved using in vivo models of 
both vertebrate and invertebrate hosts to demonstrate that consensus changes occur after 
replication within each host which was not observed previously or within the data presented 
here in vitro. The key findings are summarised below: 
 
The multiplexed amplicon method developed provided a sensitive method to generate 
deep sequence data from in vitro and in vivo propagated RVFV samples with reproducible 
results at the consensus and sub-consensus level. 
 
Two novel (reproducible) single nucleotide polymorphisms resulting in amino acid 
changes were identified at different positions of the Gn glycoprotein following replication in the 
mouse compared to the mosquito hosts. These data suggest adaptation occurs when RVFV 
switches between disparate hosts, which is in agreement with previous findings reported for 
WNV, DENV and VEE. 
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The significantly higher frequency of consensus variants detected in mosquitoes 
compared to mice offers circumstantial support that genetic variants may arise in the mosquito 
but are limited in the mouse maintaining the genetic stability, however, alternate in vivo 
passages are required to confirm this. 
 
Limited conclusions could be drawn from sub-consensus variation between samples but 
data can be used as a baseline from which to focus future research, potentially involving the use 
of a mouse model (in vivo RVFV input population) to infect mosquitoes. 
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6 Discussion 
The aim of this thesis was to improve understanding of the survival strategies of RVFV in a 
temperate climate, focussing on factors affecting the virus within the vector host. The principal 
conclusion from the research presented is that British populations of Cx. pipiens and Ae. detritus 
are susceptible to infection with, and capable of laboratory transmission of, viral RNA for two 
pathogenic strains of RVFV, 7 days after the ingestion of a viraemic blood meal. The presence of 
competent vectors for RVFV in the UK was further supported by widespread dissemination of 
virus observed in a single Cx. pipiens using a novel RNA in situ hybridisation technique. Whilst 
these data provide a foundation for potential RVFV survival and transmission in the UK, the 
complex interplay of multiple factors will affect the ability and likelihood of such events 
occurring. 
In order to understand the risks for RVFV maintenance in a temperate climate, the 
constraints of UK temperatures on the ability of mosquitoes to support RVFV were investigated. 
The use of in vitro cell systems demonstrated RVFV is able to complete its full replication cycle 
at temperatures ranging from 20˚C-37˚C but not at 12˚C. Based on these data, a conservative 
minimum threshold for replication was set at 20˚C and applied to studies designed to assess 
viral replication in wild-caught UK mosquitoes. This in vitro result was corroborated; observing 
that wild-caught Ae. detritus demonstrate a transmission potential at 20˚C and colonised Cx. 
pipiens demonstrate a transmission potential at 25˚C, with the detection of infectious virions 
within their body and legs confirming the full replication cycle is supported in vivo. Whilst 20˚C 
was a relevant temperature to have established this baseline potential for transmission, 
representative of UK summer temperatures (Figure 6.1 Panel B), an assessment of a broader 
range of temperatures is required in order to accurately evaluate the risks of RVFV 
establishment and spread. 
Discussion 
155 
 
 
Figure 6.1 Average summer and winter temperatures across UK. A. Minimum mean summer 
temperatures (range 9˚C to >12˚C), B. Maximum mean summer temperatures (15˚C to >21˚C) C. 
Minimum mean winter temperatures (0˚C to 3˚C), D. Maximum mean winter temperatures (3˚C to 
>8˚C). Graphs were obtained from the Met Office (2012) using data collected across 30 years (1981-
2010). 
 
The in vitro data suggest that RVFV can survive at low temperatures in the UK, 
independently of factors affecting the vector, by demonstrating viral stability and infectivity 
throughout the course of 10 days at 12˚C. This hypothesis is supported by previous research 
showing RVFV remains infectious for 8 months at 4˚C when maintained in proteinaceous 
mediums (reviewed by EFSA, 2005). These data provide the theoretical means for RVFV survival 
under sub-optimal conditions where average monthly temperatures rarely exceed 21˚C (Figure 
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6.1). However, experiments using constant temperatures are a simplification of events and 
mean temperatures do not reflect natural variation experienced by the vector and virus in 
nature. Temperature fluctuations will affect transmission dynamics in both the short-term when 
considering an outbreak scenario or long-term when considering virus establishment. 
Short-term transmission dynamics are affected by daily fluctuations in temperature 
occurring throughout the summer, highlighted in Figure 6.1 Panel A and B. The in vitro data 
again provide evidence of the robust nature of RVFV, with replication rates and titres returning 
when temperatures were raised from 12˚C to 28˚C. This finding is supported by previous studies 
showing attenuated RVFV transmission rates in Cx. pipiens at 13˚C were reversible when 
increasing the temperature to 26˚C (Turell et al., 1985). The implication of this finding is the 
potential for transitory high summer temperatures in temperate regions (that are optimal for 
viral replication) to be sufficient to support replication within the vector host that facilitates 
onward transmission. 
Long-term transmission dynamics are affected by seasonal fluctuations in temperature. 
The potential for virus to overwinter within infected adult mosquitoes or the eggs of a mosquito 
capable of vertical transmission is highly relevant for this long-term viral maintenance in a 
temperate region, thus facilitating its survival until conditions are favorable for replication to 
ensue. The in vitro data suggest that RVFV would not replicate within the mosquitoes at UK 
winter temperatures of 12˚C or below (Figure 6.1 Panel C and D). In the absence of data 
supporting viral maintenance in overwintering mosquitoes it can be postulated that 
autochthonous virus transmission may occur (the short-term scenario) as has been seen for 
DENV and CHIKV in France (Grandadam et al., 2011; La Ruche et al., 2010) but repeated 
introductions from endemic regions would be required for the occurrence of multiple 
outbreaks. Investigating overwintering strategies was not feasible in this project without prior 
knowledge of the susceptibility and transmission potential of British mosquitoes to RVFV under 
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more optimal conditions. The susceptible mosquitoes identified present a platform for future 
work to investigate their ability to support virus in their overwintering life stages. The RNA in 
situ hybridisation technique developed in this thesis is one advancement that may further 
facilitate investigating vertical transmission. This technique demonstrated an absence of virus in 
the eggs of a single infected gravid female mosquito. However, immunohistochemistry was 
similarly applied by Romoser et al. (2011) to support the vertical transmission hypothesis, 
observing RVFV associated with mosquito eggs. 
Temperature also affects the temporal transmission dynamics (Thomas and Blanford, 
2003). The shorter the duration from virus ingestion to the first point the mosquito is capable of 
expectorating virus via its saliva during feeding, the EIP, the higher the potential for 
transmission events to occur. EIP is typically observed to increase as temperature decreases 
(reviewed by Randolph and Rogers, 2010) and this relationship for RVFV is supported by the in 
vitro data (Chapter 3) showing replication kinetics were adversely affected at 20˚C compared to 
the invertebrate cell optimal of 28˚C. However, the in vivo evaluation of temporal dynamics 
effecting the replication and progression of virus through the vector were limited in these 
studies by low sample numbers due to high mosquito mortality rates. The earliest collection of 
samples was performed at day 7 post ingestion of virus, now known to be after virus has 
disseminated from the midgut. Future studies collecting samples at earlier time points from 
susceptible mosquitoes would enable further characterisation of factors modulating intrinsic 
barriers within the mosquito and the effects of temperature on these dynamics. It is noteworthy 
that a small temperature increase from 13˚C to 15˚C in Egyptian Cx. pipiens resulted in a five day 
reduction in the EIP (Turell et al., 1985). Furthermore mutation within the WNV genome 
correlating with a reduction in EIP by just two days, provided a fitness advantage that was 
postulated to drive displacement of the circulating genotype (Moudy et al., 2007). Together, 
these examples demonstrate the dramatic effect small changes in temperature and EIP can have 
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on the course of viral transmission. Determining a more refined estimate of the EIP, identified 
here as ≤7 days at 20˚C and 25˚C, is required to improve accuracy of any future predictive 
models of RVFV in the UK. Previous studies of RVFV have suggested this EIP could be as low as 2 
days at 26˚C (Romoser et al 1992). It is therefore feasible that the results presented within UK 
mosquitoes may underestimate the transmission potential in the field particularly if transient 
high temperatures further increase vectorial capacity. 
Ultimately; for virus to be transmitted this EIP must not exceed the lifespan of the 
mosquito. An extrinsic incubation of 7 days would support potential transmission in multiple 
feeding events based on the typical lifespan of 50 days observed during routine rearing of 
uninfected Caldbeck and Brookwood colony lines. However, increased temperature (25˚C versus 
20˚C) resulted in increased mortality independently of the virus in the wild caught populations. 
The postulated reduced EIP (based on in vitro data) and increased biting rates (Randolph and 
Rogers, 2010) occurring at higher temperatures would increase transmission but must outweigh 
the the increased mortality rates that would reduce or even eliminate infected mosquitoes. 
Additionally, ingestion of high viraemia blood meals (107 PFU/mL) that was required to support 
transmission, negatively affected the survival in two out of the three mosquito populations. It is 
feasible that this trade-off between increasing the potential for dissemination within the vector 
and maintaining the potential for onward transmission may be sufficient to support localised 
transmission but would limit further spread without abundant infected mosquito numbers to 
drive a large scale epizootic. However, extrapolating mosquito survival estimated by 
experimental studies in the laboratory to a field setting is complex as the laboratory provides 
continuous access to nutrition, in the form of sugar, and removes predation so could 
underestimate mortality rates in the field (Brady et al., 2013). Conversely, stress incurred from 
the anaesthetic and manipulation of mosquitoes during competence experiments may 
overestimate mortality. Therefore, whilst trends were observed with factors affecting survival, 
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estimates of the rates in the field may be misleading based on these data alone, requiring future 
research. There is also a need to test temperatures below 20˚C on the survival and RVFV 
transmission rates within the vector. 
Vectors and environmental temperatures that could support survival of RVFV in the UK 
have been established and genomic substitutions present a mechanism for adaptation that 
could promote survival within these potential new hosts. Prior to the commencement of these 
studies, knowledge relating to the ability for RVFV to adapt when switching between hosts was 
based on replication within in vitro cell systems. These data inferred that no consensus changes 
occurred with host switching despite such occurrences being typical for other arboviruses using 
in vivo models (Dridi et al., 2015; Forrester et al., 2012; Grubaugh et al., 2017; Lequime et al., 
2016). The research conducted in this thesis using both mosquito and mouse models 
demonstrated reproducible consensus sequence alterations occurring as the virus replicates in 
disparate hosts. These data suggest previous observations were not representative of natural 
RVFV replication dynamics but as a result of the inherent limitations of in vitro cell culture 
analysis (limited immune responses and no requirement to overcome cellular barriers). These 
mutations provide the potential for adaptation, promoting survival in new environments or 
mosquito hosts, as seen with the increased fitness of CHIKV within a more widely distributed 
vector (Tsetsarkin et al., 2007). Whether a gain in fitness is associated with the mutations 
observed, is not known. Therefore, the potential for these specific changes to promote survival 
cannot be inferred nor is it known whether they would remain within the population when 
cycling between hosts in vivo. However, these substitutions resulted in consensus changes to 
the RVFV genome at a similar frequency to those recorded in mosquitoes for other arboviruses 
(Grubaugh et al., 2017; Lequime et al., 2016) which was previously underestimated within in 
vitro studies with RVFV. 
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In addition to vectors, the presence of susceptible livestock supporting virus 
amplification is necessary to drive an outbreak of RVFV and maintain the transmission cycle. The 
ability of RVFV to replicate within European breeds of ruminants is well characterised (Antonis 
et al., 2013; Busquets et al., 2010; Kortekaas et al., 2012; Rippy et al., 1992; Vloet et al., 2017; 
Weingartl et al., 2014a) (Figure 1.4). The dose dependency reported in this thesis using artificial 
blood meals would require a mosquito biting an infected host during the short-lived peak 
viraemia (at titres of 107 PFU/mL or greater) in order to allow dissemination within the mosquito 
through to infection of the salivary glands. Similar findings with RVFV have been presented for 
other European mosquitoes (Vloet et al., 2017) and the transient nature of these interactions 
are presented in Figure 6.2. The principal limitation of the conclusions drawn is the assumption 
that these RNA titres are indicative of the presence of infectious virus capable of causing 
disease, despite the titre being below the detectable level of the virological assay used. 
However, the use of three mosquito populations and two pathogenic strains of RVFV to 
demonstrate the transmission potential offers robust support of the hypothesis. Future work is 
required to demonstrate that functional virions are transmitted in the saliva whilst blood 
feeding, resulting in disease within a susceptible host. This is the method adopted almost 
exclusively in all competency studies performed with RVFV in the United States (reviewed by 
Golnar et al., 2014). Such studies are complex and costly; however, the research presented in 
this thesis provides both justification and a foundation for conducting these experiments. 
Furthermore the BalbC mouse model utilised within these studies for NGS analysis offers a more 
sensitive approach than the plaque assay for determining the presence of infectious virus in 
samples (data not shown). Whilst this method could not be adopted for the large number of 
samples required for these studies collectively, targeted research could be developed to answer 
key questions relating to transmission frequency of infected UK mosquitoes now that the 
potential has been established. Local inflammatory responses in the vertebrate may facilitate 
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viral infection leading to an underestimation of rates determined by the forced salivation 
method used (Le Coupanec et al., 2013; Pingen et al., 2016; Styer et al., 2007; Vloet et al., 2017). 
A further benefit to adopting this approach is the ability to observe whether genetic 
substitutions arising in the mosquito maintain a fitness to replicate, and then whether these 
substitutions are maintained within the mammalian host. This approach has been used in 
previous studies of flaviviruses and alphaviruses which demonstrated mutations are removed by 
a purifying selection within the vertebrate (Coffey et al., 2008; Dridi et al., 2015; Grubaugh et al., 
2017). 
 
 
Figure 6.2 Schematic of a typical livestock viraemia profile based on experimental infection of 
ruminants reviewed by Golnar et al. (2014). However, viraemia will be affected by both age and 
species of the susceptible host, dose, strain and route of innoculum [1], therefore the schematic is 
considered representative not absolute. Dotted lines represent a high threshold based on data 
presented in this thesis using British mosquitoes and the low dose threshold required to infect 
mosquitoes was based on the findings of Vloet et al. (Vloet et al., 2017). The low dose threshold 
facilitates onward infection of the mosquito across a longer duration than the high infectious dose 
occurring at the short-lived transient peak viraemia (Daubney et al., 1931). Red arrow: would 
support transmission, black arrow would not support transmission. 
 
Using accepted knowledge and advances presented in this thesis there is evidence that 
suggests the presence of both the vector and susceptible livestock that could support RVFV in 
the UK. The confluence of events that would be needed in order for the occurrence of localised 
transmission limits the likelihood, nonetheless the UK should remain vigilant to the potential for 
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RVFV emergence. Furthermore, predicted increases in temperatures and flooding in Northern 
Europe, thereby promoting vector numbers, contributes to the predicted increase in the risk of 
arbovirus emergence (Gale et al., 2010; Snow and Medlock, 2006). The data presented in this 
thesis can be utilised to inform risk analysis and guide control strategies to limit temperate 
transmission should it arise. A coordinated multidisciplinary approach utilising vector control 
strategies based on future research on the effect of land management changes (Medlock and 
Vaux, 2015b) or genetic mosquito control strategies (Alphey, 2014), coupled with timely 
detection of the virus and targeted restriction of livestock movements should virus be 
introduced (Sumner et al., 2017) could reduce or eliminate transmission. An indirect benefit of 
this research is the strengthening of collaborations with Public and Animal Health institutes in 
the UK (PHE and APHA), facilitating the potential for a One Health approach should an 
introduction occur. 
The research undertaken has advanced current knowledge of the ability of RVFV to 
survive in a temperate climate, and the following conclusions based on the in vitro and in vivo 
experiments presented are made: British populations of Cx. pipiens and Ae. detritus can support 
both replication and transmission of RVFV at 20˚C. The dose dependency and negative effect of 
high dose and temperature on mosquito survival may limit the likelihood of events occurring to 
support transmission in the field. These data suggest transmission could be supported in the UK 
under peak conditions if all optimal factors align. 
 
Publications based on this research 
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A3 The effect of temperature on in vitro replication kinetics 
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Figure A 3. 1 qPCR assay robustness. The RVFV M segment qRT-PCR was performed using 
standardised reaction setup and cycling conditions on two PCR platforms to test assay robustness. 
Assays were performed in triplicate on the Mx3000P platform (Agilent) in comparison to the Viia 7 or 
7500 platforms (Thermo Fisher Scientific). Results show no loss in sensitivity or efficiency compared 
to performance on at PHE, there was no significant differences between the slopes (p=0.2854), data 
points represent the mean of 3 replicates, error bars: 95% confidence interval. 
 
A4 Vector competence of British mosquitoes 
A4.1 Development and optimisation of methods to assess vector competence 
Prior to the advent of the project, proof-of-concept studies with Usutu virus and colonised 
mosquitoes had been performed at the APHA. There are numerous technical and logistical 
challenges encountered whilst working with live mosquitoes, including seasonal availability and 
mortality. The additional constraints of working at high containment added importance to the 
optimisation stages of experimental design in order to maximise the output of each experiment. 
This section addresses this requirement: 
 
To develop methods to enable evaluation of the hypothesis: mosquito species 
present in the UK are competent vectors to transmit RVFV. 
 
The methods detailed in Chapter 2 present protocols in their final optimised format 
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A4.1.1 Mosquito blood feeding 
The first aspect of in vivo mosquito experimentation is the ability to perform a blood feed. 
A low standard feed rate (the proportion of mosquitoes that successfully take a blood meal) 
reduces potential data points and increases the number of input mosquitoes required to 
produce data. Optimising the feeding method was therefore crucial in order to assess the vector 
competence of mosquitoes, thereby increasing the potential data points generated and 
improving the statistical power of downstream observations reported. 
 Routine maintenance of colonies was performed by overnight blood feeding for 15-22 
hours, typically resulting in 60-80% feeding. Optimisation experiments were performed with 
colonised Cx. pipiens (Caldbeck) to improve this base rate. The ‘standard protocol’ referred to 
below replicates published methods (Mackenzie-Impoinvil et al., 2015). In brief, mosquitoes 
were deprived sucrose for 16-22 hours and water for 2-3 hours prior to feeding. A mock 
infectious blood meal (substituting virus for DMEM) with 1µM dATP was supplied by hemotek 
membrane in a darkened BugDorm. Methods were then varied exposing mosquitoes to 
conditions summarised in Figure A 4. 1 and performed in triplicate unless stated. Engorged 
mosquitoes were counted periodically to compare baseline feeding rates under these standard 
or the ‘optimisation protocols’ (Figure A 4. 1; Panel A). 
Preliminary experiments using groups of 10 mosquitoes (n=6) showed high variability, 
ranging from 10-70% feeding after 22 hours (Figure A 4. 1; Panel B). Average numbers were 
significantly lower than groups feeding in a population of 80 (p=<0.0001), therefore subsequent 
optimisation experiments were performed using sample size 80. 
The phagostimulant ATP is used at varying concentrations in competency studies. 
Increasing dATP in the blood from 1 to 5,000µM utilised by Moutailler et al. (2007) had no effect 
on feeding at 5 or 22 hours (p=0.0609) (Figure A 4. 1; Panel C Group 1). Doubling the length of 
sucrose deprivation to 44 hours also had no significant effect on the percentage feeding 
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(p=0.1493) (Figure A 4. 1; Panel C Group 2). However, increasing water deprivation to 13 hours 
negatively affected feeding rates (p=<0.0001) (Figure A 4. 1; Panel C Group 3), correlating with 
reduced survival compared to a standard 2-3 hours water starvation; this may be linked to stress 
incurred due to dehydration (Ellison et al., 2015). Richards et al. (2012b) observed the blood 
meal source affected feeding rates in Cx. quinquefasciatus. As Cx. pipiens pipiens are primarily 
ornithophilic, rates of feeding on chicken and horse blood were compared with no significant 
difference after 5 (p=1.0000) or 22 hours (p=0.2608) (Figure A 4. 1; Panel D Group 5). Increased 
feeding rates of Cx. pipiens has been reported on cotton sticks in comparison to membrane 
feeding (Moutailler et al., 2007). Here, feeding rates were significantly higher on cotton 
saturated in chicken or horse blood at 5 hours (p=<0.0001) but only the chicken blood after 22 
hours (p=0.0275) (Figure A 4. 1; Panel D Group 4-6). Despite the success of this method, it was 
not employed as it presented contamination issues as mosquitoes spread blood from the cotton 
via their legs.  
Following evaluation of several parameters with the potential to affect feeding rates; the 
standard protocol was considered optimal based on these results, therefore no changes were 
applied. 
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Figure A 4. 1 Optimising mosquito blood feeding. A. Schematic of experimental design: the 
‘standard protocol’ depicted on the left was compared to an ‘optimisation protocol’. Results are 
presented comparing: B. Sample size of 10 (n=6) vs 80 (n=3); C. Sucrose or water starvation and 
concentration of phagostimulant; D. Blood type and feeding matrix. Total numbers (sample size= 80; 
n= 3 unless stated) were compared to the standard protocol by Fisher’s exact test in GraphPad 
Prism; error bars: 95% CI; ns: p >0.05; ****p <0.0001. 
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A4.1.2 Stability of RVFV in a blood meal 
With the standard parameters of the blood meal established (Section A4.1.1), the 
duration of the blood feeding was next evaluated. A balance is required between two factors 
that can arise from a prolonged duration of blood feeding. Firstly, as shown in the preceding 
section, an increased duration of feed maximises the potential for all mosquitoes to take a 
blood meal. Secondly, despite reports that RVFV is stable in proteinaceous mediums (reviewed 
by EFSA, 2005), the effect of a prolonged period within an extracellular environment (in the 
artificial blood meal) at 37˚C may reduce viable virus titres. To inform the optimal choice of 
feeding period, the stability of RVFV in a blood meal at 37˚C was therefore evaluated. 
Setup was concordant with infectious methods: defibrinated horse blood was spiked with 
strain Lunyo or ZH501 at 106 PFU/mL and 1µM dATP. Three replicates were performed and 
incubated at 37˚C for 0, 1, 2, 4, 6 or 22 hours and stored at -80˚C. Serum was harvested by low-
speed centrifugation, 3,000 x g for 10 minutes, and virus quantified in genome equivalent copies 
(GEC) determined by qRT-PCR and plaque forming units (PFU) by plaque assay. Linear regression 
was used to test change in titre (y) by time (x), and slopes compared by t-test in GraphPad Prism 
presented in Figure A 4. 2 and Table A 4. 1. The runs test confirmed the results did not 
significantly deviate from linearity, validating the selection of model. No differences were 
observed between strains. The horizontal (zero) slope confirms no reduction in genomic titre 
(Figure A 4. 2; Panel A) and a moderate reduction (< 1 log) in infectivity (Figure A 4. 2; Panel B) 
over a simulated overnight feeding. These results demonstrated prolonged feeding does not 
alter GEC and has little effect on the infectivity of the virions. As feeding overnight should lead 
to an increased feed rate, with no significant decrease in titre, overnight feeding was adopted. 
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Figure A 4. 2 Stability of Rift Valley fever virus in the blood meal. Defibrinated horse blood was 
spiked with RVFV strain Lunyo or ZH501 at 106 PFU/mL, incubated at 37˚C for the indicated time and 
stored at -80˚C. Serum harvested by centrifugation was quantified by A. qRT-PCR presented in 
genome equivalent copies (GEC) and B. plaque assay presented in plaque forming units (PFU). Error 
bars: 95% CI of 3 replicates titred in duplicate. Data were log10 transformed and a linear regression 
model applied represented by solid lines; dotted lines: 95% confidence band, calculated in GraphPad 
Prism. Demonstrating a limited reduction in titre during an overnight feeding period. 
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Table A 4. 1 Linear regression model of Rift Valley fever virus stability in blood at 37˚C 
Units Strain Slope R2 
Comparison 
of slope (p=) 
Runs 
test 
Log10 
reduction 
GEC 
Lunyo 
-0.0016 ± 
0.0039 
0.0050 n.s 
 
0.2202 
1.0000 0.0726 
ZH501 
0.0042 ± 
0.0027 
0.0669 0.4000 -0.1174 
PFU 
Lunyo 
-0.0214 ± 
0.0051 
0.3433 n.s 
 
0.178 
0.3000 0.3357 
ZH501 
-0.0124 ± 
0.0042 
0.2061 0.8000 0.1871 
GEC: genome equivalent copies; PFU: plaque forming units; ns: non-significant p >0.05 
Homogenisation and disruption of mosquito samples for RVFV assessment 
 
A4.1.3 Homogenisation and disruption of mosquito samples for RVFV assessment 
Assessment of RVFV infection of blood fed mosquitoes was achieved through analysing 
homogenised mosquitoes for the presence of infectious virus via plaque assay, or for RVFV 
specific RNA via qRT-PCR. Both techniques require disruption and homogenisation of the 
sample. This can be achieved for tissues, including mosquitoes, using a bead-beater to agitate 
the sample at high-speeds. However, the nature of the method using crushing and shearing to 
disrupt cells can negatively affect target RNA yields if not optimised. To balance efficient 
extraction with target RNA integrity; speed (rpm) and bead size were compared across two 
platforms detailed in Table A 4. 2. Homogenisation was performed in two 20 seconds cycles with 
a 30 second mid-cycle pause (Bertin Instruments, 2016). 
To evaluate degradation by homogenisation, viral RNA was spiked into DMEM and 
homogenised using varying speeds and bead sizes. Samples were extracted, genome copies 
quantified (Methods Section 2.2.3 and 2.2.4), and baseline titres (spiked vRNA without 
homogenisation step) subtracted to calculate the log reduction (Figure A 4. 3; Panel A). To 
evaluate the efficacy of the process, whole mosquitoes were subjected to the same conditions 
and host nucleic acid yields assessed by PCR targeting GAPDH (Figure A 4. 3; Panel B). Despite 
homogenisation at 6,000 rpm yielding the highest host titres (lowest Ct), there was a significant 
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reduction in spiked RVFV RNA indicating increased degradation compared to lower speeds. 
Visual assessment of incomplete homogenisation at 2,000 rpm was supported by significantly 
reduced host titres, despite maintaining RNA integrity. Homogenisation at 4,000 rpm using 
1.8mm ceramic beads on the Precelly platform was selected for use, demonstrating the best 
balance between efficacy and sample integrity. 
 
Table A 4. 2 Comparison of homogenisation platforms 
Platform Speed range (rpm) Bead O-ring fitted tube 
MagNA lyser 2,000-7,000 1.4 mm ceramic  
Precellys 24 4,000-6,800 
1.4 mm ceramic x 
1.8 mm ceramic*  
*: Available in reinforced homogenisation tube recommended for use when performing experiments 
with ACDP hazard group 3 pathogens 
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Figure A 4. 3 Comparison of bead-beater methods to disrupt and homogenise mosquito samples. 
A. RVFV RNA was spiked in media, homogenised at 2,000-6,000 rpm using 1.4 or 1.8mm ceramic 
beads, extracted and quantified by qRT-PCR. Spiked vRNA (without homogenisation) was quantified 
and used as a baseline to subtract from results, transforming data to log reduction. B. Whole 
mosquitoes were homogenised as above, extracted and host nucleic acid semi-quantified by RT-PCR 
targeting GAPDH. Data points represent the mean (n=5); error bars: 95% CI; differences between 
homogenisation methods were calculated by Kruskal-Wallis with Dunn’s post-test. The Precellys was 
not evaluated at the lower speed of 2,000 rpm as the lower range of platform is 4,000 rpm. 
 
A4.1.4 Extraction of viral RNA from mosquito samples 
Another parameter that can affect the ability to assess infection and transmission rates is 
the efficiency of RNA extraction and recovery. Four extraction methods were compared all using 
lysis buffers containing denaturing guanidine-thiocyanate. TRIzol (Thermo Fisher Scientific) uses 
phase-separation based on a phenol-chloroform extraction. The QIAamp viral RNA and RNeasy 
mini kits (Qiagen) both use silica-based membrane binding, with the latter optimised for tissue 
samples. The EZ1 virus RNA mini kit (Qiagen) is an automated method using silica-based binding 
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to magnetic particles. Viral RNA was spiked into dissected mosquito samples in DMEM, 
homogenised on the Precellys platform using the method determined in Section A4.1.3 and 
extracted using one of the four kits. Quantities were determined by qRT-PCR and transformed 
to log reduction (Figure A 4. 4). The optimum method, yielding the least reduction in titre across 
sample types, was the QIAamp spin column with a mean log reduction of 1.02 in the bodies. PCR 
inhibition is indicated by a reduction in titre in samples containing mosquito tissues compared 
to a ‘non-mosquito’ control. Some level of inhibition was seen using all methods, most 
prominent in the body samples. TRIzol exhibited the least inhibition and variation between 
sample types. The QIAamp kit (validated inactivation method at ACDP CL 3 at PHE) was selected 
for use; however, TRIzol (validated inactivation method at ACDP CL 3 at APHA) can be used 
interchangeably with minimal effect on titres. As a result of the observed inhibition, an internal 
control using spiked MS2 RNA was duplexed with the S segment RVFV RT-PCR assay, and RNA 
spiked during the extraction phase following manufacturer’s instructions (Methods Section 
2.2.3). 
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Figure A 4. 4 Comparison of commercial kits to extract spiked viral RNA from mosquito samples. 
RNA was spiked in media containing dissected mosquitoes, homogenised, extracted and quantified 
by qRT-PCR. Spiked vRNA (without homogenisation and extraction) was quantified and used as a 
baseline to subtract from results, transforming data to log reduction. Data points represent the 
mean (n=5); error bars: 95% CI; differences between extraction kits were calculated by Kruskal-
Wallis with Dunn’s post-test; coloured * corresponded to the sample type tested. 
 
A4.1.5  Utilising honey feeding to detect nucleic acid in saliva 
With the methods required to infect mosquitoes with RVFV optimised (Sections A4.1.1-
A4.1.4), the next requirement was to formalise protocols for assessing infectivity. More refined 
techniques were required in order to demonstrate transmission potential by detecting the 
presence or absence of infectious virus in the saliva. This is typically detected by transmission to 
a susceptible animal model or in vitro collection of saliva. The latter method was historically a 
destructive end-point collection requiring immobilisation of the mosquito (achieved by 
removing their wings and legs), therefore data can only be collected once from each mosquito 
specimen. Non-destructive methods using Flinders Technology Associates (FTA) cards have 
recently been developed exploiting the trait that mosquitoes expectorate saliva whilst sugar 
feeding (Hall et al. 2010) and therefore analysis can be performed multiple times on the same 
mosquito. The FTA cards, soaked in mānuka honey, are used as the feeding substrate and 
capture nucleic acids present within the saliva as the mosquito feeds. However, the effect of 
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ingesting small quantities of lysis buffer embedded within the FTA cards, on either the mosquito 
or virus present within, is not known. Therefore this method was modified substituting FTA 
cards for filter papers. Mosquitoes were housed in conditions replicating competence 
experiments and survival monitored periodically for 14 days (Figure A 4. 5; Panel A). Initial 
comparisons were made using colonised Cx. pipiens (Caldbeck) at ACDP CL 2, these experiments 
highlighted the requirement for water in addition to honey-filters for survival (Figure A 4. 5; 
Panel B). Wild-caught Cx. pipiens S.L were compared replicating experimental conditions at CL 3. 
Mosquito survival was not significantly different in the groups maintained on cotton wool 
saturated in 10% sucrose or honey-filter paper (p=0.2376) (Figure A 4. 5; Panel C). This method 
was therefore adopted for use in competency experiments. 
Appendix 
197 
 
 
Figure A 4. 5 Survival of mosquitoes maintained on honey-filters or sucrose cottons. A. Schematic 
of experimental conditions B. Survival of colonised Cx. pipiens (Caldbeck): honey-filters without 
additional water significantly reduced survival (p=<0.0001) C. Survival of wild-caught Cx. pipiens S.L 
(Byfleet) was performed under experimental conditions at ACDP CL3, maintenance on sucrose or 
honey-filters had no effect on survival (p=0.2153). Kaplan-Meier plots were generated in GraphPad 
Prism; error bars: 95% CI; parentheses: the number tested (N), significance was tested by Log-rank 
test. 
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A4.1.6 Development of an RNA in situ hybridisation method to detect RVFV in mosquitoes 
Formalin fixed whole mosquitoes were processed by the Histology Department at APHA. 
Mosquitoes were pre-embedded in agarose within the processing cassettes (Sakura- Tissue Tek) 
to ensure uniform orientation of specimens prior to paraffin embedding. Automated tissue 
processing, dehydration through a series of graded ethanol baths and infiltration with paraffin 
wax, was performed on the Tissue-Tek VIP 6 AI Vacuum Infiltration Processor (Sakura), the 
automated processing schedule is detailed in Table A 4. 3 Sections (5 µm) of tissue blocks were 
made using a microtome and mounted at 65˚C on slides for 20 minutes. 
 
 Table A 4. 3 Histology processing schedule for paraffin embedding mosquito samples 
Position Reagent Immersion time 
(minutes) 
1 Buffered Formalin 1 
2 70% ethanol 20 
3 70% ethanol 30 
4 90% ethanol 20 
5 90% ethanol 20 
6 100% ethanol 20 
7 100% ethanol 20 
8 100% Ethanol 60 
9 Chloroform 90 
10 Chloroform 30 
11 Wax 15 
12 Wax 15 
13 Wax 15 
14 Wax 15 
 
RNAscope staining procedures were performed by the Histology Department at PHE 
following manufacturer’s instructions, all steps were performed at room temperature with 
reagents supplied with the kit (Advanced Cell Diagnostics) unless stated. Slides were dewaxed 
for 5 minutes in xylene, immersed in 100% alcohol for 2 minutes then dried. Slides were treated 
with hydrogen peroxide for 10 minutes, washed in water and placed into the target retrieval 
solution (supplied with the kit) for 15 minutes at 98-100˚C, then washed immediately with 
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distilled water followed by 100% alcohol and left to dry. A hydrophobic barrier was drawn 
around the section using the pen and templates provided and dried for 20 minutes or overnight. 
Sections were treated with Protease Plus at 40˚C for 15 minutes. Sections were washed with 
water before applying the RVFV probe (V-RVFV-ZH501-NP or negative probe DapB) for 2 hours 
at 40˚C and then washed in 1x wash buffer (twice for 2 minutes). After each of the subsequent 
hybridisation steps the sections are washed in 1x wash buffer (twice for 2 minutes). Soultion 
AMP 1 is applied for 30 minutes, followed by AMP 2 for 15 minutes, AMP 3 for 30 minutes and 
AMP 4 for 15 minutes all at 40⁰C. AMP 5 and 6 are carried out at room temperature for 30 and 
15 minutes respectively. Fast Red is then used to detect the signal by incubating at RT for 10 
minutes. Slides were washed with tap water and counterstain with Gills 1 haematoxylin for 2 
minutes and dried for either, an hour at 60°C, or overnight at room temperature and then 
coverslip using EcoMount (Biocare Medical, California, USA). Images then were taken on the 
Pannoramic 250 Flash II slide scanner (3D HISTECH) and image selection performed on digitised 
images in Pannoramic Viewer (1.15.2 SP 2, 3D HISTECH). Preliminary images produced by 
standard haematoxylin and eosin staining of uninfected Cx. pipiens Caldbeck are presented in 
Figure A 4. 6. 
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Figure A 4. 6 Haematoxylin and eosin stained section of an uninfected mosquito. Uninfected Cx. 
pipiens (Caldbeck) were fixed in 4.5% formaldehyde. Specimens were paraffin embedded and 5µM 
sections mounted and stained by haematoxylin and eosin. A. unfed mosquito B. blood fed mosquito 
containing blood meal within the midgut. 
 
A4.1.7 Discussion of optimisation and selection of methods 
The over-arching aim of this chapter was to establish methods to robustly and reliably 
monitor viral infection, dissemination and transmission within UK mosquitoes, in order to 
ascertain their potential vector competence for RVFV. In vivo mosquito experiments are 
technically and logistically challenging and prone to high variability, especially when performed 
within a microbiological safety cabinet. Prior to this study, proof-of-principle work had been 
conducted on laboratory-adapted colonies performed at ACDP containment level 3 using Usutu 
virus, an ACDP hazard group 2 pathogen. However, considerable work was required in order to 
develop methods suitable for working with both wild-caught mosquitoes and for RVFV which 
requires conformance with ACDP CL3 practices and procedures. Optimal sample collection, 
homogenisation, extraction and storage parameters were established to limit the effects of virus 
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degradation during mosquito processing. Endogenous host and spiked internal PCR controls 
were employed to confirm the validity of negative results; confirming procedures maintained 
sample integrity and removed PCR inhibitors. Endogenous control negative samples were 
omitted from results. 
Further confidence in the reporting of negative results herein is afforded by the use of a 
herd sensitivity model for an infinite population, to guide selection of sample sizes. Assuming 
less than 10% of the population can transmit virus, the number of test specimens required to 
detect a single positive with 95% confidence is 29 (DiGiacomo and Koepsell, 1986; Sergeant, 
2017). The low risk of transmission reported for mosquitoes ingesting 106 PFU/mL RVFV, was 
determined by negative results from the following sample numbers: 43 (ZH501) Cx. pipiens 
(Caldbeck), 41 (Lunyo) Cx. pipiens (Brookwood) and 36 (Lunyo) Ae. detritus. 
Increased sample numbers would improve the statistical power of these data, however 
one of the biggest challenges, as with previous studies, was the high mosquito mortality rates 
(Mackenzie-Impoinvil et al., 2015). Understanding feeding preferences would improve starting 
numbers to counterbalance high mortality. However, the ecology of wild-caught mosquitoes 
was outside the remit of this project. Preliminary experiments suggested the role of population 
density or size was key for feeding colonised Cx. pipiens, observing higher percentages in groups 
of 80 versus 10. This relationship has been observed previously but further work is required to 
see if it holds true with wild populations (Barnard et al., 1998). In the absence of these data, 
developing techniques may be key to maximising numbers, such as the use of filter papers 
employed here as a non-destructive measure to detect viral RNA in saliva. Additionally 
membrane feeding methods were advanced from one hour protocols routinely reported in the 
literature. The methods adopted here demonstrate RVFV is stable within a 37˚C blood meal 
during overnight feeding with minimal reduction in titre, 0.26 logs. Although this approach was 
Appendix 
202 
 
not successful for wild-caught populations of Culex, the percentage of blood feeding Aedes 
increased compared to previous reports (Mackenzie-Impoinvil et al., 2015). 
Evaluating two lines of the Cx. pipiens complex from the UK would not have been possible 
within the timeframe of this project without the use of colonised mosquitoes. However, their 
representativeness to natural populations is questionable due to adaptation to the laboratory 
environment and reduction of the genetic pool. Altered rates of RVFV vector competence have 
been reported in colonised species (Gargan et al., 1983; Meegan et al., 1980).There are 
however, advantages of the homologous population produced by colonisation including: 
reduction of confounding variables, predictable feeding rates and removal of seasonality. 
Further work is required to understand feeding preferences of wild species allowing comparison 
with colonised populations. 
 
A4.2 Results 
A4.2.1 Dose uniformity between experiments 
As the proposed viraemia range to challenge mosquitoes with was narrow (ranging by one 
log), confidence in the titre of infected blood meal and uniformity between experiments was 
paramount. Viral titres were calculated within the blood meal pre and post-feeding (18-22 hours 
later) as well as within the ingested blood meal in 4-20 engorged mosquitoes post-feed (day 0). 
Titres calculated by qRT-PCR (genome equivalent copies: GEC) and plaque assays (plaque 
forming units: PFU) demonstrate the uniformity of dose between experimental groups (Figure A 
4. 7). Mean titres of RVFV in the blood were 106.0 and 107.2 PFU/mL matching the predicted 
viraemia anticipated in infected livestock. On average viral titres decreased by 0.26-logs (range -
0.08: 0.48) during the overnight feeding period. The average log difference in viral titre in the 
mosquito on Day 0 compared to the blood meal was 2.85 GEC and 3.16 PFU, consistent with 
previous reports that mosquitoes ingest 1-10µL (Clements, 1992). There was no difference 
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between mosquito species for RNA titres but a significant difference between titres reported in 
PFU: ZH501 (GEC: p=0.6315, PFU: p=0.0277) and Lunyo (GEC: p=0.1466, PFU: p=0.0002). 
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Figure A 4. 7 Viral titres within the blood meal and ingested by mosquitoes. Dots represent median 
Rift Valley fever virus titres per mL of blood, quantified before and after feeding. Boxes represent 
the RVFV titres ingested by mosquitoes, with horizontal lines at the median and whiskers showing 
minimum and maximum values. Samples were stored at -80˚C. Genome equivalent copies (GEC) and 
infectious virus titres (PFU) were calculated by qRT-PCR and plaque assay. CBK: Cx. pipiens (Caldbeck 
colony); BKW: Cx. pipiens (Brookwood colony); Ae.d: Ae. detritus; Ae.r: Ae. rusticus. 
 
A4.2.2  Assessment of host endogenous controls 
To determine if sample collection and extraction steps from infected mosquitoes were 
successful, endogenous PCR controls were performed targeting host DNA: actin for the bodies 
and legs, and mitochondrial DNA for saliva. A control for saliva was introduced in the latter parts 
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of this project so results are reported for experiments performed at the higher dose only. Saliva 
was harvested by end-point collection using forced salivation (Aitken, 1977) from single 
specimens in parallel to legs and bodies, or by periodic collection of honey-filters from groups of 
10-15 mosquitoes housed together. The proportion of samples testing positive for host are 
presented in Table A 4. 4, negative samples were removed from the population number for 
calculating infection rates. In addition, positivity in all samples for the spiked MS2 internal 
control PCR indicated inhibition did not limit the ability to detect vRNA in these experiments. 
 
Table A 4. 4 Proportions of mosquito samples positive for host endogenous control. 
Mosquito species 
Endogenous control positive samples % (proportion positive) 
Bodies Legs Saliva Honey-filter 
Cx. pipiens (Caldbeck) 100 (91/91) 96 (87/89) 92 (44/48) 100 (65/65) 
Cx. pipiens (Brookwood) 100 (138/138) 96 (132/138) 92 (89/97) 100 (73/73) 
Ae. detritus 100 (118/118) 94 (111/118) 86 (36/42) 100 (35/35) 
Ae. rusticus 100 (27/27) 100 (27/27) 89 (24/27) 100 (23/23) 
 
A4.2.3 Comparison of colonised and wild-caught mosquito numbers and feeding rates 
Additional competence experiments were performed with wild-caught species listed in 
Methods Section 2.3.2. Cx. pipiens collected from three locations failed to take a blood meal. Cx. 
modestus and Ae. caspius were collected from sites with mixed populations. Although sample 
numbers were low, a single (1/5 tested) Cx. modestus had disseminated virus and a single (1/6) 
Ae. caspius had RVFV RNA in the saliva after ingesting 106 PFU/mL. Due to poor feeding rates or 
numbers when compared to the other populations highlighted by Figure A 4. 8, experiments 
were not repeated using the 107 PFU dose. 
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Figure A 4. 8 Mosquito blood feeding rates during vector competence studies. The numbers tested 
are written within parentheses (N) based on pooling all experiments, controls and strains. 
*predominant species in a mixed population. 
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A4.2.4  Infectious virus titres of RVFV within the mosquito host 
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Figure A 4. 9 Infectious virus titres of RVFV within the mosquito host. Data-points represent the 
infectious titre, in plaque forming units, in single positive mosquito samples. Samples were screened 
by qRT-PCR and positive samples titred by plaque assay. Samples were collected weekly for up to 21 
days after ingestion of infected blood. Time points and temperatures were pooled for analysis. Solid 
and hollow data-points represent mosquitoes ingesting 106 and 107 PFU/mL respectively, total 
numbers tested are written in parentheses (n). Dotted lines: assay limit of detection; solid lines: 
mean infectious titre of positive samples. n.s: not significant tested by Mann Whitney or Kruskal 
Wallis for multiple comparisons. The number of positive leg samples was too low to perform 
statistical comparison. CBK: Cx. pipiens (Caldbeck colony); BKW: Cx. pipiens (Brookwood colony); 
Ae.d: Ae. detritus; Ae.r: Ae. rusticus. 
 
A5 Inter and intra-host sequence variation of RVFV 
A5.1 Development and optimisation of an RVFV sequencing strategy 
RVFV RNA extracted from stocks described in Methods Section 2.1.2, was used as 
template to evaluate sequencing strategies. 
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A5.1.1 Metagenomic NGS method 
The metagenomic approach was used to generate sequence data to confirm RVFV strain 
identify at the onset of the project, as described previously (Lumley et al., 2016). RVFV was 
extracted following standard methods set out in Methods Section 2.2.3. Double stranded cDNA 
(ds cDNA) was generated using random hexamers and the cDNA Synthesis System (Roche) in 
accordance with the manufacturer’s instructions. Downstream sequencing protocols are 
described in Sections 5.2.3 and 5.2.4. 
 
A5.1.2 Amplicon NGS method 
RNA was reverse transcribed using the SS VILO cDNA synthesis kit (Thermo Fisher 
Scientific) a reaction comprised of water (14µL), 5x master mix (6µL) and template (10µL) was 
incubated at 42˚C for 1 hour, then amplified using four published primer sets (Weingartl et al., 
2014c) detailed in Table A5. 1, reaction composition in Table A5. 2 and cycling parameters in 
Table A5. 3. Amplicons were visualised by 1.5% agarose gel electrophoresis and purified by 
QIAquick PCR purification kit (Qiagen). Amplicons were pooled in a library comprised of a single 
amplicon for the complete S (1690bp) and M (3885bp) segments and two overlapping amplicons 
for the L segment (3449bp and 2923bp). The DNA concentration was confirmed using the 
Quant-iT dsDNA BR assay kit (broad range) (Thermo Fisher Scientific) on the Qubit 4 fluorometer 
(Thermo Fisher Scientific) and sequencing detailed in Section 5.2.3 and 5.2.4.  
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Table A5. 1 Amplicon sequencing oligonucleotides 
Assay Name Sequence 5’ – 3’ 
Amplicon 
size (bp) 
Region 
(accession#) 
S segment 
RVFS-Fwd ACACAAAGCTCCCTAGAGATAC 
1690 
1-1690 
(DQ380149) RVFS-Rev ACACAAAGACCCCCTAGTG 
M segment 
RVFM-Fwd ACACAAAGACGGTGC 
3885 
1-3885 
(DQ380200) RVFM-Rev ACACAAAGACCGGTGC 
L segment 1 
RVFL-L1Fwd ACACAAAGGCGCCCAATC 
3499 
1-3499 
(DQ375406) RVFL-L13482 Rev GGAAGCATATAGCTGCGG 
L segment 2 
RVFL-L22845Fwd GAGACAATAGCCAGGTC 
2923 
3482-6404 
(DQ375406) RVFL-L2Rev ACACAAAGACCGCCCAATATTG 
Sequences derived from (Bird et al., 2007) 
 
Table A5. 2 Amplicon PCR reaction mix composition 
Component Stock concentration Volume (µl) 
Water n/a 4.5 
2 x reaction mix* 2x 12.5 
Forward primer 10µM 1 
Reverse primer 10µM 1 
Enzyme* n/a 1 
cDNA Template n/a 5 
* Component of the SuperScript III One-Step RT-PCR kit (Thermo Fisher Scientific) 
 
Table A5. 3Amplicon PCR cycling parameters 
Step name Temperature (°C) Time (M:S) Cycles 
Reverse transcription 50 30:00 1 
Denature 94 02:00 1 
Amplify 94 00:15 
35 
56 00:30 
68 02:00 (S) 
04:00 (M&L) 
Extension 68 05:00 (S) 
10:00 (M&L) 
1 
Hold 4 ∞ 1 
M: minutes; S: seconds; letters in parentheses: genome segment which times apply to. Cycling 
parameters were performed as described by Bird et al. (2007). 
 
A5.1.3 Multiplexed amplicon NGS (primal scheme) method 
The reference sequences used to design the oligonucleotides are detailed in Table A5. 4 
and the oligonucleotides in Table A5. 5. 
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Table A5. 4 Reference accession numbers of sequences used to design primal scheme method 
Location Year 
S segment 
accession # 
M segment 
accession # 
L segment 
accession # 
Egypt 1977 DQ380149 DQ380200 DQ375406 
Madagascar 2008 JF311386 JF311377 JF311368 
Saudi Arabia 2000 DQ380170 DQ380197 DQ375401 
Central African Republic 1969 DQ380167 DQ380217 DQ375419 
Uganda 1955 KU167025 KU167026 KU167027 
South Africa 1951 DQ380158 DQ380195 DQ375433 
 
Table A5. 5 Primal scheme oligonucleotides 
Primer Name Sequence Pool Length Start End Amplicon 
RVFVS_1_LEFT ACACAAAGACCCCCTAGTGCTT A 22 0 22 
387 
RVFVS_1_RIGHT GGTTCTCCAAGAGGCCAGGATAT A 23 387 365 
RVFVS_2_LEFT CCACCAGCAAAGCCTTTTCAGA B 22 275 296 
410 
RVFVS_2_RIGHT GCAATGAGGGCTGAGTTTGGAA B 22 684 663 
RVFVS_3_LEFT_A ATCCTCAGAGGGATTGACCTGT A 23 544 566 
285 
RVFVS_3_RIGHT_A* TCAACCTCAACAAATCCATCA A 21 828 808 
RVFVS_4_LEFT_ D* TGACAGCAGCTGACGGCTTC B 20 950 969 
232 
RVFVS_4_RIGHT_D CCAGGAGACTATCTAAGGGCAA B 22 1181 1160 
RVFVS_5_LEFT CTCGGAGGTTTGGGTTGATGAC A 22 1097 1118 
411 
RVFVS_5_RIGHT ACTGGGAGAAGGATGCCAAGAA A 22 1507 1486 
RVFVS_6_LEFT GAAGCCACTCACTCAAGACGAC B 22 1274 1295 
417 
RVFVS_6_RIGHT_A ACACAAAGCTCCCTAGAGATAC B 22 1690 1669 
RVFVM_1_LEFT CACAAAGACGGTGCATTAAATGTATGT A 27 1692 1718 
418 
RVFVM_1_RIGHT CCTGCCATGGTTTCTCTCCCTA A 22 2108 2087 
RVFVM_2_LEFT GCCATGGTAAGAATCCTGAGGAC B 23 1982 2004 
410 
RVFVM_2_RIGHT AGGTGGATCAGCCTTTGCAATG B 22 2391 2370 
RVFVM_3_LEFT GCATGTAGCAGTTTTGATGTCTTGC A 25 2269 2293 
414 
RVFVM_3_RIGHT CACTTCGCAGACCCCTTTCATTT A 23 2682 2660 
RVFVM_4_LEFT GACAGATGACAGGTGCTAGCCT B 22 2564 2585 
394 
RVFVM_4_RIGHT TCCCCAGTGCACTTCTTACTACC B 23 2957 2935 
RVFVM_5_LEFT_A AGACTGAGGAGAATCTGCTACCAG A 24 2795 2818 
410 
RVFVM_5_RIGHT_A GAACCCTGTTGATCGGACAACC A 22 3204 3183 
RVFVM_6_LEFT ATCCAGAGAGTTGAGCCTTGCA B 22 3127 3148 
424 
RVFVM_6_RIGHT GGGCAATCTTTAAGCACTTGAGC B 23 3550 3528 
RVFVM_7_LEFT GGCCTGATAAATTACCAGTGTCACA A 25 3427 3451 
398 
RVFVM_7_RIGHT GAGCAAGTGGTGATTCTGGAGC A 22 3824 3803 
RVFVM_8_LEFT CCTATTCCTCGTCATGCCCCAA B 22 3703 3724 
389 
RVFVM_8_RIGHT TTGTCCCTCCAAGACAGACACC B 22 4091 4070 
RVFVM_9_LEFT AAGTGAGCTATCGTGCAGGGAG A 22 3963 3984 
409 
RVFVM_9_RIGHT TGAACCCCAGTTTGTGAAACGG A 22 4371 4350 
RVFVM_10_LEFT CGACTGGGTGCATAAACTCACTC B 23 4269 4291 
404 
RVFVM_10_RIGHT TGTCATTCCTTGTCTGTGGCAG B 22 4672 4651 
RVFVM_11_LEFT_A GGCACCAAACCTTATCTCATAC A 22 4557 4578 406 
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RVFVM_11_RIGHT_A CTGACACTGATCTTTTGTTCCAT A 23 4962 4940 
RVFVM_12_LEFT AGTCTGCCTGTCCATCACATCC B 22 4851 4872 
418 
RVFVM_12_RIGHT AGAGAGGCCTGTTCTTCCAAGA B 22 5268 5247 
RVFVM_13_LEFT CTCATGAGTTGGTTTGGAGGGC A 22 5155 5176 
420 
RVFVM_13_RIGHT CACAAAGACCGGTGCAACTTCA A 22 5574 5553 
RVFVL_1_LEFT TGGATTCTATATTATCAAAACAGCTGGTTG A 30 5595 5624 
417 
RVFVL_1_RIGHT CAGCCTGGAATGCACCTCTTTC A 22 6011 5990 
RVFVL_2_LEFT ACGGGTTTGATCATTTGAGCCC B 22 5901 5922 
375 
RVFVL_2_RIGHT TAGAGGAGACCATGGCTAGCAAC B 23 6275 6253 
RVFVL_3_LEFT TGCTCTTAGTGTGATGGATGAGCT A 24 6169 6192 
392 
RVFVL_3_RIGHT ACTTGTGGTCATTGAGGTCCCT A 22 6560 6539 
RVFVL_4_LEFT_A GCTGAAGGGAATGATAAGGCTCTG B 24 6437 6460 
381 
RVFVL_4_RIGHT_A TGAGCCCATATTTAGGTGGACTCT B 24 6817 6794 
RVFVL_5_LEFT CTGCAGAACTTGAGTTTGCCCT A 22 6729 6750 
417 
RVFVL_5_RIGHT TGACCATTTGGCACCATGAACC A 22 7145 7124 
RVFVL_6_LEFT TAGATTGGCAGCCCAGAGGATT B 22 7027 7048 
401 
RVFVL_6_RIGHT ATGAAACGCACTTGCAGAGGTT B 22 7427 7406 
RVFVL_7_LEFT TGGGCCTTTGATCTCTCCACTT A 22 7304 7325 
409 
RVFVL_7_RIGHT AGTAAACCTGCAGCTCTGACCT A 22 7712 7691 
RVFVL_8_LEFT TGCAAGATATATAATCATGGAGGGCTT B 27 7603 7629 
375 
RVFVL_8_RIGHT CCCAAGAAAGCATCTGACTGTGG B 23 7977 7955 
RVFVL_9_LEFT_B TCTCCACCACCGATTGAACAA A 23 7831 7853 
593 
RVFVL_9_RIGHT_B TCTCCACCACCGATTGAACAA A 21 8423 8403 
RVFVL_10_LEFT AAGGCCACAAGCAACTTCAATGA B 23 8156 8178 
403 
RVFVL_10_RIGHT ATGTTGCACAAGTCCACACAGG B 22 8558 8537 
RVFVL_11_LEFT TTCTGATACCCTCTGTAACCCCC A 23 8455 8477 
397 
RVFVL_11_RIGHT CTGCATCATCCCTGTTGTGGTT A 22 8851 8830 
RVFVL_12_LEFT TCGGGAGCTTGACATTAGAGATGA B 24 8728 8751 
376 
RVFVL_12_RIGHT AAGGTACACTCCCAGCTCCTTC B 22 9103 9082 
RVFVL_13_LEFT GCAAGGATCAGATGATAGTAGCATGC A 26 8980 9005 
407 
RVFVL_13_RIGHT ATAGCTCAGACACTCCCATGCC A 22 9386 9365 
RVFVL_14_LEFT AGGCCTCTAACCTAATGACTTCAGT B 25 9264 9288 
377 
RVFVL_14_RIGHT AAGAATTAGAGCGCCACCTGGG B 22 9640 9619 
RVFVL_15_LEFT TCATGAAGAAGGTCAAGGGCTCA A 23 9540 9562 
382 
RVFVL_15_RIGHT TTGAACTCAGGACGTCCAGTGT A 22 9921 9900 
RVFVL_16_LEFT TAGCCCAGGTGTTGTGTCATCA B 22 9805 9826 
394 
RVFVL_16_RIGHT CCCAAACCACTTGTCTGACACC B 22 10198 10177 
RVFVL_17_LEFT AGTCAACATCAGGGATGCAACC A 22 10096 10117 
398 
RVFVL_17_RIGHT GAGTGAAGCCAGCAAGGTCTTC A 22 10493 10472 
RVFVL_18_LEFT GGAGCCCCTGTAAAGAAGAGGT B 22 10382 10403 
422 
RVFVL_18_RIGHT AAGCCTCTCCAGATCCCAACTC B 22 10803 10782 
RVFVL_19_LEFT ATTGAAGAGATGGGAGCCGGAA A 22 10697 10718 
420 
RVFVL_19_RIGHT CCGCACTTTCATCTCCACCTCT A 22 11116 11095 
RVFVL_20_LEFT AGGACCTAGCAAGCCATTTGGA B 22 11017 11038 376 
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RVFVL_20_RIGHT CACAATCTCTGAAAGTCTGGTTCTGT B 26 11392 11367 
RVFVL_21_LEFT AGATGCGAGTCTGTAGCTCCAA A 22 11288 11309 
425 
RVFVL_21_RIGHT GCTCTCCCCATCTTAGAAATAGCAT A 25 11712 11688 
RVFVL_22_LEFT ATGTCAATCTCTTTGGGCCAGC B 22 11601 11622 
376 
RVFVL_22_RIGHT CAAAGACCGCCCAATATTGTAGCA B 24 11976 11953 
Primer start and end locations are relative to concatenated reference sequence for the entire 
11,797bp genome of RVFV strain ZH501 (Accession numbers: DQ380149; DQ380200; DQ375406 for 
the S, M, and L segments respectively). Primer names written in bold typeface represent manually 
redesigned oligonucleotides. *:overlapping amplicon could not be generated for the region 
encompassing the intergenic region of the S segment, instead primers flanking this region were 
designed. 
 
A5.1.4  Results of NGS strategy optimisation 
Generation of sequence data from the metagenomic approach was attained from cell 
culture material containing high viral yields (ZH501 6.97 log10 PFU/mL and 9.94 log10 GEC/mL). 
However, the requirement of a more sensitive approach was necessary for lower abundance of 
viral RNA within the in vivo infected mosquito samples. The mapping statistics for each 
approach is summarised in Table A5. 6. 
 
Table A5. 6 Coverage statistics comparing the different NGS approaches 
Method 
Total reads 
(Log10) 
Viral reads 
(%) 
Genome 
coverage (%) 
Average depth/ 
nucleotide 
Max depth/ 
nucleotide 
Metagenomic 6.20 2.4 99.9 351 833 
Amplicon 5.82 83.3 100 6,223 61,635 
Multiplexed amplicon 
Raw format 
 
5.59 95.1 98.6 4,029 11,154 
Redesigned published 
parameters 
 
7.12 93.3 99.4 102,256 352,133 
 Redesigned optimised 
parameters 
 
7.50 98.5 99.7 273,898 1,012,977 
Statistics based on sequencing RVFV strain ZH501 propagated in Vero E6 cells. No changes to 
consensus sequence were recorded. Metagenomic approach replicate methods described by 
Marston et al. (2013), amplicon utilises 4 primer sets described by Bird et al.(2007), and multiplexed 
amplicon applies method described by Quick et al. (2017) using 41 novel primer pairs. 
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The amplicon approach increased the depth of viral yields by an order of magnitude of 1.2 
and the short 400 nucleotide overlapping multiplexed amplicon approach further increased 
sensitivity by 1.6 logs. Optimisation of the multiplexed method increased the yielded read depth 
by 1.8 logs (1.4 log increase attributed to redesigning oligonucleotides and 0.4 logs by 
optimising the reaction conditions) coupled with an increase in genome coverage, 
demonstrating the benefit of optimising for the intended downstream use for evaluating sub-
consensus variation. 
Despite multiple rounds of primer redesigns, two regions yielded low coverage in by the 
multiplexed method: a region within the RdRp and intergenic region of the S segment. Non-
overlapping primers were designed for the intergenic region to reduce coverage loss due to 
secondary structures limiting primer binding and amplification. Relatively uniform distribution of 
coverage across the genome was, however, attained by the multiplex amplicon and 
metagenomic approaches by comparison to the amplicon protocol (Figure A 5. 1; Panel A and 
for reference the coverage prior to optimisation of the multiplexed amplicon method is 
presented in Figure A 5. 1; Panel B).  
The multiplexed amplicon method was selected for use providing ample depth across the 
genome to evaluate genetic diversity in the consensus and sub-consensus sequence within and 
between host environments. 
Additionally the multiplexed amplicon approach was trialled with a single mosquito 
infected with strain Lunyo resulting in 99.4% coverage and an average depth of 10,818 reads per 
nucleotide, demonstrating the robustness of primers primarily designed to amplify strain ZH501. 
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Figure A 5. 1 Depth of sequence obtained by three NGS methods. A. Comparison of sequence 
coverage attained by metagenomic, amplicon and optimised multiplexed amplicon (primal scheme) 
methods. B. Comparison of coverage attained by the multiplexed-amplicon (primal scheme) method 
before and after to optimisation and primer redesign. The nucleotide position is presented relative 
to concatenated reference sequence for the entire 11,797bp genome of RVFV strain ZH501 
(Accessions: DQ380149; DQ380200; DQ375406), with a dotted line to separate the segments. A 
broken axis was used to visualise difference between metagenomic and amplicon methods. 
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A5.2 Supplementary methods 
 
Figure A 5. 2 NGS analysis pipeline developed in Galaxy (http://usegalaxy.org) facilitating the use 
and manipulation of bioinformatics tools utilising a web browser without the need for informatics 
expertise. Tools include Trimmomatic (Bolger et al., 2014); BWA (Li and Durbin, 2010); and SAMtools 
(Li et al., 2009). 
 
A5.3 Results 
A summary of positive mosquito samples attained in competency studies that were 
selected for sequence analysis are presented in Table A5. 7. Samples in the first instance were 
amplified by the two multiplexed amplicon RT-PCRs and amplicons were visualised by gel 
electrophoresis. Samples failing to produce or producing weak amplicons were not sequenced, 
Figure A 5. 3 shows a representative gel image of this analysis  
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Table A5. 7 Sensitivity of multiplexed amplicon (primal scheme) NGS method 
Species Sample 
Log10 GEC/ 
mosquito 
Log10 GEC/ 
sequencing reaction 
NGS 
amplicon 
Average 
read depth 
Cx. pipiens (Brookwood) Saliva 1.76 0.13 Neg  
Ae. detritus Legs 2.04 0.41 Neg  
Cx. pipiens (Caldbeck) Saliva 2.07 0.44 Neg  
Ae. detritus Legs 2.41 0.78 Neg  
Cx. pipiens (Caldbeck) Saliva 2.50 0.86 Neg  
Ae. detritus Legs 2.64 1.00 Neg  
Cx. pipiens (Caldbeck) Saliva 2.84 1.21 Neg  
Cx. pipiens (Brookwood) Saliva 2.86 1.23 Neg  
Ae. detritus Legs 2.87 1.24 Neg  
Cx. pipiens (Caldbeck) Legs 3.05 1.41 Neg  
Cx. pipiens (Caldbeck)* legs 3.14 1.51 Neg  
Cx. pipiens (Caldbeck)* legs 3.15 1.52 Neg  
Cx. pipiens (Caldbeck) Legs 3.37 1.74 Neg  
Cx. pipiens (Caldbeck)* legs 3.40 1.77 Neg  
Cx. pipiens (Caldbeck)* legs 3.54 1.91 Neg  
Ae. detritus Legs 3.58 1.95 Neg  
Ae. detritus Legs 3.58 1.95 Neg  
Cx. pipiens (Caldbeck) Legs 3.61 1.98 Neg  
Cx. pipiens (Caldbeck) Legs 3.66 2.03 Neg  
Cx. pipiens (Caldbeck) Legs 3.78 2.14 Neg  
Ae. detritus Body 3.81 2.18 Neg  
Cx. pipiens (Brookwood) Saliva 3.83 2.20 Neg  
Cx. pipiens (Caldbeck) Legs 4.05 2.42 Neg  
Ae. detritus Legs 4.12 2.48 Neg  
Cx. pipiens (Brookwood) Saliva 4.12 2.49 Neg  
Cx. pipiens (Caldbeck) Legs 4.12 2.49 Neg  
Cx. pipiens (Brookwood) Body 4.26 2.62 Neg  
Ae. detritus Legs 4.41 2.78 Neg  
Cx. pipiens (Brookwood) Legs 4.46 2.83 Neg  
Cx. pipiens (Caldbeck)* Body 4.62 2.99 Neg  
Cx. pipiens (Brookwood) Body 4.76 3.13 Neg  
Cx. pipiens (Brookwood) Legs 4.81 3.17 Neg  
Cx. pipiens (Brookwood) Body 4.95 3.32 Neg  
Cx. pipiens (Brookwood) Legs 5.02 3.39 Neg  
Ae. detritus Body 5.10 3.47 Neg  
Ae. detritus Body 5.25 3.62 Neg  
Ae. detritus Body 5.29 3.66 Wk  
Cx. pipiens (Caldbeck)* Body 5.61 3.98 Neg  
Cx. pipiens (Brookwood) Body 5.65 4.02 Neg  
Ae. detritus Body 5.69 4.06 Neg  
Cx. pipiens (Caldbeck) Body 5.72 4.08 Neg  
Ae. detritus Body 5.85 4.22 Neg  
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Cx. pipiens (Brookwood) Legs 5.94 4.31 Neg  
Ae. detritus Body 6.20 4.57 Neg  
Ae. detritus Body 6.39 4.76 Neg  
Cx. pipiens (Caldbeck)* Body 6.56 4.93 Pos  
Cx. pipiens (Caldbeck) Body 7.03 5.40 Wk  
Cx. pipiens (Caldbeck) Body 7.11 5.48 Pos  
Cx. pipiens (Caldbeck) Body 7.36 5.73 Pos  
Cx. pipiens (Caldbeck) Body 7.68 6.05 Pos  
Cx. pipiens (Caldbeck) Body 7.72 6.09 Pos  
Cx. pipiens (Caldbeck) Body 7.85 6.22 Pos  
Cx. pipiens (Caldbeck) Body 8.08 6.45 Pos  
Cx. pipiens (Brookwood) Legs 8.16 6.53 Pos  
Cx. pipiens (Brookwood) Legs 8.30 6.66 Pos  
Cx. pipiens (Brookwood) Legs 8.45 6.82 Pos  
Cx. pipiens (Brookwood) Legs 8.68 7.05 Pos  
Cx. pipiens (Caldbeck)* Body 8.78 7.15 Pos  
Cx. pipiens (Brookwood) Body 9.34 7.71 Pos  
Cx. pipiens (Brookwood) Body 9.49 7.86 Pos  
Cx. pipiens (Brookwood) Body 9.51 7.88 Pos  
Cx. pipiens (Brookwood) Body 9.54 7.90 Pos  
 
 
 
Figure A 5. 3 Representative gel electrophoresis image of multiplexed amplicon RT-PCR. A series of 
nested amplicons around 400 nucleotides in length spanning the genome, were generated by RT-
PCR of RVFV strain ZH501 utilising 41 primer pairs multiplexed in two pools (A and B). Amplicons 
were visualised on a 2% agarose gel using SYBR safe (Thermo Fisher Scientific) and a 100bp ladder on 
the left (promega). Lanes labelled with odd numbers are from primer pool A and even numbers 
primer pool B. Amplicons from lanes 1-8 would be sequenced lane 9 and 10 would not be sequenced 
due to low quantity. 
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Figure A 5. 4 Read depth of sequence coverage across genome of individual samples. RVFV 
propagated in vitro and in vivo was sequenced by a multiplexed amplicon NGS method, the resultant 
read depth across the genome after quality, length and duplicate filtering is presented. The 
nucleotide position is presented relative to concatenated S, M and L segment sequence for the 
entire 11,797bp genome of RVFV strain ZH501, with a dotted line to separate the segments. Sample 
numbers 4-10: Cx. pipiens Caldbeck bodies; 11-14: Cx. pipiens Brookwood legs; 16-19 Cx. pipiens 
Brookwood bodies; 20-23: BalbC mouse liver; 24-28: C6/36 cells; 29, 30, 33 and 36: Vero E6 cells. 
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Table A5. 8 Proportion of consensus nucleotide substitutions  
Sample 
cohort 
Region 
No. of 
substitutions 
Nucleotides 
sequenced 
Log10 
proportion 
Cx. pipiens 
Caldbeck 
(n=6) 
NSs 1 4,715 -3.67 
N 1 4,186 -3.62 
GP 6 21,162 -3.55 
L 8 33,514 -3.62 
All 16 65,863 -3.61 
     Cx. pipiens 
Brookwood 
(n=4) 
NSs 0 3,148  
N 0 2,783  
GP 8 14,339 -3.25 
L 8 25,036 -3.50 
All 16 46,938 -3.47 
     
Mouse 
(n=4) 
NSs 1 4,722 -3.67 
N 0 4,172 
 GP 3 19,330 -3.81 
L 0 36,650 
 All 4 67,060 -4.22 
     
C6/36 
(n=5) 
NSs 0 3,906  
N 0 3,484  
GP 0 16,712  
L 0 30,336  
All 0 56,004  
Vero E6 
(n=4) 
NSs 0   
N 0   
GP 0   
L 0   
All 0   
The cumulative number of consensus nucleotide substitutions across all samples within a cohort 
were dived by the cumulative number of nucleotide coverage per region and complete genome, the 
proportions were compared by Chi-square test in GraphPad prism as performed previously (Ebel et 
al., 2004). 
 
Appendix 
219 
 
H-index
S
h
a
n
n
o
n
 E
n
tr
o
p
y
0 1000 2000 3000 4000
0
50
100
150
200
250
Variant count (VCF)
V
a
ri
a
n
t 
fr
e
q
u
e
n
c
y
 (
V
iV
a
n
)
0 500 1000 1500 2000 2500
0
10
20
30
40
50
p=<0.0001
R
2
=0.5237
p=<0.0001
R
2
=0.8998
A.
B.
 
Figure A 5. 5 Correlation between in-house and published measured of genetic diversity. Genetic 
diversity in deep sequence data from RVFV propagated in vitro and in vivo mosquito and mammalian 
hosts was evaluated by in-house and published methods (Isakov et al., 2015). Comparison between 
A. the two methods of sequence complexity and B. rates of variants in the population. Pearson’s 
correlation coefficients (r) and significance were calculated in GraphPad Prism, the solid line 
represents the linear regression. Samples highlighted with the red circle in panel A are the Cx. 
pipiens Caldbeck line. 
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Figure A 5. 6 Discrepant measures of genetic complexity in mosquito host. Genetic diversity in deep 
sequence data from RVFV propagated in vitro and in vivo mosquito and mammalian hosts was 
evaluated by in-house and published methods (Isakov et al., 2015). Results yielded the same 
outcome except for within the Cx. pipiens Caldbeck sample cohort. The discrepant results are 
compared by compared side by side in comparison to Brookwood for context for A. In-house H-
index; B. Published Shannon entropy. 
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Figure A 5. 7 The effect of viral sequence reads and titres on diversity indices. A and B: Shannon 
entropy as measure of sequence complexity was plotted as a function of viral sequence read and 
viral titre respectively. C and D: Variant frequency was plotted as a function of viral sequence read 
and viral titre respectively. Showing that the diversity measures correlated with viral tire but were 
not skewed by correlation with sequence reads. Pearson’s correlation coefficients (r) and 
significance were calculated in GraphPad Prism, the solid line represents the linear regression. 
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Figure A 5. 8 Genome location of common variants occurring within sample cohorts. Common 
variants were detected within all samples within cohorts A. Cx. pipiens Caldbeck bodies; B. Cx. 
pipiens Brookwood bodies; C. Cx. pipiens Brookwood legs; D. BalbC mouse liver; E. C6/36 cells; F. 
Vero E6 cells. The average variant frequency within each cohort is plotted along each position in the 
genome. Variants present in a population but absent from the Vero E6 culture (at positions with 
>100 depth) are highlighted by a red dot. 
